# ::snt Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model .
# ::tok Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model .
# ::alignments 15-16|0.1.1 14-15|0.1.1.0 13-14|0.3 12-13|0.1.1.1 10-11|0.2 9-10|0.1 8-9|0 7-8|0.0.1 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:05.818
(a / and 
      :op1 (a2 / abolish-01 
            :ARG0 (e / express-01 
                  :ARG0 (p3 / protein) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10"))) 
            :ARG1 (p2 / potential)) 
      :op2 (c / cause-01 
            :ARG0 (l / los) 
            :ARG1 (m / model 
                  :mod (m2 / mouse) 
                  :mod (p / pendr))) 
      :op3 (d / deafnes) 
      :poss (s / syndrome))

# ::snt Pendred syndrome , a common autosomal-recessive disorder characterized by congenital deafness and goiter , is caused by mutations of SLC26A4 , which codes for pendrin .
# ::tok Pendred syndrome , a common autosomal-recessive disorder characterized by congenital deafness and goiter , is caused by mutations of SLC26A4 , which codes for pendrin .
# ::alignments 24-25|0.0.0.0.0 22-23|0.0.0.0 19-20|0.0.0.1.0+0.0.0.1+0.0.0 17-18|0.0 15-16|0 12-13|0.1.1.0.0.1 11-12|0.1.1.0.0 10-11|0.1.1.0.0.0 9-10|0.1.1.0.0.0.0 7-8|0.1.1.0 6-7|0.1.1 4-5|0.1.1.1 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:06.898
(c3 / cause-01 
      :ARG0 (m / mutate-01 
            :ARG1 (c2 / country 
                  :mod-of (c / code 
                        :purpose (p / pendrin)) 
                  :name (n / name 
                        :op1 "SLC26A4"))) 
      :ARG1 (s / syndrome 
            :mod (p2 / pendr) 
            :mod (d2 / disord 
                  :ARG1-of (c5 / characterize-01 
                        :ARG0 (a / and 
                              :op1 (d / deafnes 
                                    :mod (c4 / congenital)) 
                              :op2 (g / goit))) 
                  :mod (c6 / common))))

# ::snt We investigated the relationship between pendrin and deafness using mice that have ( Slc26a4 + / + ) or lack a complete Slc26a4 gene ( Slc26a4 - / - ) .
# ::tok We investigated the relationship between pendrin and deafness using mice that have ( Slc26a4 + / + ) or lack a complete Slc26a4 gene ( Slc26a4 - / - ) .
# ::alignments 27-28|0.1.1 23-24|0.1.0.0.0 21-22|0.1.0.0.0.0 19-20|0.1.0.0.2 18-19|0.1.0.0 15-16|0.0.0.0 9-10|0.1.0.0.1 8-9|0.1.0 6-7|0.1 5-6|0.1.0.0.2.0 3-4|0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:08.236
(i / investigate-01 
      :ARG0 (w / we 
            :ARG0-of (r / relation-03 
                  :ARG1 (s2 / slash))) 
      :op1-of (a / and 
            :op2 (u / use-01 
                  :ARG1 (o / or 
                        :domain (g / gene 
                              :ARG1-of (c / complete-02)) 
                        :op1 (m / mouse) 
                        :op2 (l / lack-01 
                              :ARG1 (p / pendrin)))) 
            :op3 (s / slash)))

# ::snt Expression of pendrin and other proteins was determined by confocal immunocytochemistry .
# ::tok Expression of pendrin and other proteins was determined by confocal immunocytochemistry .
# ::alignments 10-11|0.0 9-10|0.0.0 7-8|0 5-6|0.1.2 4-5|0.1.2.0 3-4|0.1 2-3|0.1.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:08.379
(d / determined-02 
      :ARG0 (i / immunocytochemistry 
            :mod (c / confocal)) 
      :ARG1 (a / and 
            :op1 (e / expression) 
            :op2 (p2 / pendrin) 
            :op3 (p / protein 
                  :mod (o / other))))

# ::snt Expression of mRNA was determined by quantitative RT-PCR .
# ::tok Expression of mRNA was determined by quantitative RT-PCR .
# ::alignments 6-7|0.2 4-5|0 2-3|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:08.449
(d / determined-02 
      :ARG0 (e / expression) 
      :ARG1 (m / mrna) 
      :ARG2 (q / quantitative))

# ::snt The endocochlear potential and the endolymphatic K + concentration were measured with double-barreled microelectrodes .
# ::tok The endocochlear potential and the endolymphatic K + concentration were measured with double-barreled microelectrodes .
# ::alignments 13-14|0.0 12-13|0.0.0 10-11|0 8-9|0.1.1 5-7|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:08.924
(m2 / measure-01 
      :ARG0 (m / microelectrod 
            :mod (d / double-barrel)) 
      :ARG1 (a / and 
            :op1 (p / potential) 
            :op2 (c / concentrate-02 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (e / endolymphatic) 
                              :op2 (k / K))))))

# ::snt Currents generated by the stria marginal cells were recorded with a vibrating probe .
# ::tok Currents generated by the stria marginal cells were recorded with a vibrating probe .
# ::alignments 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 8-9|0 6-7|0.0.0.0 5-6|0.0.0.0.1 4-5|0.0.0.0.2 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:09.097
(r / record-01 
      :ARG1 (c2 / current 
            :ARG1-of (g / generate-01 
                  :ARG0 (c / cell 
                        :ARG0-of (p / probe-01 
                              :ARG1-of (v / vibrate-01)) 
                        :mod (m / marginal) 
                        :mod (s / stria)))))

# ::snt Tissue masses were evaluated by morphometric distance measurements and pigmentation was quantified by densitometry .
# ::tok Tissue masses were evaluated by morphometric distance measurements and pigmentation was quantified by densitometry .
# ::alignments 13-14|0.1.0 11-12|0.1 9-10|0.1.1 8-9|0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:09.256
(a / and 
      :op1 (e / evaluate-01 
            :ARG0 (m / measure-01 
                  :ARG1 (d2 / distance-01 
                        :ARG1 (m2 / morphometric))) 
            :ARG1 (m3 / mass 
                  :mod (t / tissue))) 
      :op2 (q / quantify-01 
            :ARG0 (d / densitometry) 
            :ARG1 (p / pigmentation)))

# ::snt Pendrin was found in the cochlea in apical membranes of spiral prominence cells and spindle-shaped cells of stria vascularis , in outer sulcus and root cells .
# ::tok Pendrin was found in the cochlea in apical membranes of spiral prominence cells and spindle-shaped cells of stria vascularis , in outer sulcus and root cells .
# ::alignments 25-26|0.1 24-25|0.1.0 23-24|0 22-23|0.0 21-22|0.0.0 18-19|0.2.2.1 17-18|0.2.2.1.0 15-16|0.2.2 14-15|0.2.2.0 13-14|0.2 12-13|0.2.1 11-12|0.2.1.2 10-11|0.2.1.0 8-9|0.2.1.1 7-8|0.2.1.1.0 5-6|0.2.0.1 2-3|0.2.0 0-1|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:09.465
(a / and 
      :op1 (s / sulcu 
            :mod (o / outer)) 
      :op2 (c / cell 
            :mod (r / root)) 
      :op3-of (a2 / and 
            :ARG0-of (f / find-01 
                  :ARG1 (p2 / person 
                        :name (n / name 
                              :op1 "Pendrin")) 
                  :location (c4 / cochlea)) 
            :op1 (c3 / cell 
                  :ARG1-of (s4 / spiral-01) 
                  :domain-of (m / membran 
                        :mod (a3 / apical)) 
                  :mod (p / prominence)) 
            :op2 (c2 / cell 
                  :mod (s3 / spindle-shap) 
                  :part-of (v / vasculari 
                        :mod (s2 / stria)))))

# ::snt Endolymph volume in Slc26a4 - / - mice was increased and tissue masses in areas normally occupied by type I and II fibrocytes were reduced .
# ::tok Endolymph volume in Slc26a4 - / - mice was increased and tissue masses in areas normally occupied by type I and II fibrocytes were reduced .
# ::alignments 24-25|0.2.1 22-23|0.2.1.1 21-22|0.2.1.1.0.1+0.2.1.1.0.0.2+0.2.1.1.0.0.1+0.2.1.1.0.0.0+0.2.1.1.0.0+0.2.1.1.0 20-21|0.2 19-20|0.2.1.2 18-19|0.2.0.0 16-17|0.2.0 15-16|0.2.0.2 14-15|0.2.1.0.0 12-13|0.2.1.0 11-12|0.2.1.0.1 10-11|0 9-10|0.1 7-8|0.0 5-6|0.2.0.2.0 1-2|0.2.0.1 0-1|0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:10.450
(a3 / and 
      :op1 (m2 / mouse) 
      :op2 (i2 / increase-01) 
      :op3 (a / and 
            :op1 (o / occupy-01 
                  :ARG0 (t / type) 
                  :ARG1 (v / volume 
                        :mod (e / endolymph)) 
                  :ARG1-of (n2 / normal-02 
                        :ARG0 (s / slash))) 
            :op2 (r / reduce-01 
                  :ARG0 (m / mass 
                        :location (a2 / area) 
                        :mod (t2 / tissue)) 
                  :ARG1 (f / fibrocyt 
                        :mod (w / war 
                              :name (n / name 
                                    :op1 "World" 
                                    :op2 "War" 
                                    :op3 "II") 
                              :wiki "World_War_II")) 
                  :ARG2 (i / i))))

# ::snt Slc26a4 - / - mice lacked the endocochlear potential , which is generated across the basal cell barrier by the K + channel KCNJ10 localized in intermediate cells .
# ::tok Slc26a4 - / - mice lacked the endocochlear potential , which is generated across the basal cell barrier by the K + channel KCNJ10 localized in intermediate cells .
# ::alignments 27-28|0.0 26-27|0 24-25|0.0.0 23-24|0.0.0.1.1.0+0.0.0.1.1+0.0.0.1 22-23|0.0.0.1.0.1.2 20-21|0.0.0.0 17-18|0.0.0.1.0.1 16-17|0.0.0.1.0.1.0 15-16|0.0.0.1.0.1.1 13-14|0.0.0.1.0.2 12-13|0.0.0.1.0 8-9|0.0.0.1.0.0 7-8|0.0.0.1.0.0.1 5-6|0.0.0.1.0.0.0 4-5|0.0.0.1.0.0.0.0 2-3|0.0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:11.300
(i / intermediate 
      :mod-of (c / cell 
            :beneficiary-of (l / localize-01 
                  :ARG0 (k / k) 
                  :ARG1 (t / thing 
                        :ARG0-of (g / generate-01 
                              :ARG1 (p / potential 
                                    :ARG1-of (l2 / lack-01 
                                          :ARG0 (m / mouse)) 
                                    :mod (e / endocochlear)) 
                              :ARG2 (b / barrier 
                                    :mod (c3 / cell) 
                                    :mod (b2 / basal) 
                                    :mod-of (c2 / channel)) 
                              :location (a / across)) 
                        :name (n / name 
                              :op1 "KCNJ10") 
                        :op1-of (s / slash)))))

# ::snt Stria vascularis was hyperpigmented , suggesting unalleviated free radical damage .
# ::tok Stria vascularis was hyperpigmented , suggesting unalleviated free radical damage .
# ::alignments 9-10|0.1 8-9|0.1.1 7-8|0.1.0 6-7|0.1.2 5-6|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:11.390
(s / suggest-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (s2 / Stria) 
                  :op2 (v / vascularis))) 
      :ARG1 (d / damage-01 
            :ARG1-of (f / free-04) 
            :mod (r / radical) 
            :mod (u / unalleviat)))

# ::snt The basal cell barrier appeared intact ; intermediate cells and KCNJ10 mRNA were present but KCNJ10 protein was absent .
# ::tok The basal cell barrier appeared intact ; intermediate cells and KCNJ10 mRNA were present but KCNJ10 protein was absent .
# ::alignments 18-19|0.0.0.0.0 16-17|0.0.0.0.0.0 14-15|0 13-14|0.0 11-12|0.0.0.1.0 10-11|0.0.0.1.1.0+0.0.0.1.1+0.0.0.1 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.0.1 6-7|0.0.0.0.2 5-6|0.0.0.0.2.0.1 4-5|0.0.0.0.2.0 3-4|0.0.0.0.2.0.0 2-3|0.0.0.0.2.0.0.0 1-2|0.0.0.0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:11.839
(c / contrast-01 
      :ARG1 (p2 / present 
            :domain (a2 / and 
                  :op1 (c2 / cell 
                        :ARG0-of (a / absent-01 
                              :ARG1 (p / protein)) 
                        :mod (i / intermediate) 
                        :poss (a3 / and 
                              :op1 (a4 / appear-01 
                                    :ARG1 (b / barrier 
                                          :mod (c3 / cell 
                                                :mod (b2 / basal))) 
                                    :ARG2 (i2 / intact)))) 
                  :op2 (t / thing 
                        :mod-of (m / mrna) 
                        :name (n / name 
                              :op1 "KCNJ10")))))

# ::snt Endolymphatic K + concentrations were normal and membrane proteins necessary for K + secretion were present , including the K + channel KCNQ1 and KCNE1 , Na + / 2Cl - / K + cotransporter SLC12A2 and the gap junction GJB2 .
# ::tok Endolymphatic K + concentrations were normal and membrane proteins necessary for K + secretion were present , including the K + channel KCNQ1 and KCNE1 , Na + / 2Cl - / K + cotransporter SLC12A2 and the gap junction GJB2 .
# ::alignments 40-41|0.0.0.0.1.1.0.2.1.0+0.0.0.0.1.1.0.2.1+0.0.0.0.1.1.0.2 39-40|0.0.0.0.1.1.0.2.0 38-39|0.0.0.0.1.1.0.2.0.0 36-37|0.0.0.0.1.1.0 34-36|0.0.0.0.1.1.0.1.0.1+0.0.0.0.1.1.0.1.0.0+0.0.0.0.1.1.0.1.0+0.0.0.0.1.1.0.1 31-32|0.0.0.0.1.1 28-29|0.0.0.0.0 26-27|0.0.0.0.1.1.0.0.1.0 23-24|0.0.0.0.1.1.0.0.1 22-23|0.0.0.0.1.1.0.0 21-22|0.0.0.0.1.1.0.0.0 15-16|0.0 13-14|0.0.0.1 8-9|0 7-8|0.1 6-7|0.0.0.0.2 5-6|0.0.0.0 3-4|0.0.0 0-2|0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:12.888
(p2 / protein 
      :domain-of (p / present 
            :domain (c4 / concentration 
                  :ARG1-of (n4 / normal-02 
                        :ARG0 (s3 / slash) 
                        :ARG2 (t2 / thing 
                              :name (n5 / name 
                                    :op1 (e / Endolymphatic) 
                                    :op2 (k2 / K)) 
                              :op1-of (s2 / slash 
                                    :op2-of (a / and 
                                          :op1 (k / KCNQ1 
                                                :mod (c3 / channel) 
                                                :op1-of (a2 / and 
                                                      :op2 (n3 / na))) 
                                          :op3 (t / thing 
                                                :name (n2 / name 
                                                      :op1 (c2 / cotransporter) 
                                                      :op2 (s / SLC12A2))) 
                                          :op4 (c / country 
                                                :mod (j / junction 
                                                      :mod (g / gap)) 
                                                :name (n / name 
                                                      :op1 "GJB2"))))) 
                        :op1-of (a3 / and)) 
                  :mod-of (s4 / secretion))) 
      :mod (m / membrane))

# ::snt These observations demonstrate that pendrin dysfunction leads to a loss of KCNJ10 protein expression and a loss of the endocochlear potential , which may be the direct cause of deafness in Pendred syndrome .
# ::tok These observations demonstrate that pendrin dysfunction leads to a loss of KCNJ10 protein expression and a loss of the endocochlear potential , which may be the direct cause of deafness in Pendred syndrome .
# ::alignments 32-33|0.4 31-32|0.4.0 29-30|0.1 27-28|0 26-27|0.2 23-24|0.3 20-21|0.0.2.1.0 19-20|0.0.2.1 14-15|0.0 13-14|0.0.2 12-13|0.0.2.0 11-12|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 9-10|0.0.1 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:13.654
(c / cause-01 
      :ARG0 (a / and 
            :ARG1-of (l2 / lead-03 
                  :ARG0 (d3 / dysfunction 
                        :mod (p5 / pendrin)) 
                  :ARG1-of (d4 / demonstrate-01 
                        :ARG0 (o / observation 
                              :mod (t2 / this))) 
                  :ARG2 (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10"))) 
            :op1 (l / loss) 
            :op2 (e2 / express-01 
                  :ARG1 (p4 / protein) 
                  :ARG2 (e / endocochlear 
                        :mod-of (p3 / potential)))) 
      :ARG1 (d / deafnes) 
      :ARG1-of (d2 / direct-02) 
      :ARG1-of (p2 / possible-01) 
      :ARG2 (s / syndrome 
            :mod (p / pendr)))

# ::snt Pendred syndrome is a relatively common autosomal-recessive disorder characterized by deafness and goiter [ 1 ] .
# ::tok Pendred syndrome is a relatively common autosomal-recessive disorder characterized by deafness and goiter [ 1 ] .
# ::alignments 14-15|0.0.1.1.0.0 12-13|0 11-12|0.0.1.0.0 10-11|0.0.1.0.0.0 8-9|0.0.1.0 7-8|0.0.1 5-6|0.0 4-5|0.0.0 1-2|0.0.1.1 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:14.117
(g / goit 
      :location (c2 / common 
            :degree (r / relative) 
            :mod-of (d2 / disord 
                  :ARG1-of (c / characterize-01 
                        :ARG0 (a / and 
                              :op1 (d / deafnes))) 
                  :domain (s / syndrome 
                        :mod (p / pendr 
                              :mod-of 1)))))

# ::snt The syndrome is caused by mutations of the PDS gene SLC26A4 , which codes for the protein pendrin [ 2 ] .
# ::tok The syndrome is caused by mutations of the PDS gene SLC26A4 , which codes for the protein pendrin [ 2 ] .
# ::alignments 19-20|0.0.2 17-18|0.3 16-17|0.3.0 13-14|0.2 10-11|0.0.0.1.0+0.0.0.1+0.0.0 9-10|0.0.0.0 8-9|0.0.1.0.0+0.0.1.0+0.0.1 5-6|0.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:14.362
(c3 / cause-01 
      :ARG0 (m / mutate-01 
            :ARG1 (c2 / country 
                  :mod (g / gene) 
                  :name (n / name 
                        :op1 "SLC26A4")) 
            :ARG2 (o / organization 
                  :name (n2 / name 
                        :op1 "PDS")) 
            :op1-of 2) 
      :ARG1 (s / syndrome) 
      :ARG2 (c / code) 
      :op1-of (p / pendrin 
            :mod (p2 / protein)))

# ::snt Deafness is congenital and generally profound although sometimes late in onset and provoked by light head injury .
# ::tok Deafness is congenital and generally profound although sometimes late in onset and provoked by light head injury .
# ::alignments 16-17|0.1.0 15-16|0.1.0.0 14-15|0.1.0.2 12-13|0.1 11-12|0 10-11|0.1.1 8-9|0.0 7-8|0.0.0 5-6|0.1.0.1.1 4-5|0.1.0.1.1.0 3-4|0.1.0.1 2-3|0.1.0.1.0 0-1|0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:14.463
(a / and 
      :op1 (l2 / late 
            :time (s / sometimes)) 
      :op2 (p / provoke-01 
            :ARG0 (i / injure-01 
                  :ARG0-of (h / head-01) 
                  :ARG1 (a2 / and 
                        :op1 (c / congenital 
                              :domain (d / deafnes)) 
                        :op2 (p2 / profound 
                              :ARG1-of (g / general-02))) 
                  :ARG1-of (l / light-06)) 
            :ARG1 (o / onset)))

# ::snt Vestibular dysfunction is uncommon .
# ::tok Vestibular dysfunction is uncommon .
# ::alignments 3-4|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:14.481
(d / dysfunction 
      :domain-of (c / common) 
      :mod (v / vestibular))

# ::snt Goiter is variable and generally develops around puberty [ 3 ] .
# ::tok Goiter is variable and generally develops around puberty [ 3 ] .
# ::alignments 9-10|0.0.2.0 7-8|0.0.1 6-7|0.0.3 5-6|0.0 4-5|0.0.2 3-4|0 2-3|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:14.561
(a2 / and 
      :op1 (d / develop-02 
            :ARG0 (g2 / goit 
                  :domain-of (v / variable)) 
            :ARG1 (p / puberty) 
            :ARG1-of (g / general-02 
                  :ARG0 3) 
            :ARG2 (a / around)))

# ::snt The cause of goiter appears to be an impairment of iodide fixation in the follicular lumen due to a reduced rate of iodide transport across the apical membrane of thyroid gland epithelial cells [ 4 ] .
# ::tok The cause of goiter appears to be an impairment of iodide fixation in the follicular lumen due to a reduced rate of iodide transport across the apical membrane of thyroid gland epithelial cells [ 4 ] .
# ::alignments 34-35|0.0.0.2.3.0.0 32-33|0.0.0.2.1.0 31-32|0.0.0.2.1.0.0 30-31|0.0.0.2.0 29-30|0.0.0.1 27-28|0.0.0.2.1 26-27|0.0.0.2.1.1 24-25|0.0.0.2.1.2 23-24|0.0.0.2 22-23|0.0.0.2.2 20-21|0.0.0.2.3 19-20|0.0.0.2.3.0 15-16|0.0.0.0.0 14-15|0.0.0.0 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1 4-5|0 3-4|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:15.477
(a3 / appear-02 
      :ARG0 (g2 / goit 
            :ARG1-of (c2 / cause-01 
                  :ARG0 (f / follicular 
                        :mod-of (l / lumen)) 
                  :mod (t / thyroid) 
                  :purpose (t2 / transport-01 
                        :ARG0 (g / gland) 
                        :ARG1 (m / membrane 
                              :domain (c / cell 
                                    :mod (e / epithelial)) 
                              :mod (a / apical) 
                              :op1-of (a2 / across)) 
                        :mod (i / iodide) 
                        :mod-of (r / rate 
                              :ARG1-of (r2 / reduce-01 
                                    :ARG0 4))))) 
      :ARG1 (i3 / impairment 
            :mod (f2 / fixation 
                  :mod (i2 / iodide))))

# ::snt A positive perchlorate discharge test and an enlarged vestibular aqueduct appear to be the most reliable clinical signs of Pendred syndrome [ 5 ] .
# ::tok A positive perchlorate discharge test and an enlarged vestibular aqueduct appear to be the most reliable clinical signs of Pendred syndrome [ 5 ] .
# ::alignments 22-23|0.0.2.0.0 20-21|0.1.0 19-20|0.1.0.0 17-18|0.1 16-17|0.0.3 15-16|0.0.1 14-15|0.0.1.0 10-11|0 9-10|0.0.2 8-9|0.0.2.1 7-8|0.0.2.0 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:15.676
(a / appear-02 
      :ARG0 (a3 / and 
            :op1 (t / test-01 
                  :ARG1 (d / discharge-01 
                        :ARG1 (p2 / perchlorate)) 
                  :manner (p3 / positive)) 
            :op1-of (r / reliable 
                  :degree (m / most)) 
            :op2 (a2 / aqueduct 
                  :ARG1-of (e / enlarge-01 
                        :ARG0 5) 
                  :mod (v / vestibular)) 
            :poss-of (c / clinical)) 
      :ARG1 (s2 / sign 
            :topic (s / syndrome 
                  :mod (p / pendr))))

# ::snt Pendrin is an anion exchanger that can transport Cl - , I - , HCO3 - and formate [ 6,7 ] .
# ::tok Pendrin is an anion exchanger that can transport Cl - , I - , HCO3 - and formate [ 6,7 ] .
# ::alignments 16-17|0 11-12|0.0.0.0.1 8-10|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 7-8|0.0.0 6-7|0.0 4-5|0.0.0.0 3-4|0.0.0.0.2 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:15.889
(a / and 
      :op1 (p / possible-01 
            :ARG1 (t2 / transport-01 
                  :ARG0 (e / exchange-01 
                        :ARG0 (p2 / person 
                              :name (n2 / name 
                                    :op1 "Pendrin")) 
                        :ARG1 (i / i) 
                        :mod (a2 / anion)) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (c / Cl) 
                              :op2 -)))))

# ::snt Expression has been found in the inner ear and thyroid gland consistent with the clinical signs of deafness and goiter [ 2,3,8 ] .
# ::tok Expression has been found in the inner ear and thyroid gland consistent with the clinical signs of deafness and goiter [ 2,3,8 ] .
# ::alignments 19-20|0.0.0.0.0.0 18-19|0 17-18|0.1 15-16|0.0 14-15|0.0.0.0.1 11-12|0.0.0 10-11|0.0.0.1.1 9-10|0.0.0.1.1.0 8-9|0.0.0.1 7-8|0.0.0.1.0 6-7|0.0.0.1.0.0 3-4|0.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:15.988
(a / and 
      :op1 (s / sign 
            :ARG2-of (c2 / consistent-01 
                  :ARG1 (e2 / expression 
                        :ARG1-of (f / find-01 
                              :ARG0 (g / goit)) 
                        :mod-of (c / clinical)) 
                  :op3-of (a2 / and 
                        :op1 (e / ear 
                              :mod (i / inner)) 
                        :op2 (g2 / gland 
                              :mod (t / thyroid))))) 
      :op2 (d / deafnes))

# ::snt In addition , pendrin expression has been found in the kidney [ 9 ] , mammary gland [ 10 ] , uterus [ 11 ] , testes [ 12 ] and placenta [ 13 ] .
# ::tok In addition , pendrin expression has been found in the kidney [ 9 ] , mammary gland [ 10 ] , uterus [ 11 ] , testes [ 12 ] and placenta [ 13 ] .
# ::alignments 33-34|0.0.4 31-32|0.0.6 30-31|0 28-29|0.0.3 23-24|0.0.5 21-22|0.0.7 18-19|0.0.0.1 16-17|0.0.2 15-16|0.0.2.0 12-13|0.0.4.0 10-11|0.0.8 7-8|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:16.276
(a / and 
      :op1 (f / find-01 
            :ARG1 (e / express-01 
                  :mod (p2 / pendrin) 
                  :op1-of 10) 
            :location (a2 / addition) 
            :location (g / gland 
                  :mod (m / mammary)) 
            :op1-of 12 
            :op1-of (1 / 13 
                  :mod 9) 
            :op1-of 11 
            :op1-of (p / placenta) 
            :op1-of (u / uteru) 
            :time (k / kidney)))

# ::snt No expression was found in fetal or adult brain , consistent with a peripheral cause of deafness [ 2,11 ] .
# ::tok No expression was found in fetal or adult brain , consistent with a peripheral cause of deafness [ 2,11 ] .
# ::alignments 16-17|0.0 14-15|0 13-14|0.2 10-11|0.1 8-9|0.1.0.2 7-8|0.1.0.2.0 6-7|0.1.0 5-6|0.1.0.1 3-4|0.1.0.0 1-2|0.1.0.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:16.690
(c / cause-01 
      :ARG1 (d / deafnes) 
      :ARG2-of (c2 / consistent-01 
            :ARG1 (o / or 
                  :ARG2-of (f2 / find-01 
                        :ARG1 (e / express-01) 
                        :polarity -) 
                  :op1 (f / fetal) 
                  :op2 (b / brain 
                        :mod (a / adult)))) 
      :mod (p / peripheral))

# ::snt Expression of pendrin mRNA in the inner ear has been found in several places including the cochlea , the vestibular labyrinth and the endolymphatic sac [ 8 ] .
# ::tok Expression of pendrin mRNA in the inner ear has been found in several places including the cochlea , the vestibular labyrinth and the endolymphatic sac [ 8 ] .
# ::alignments 26-27|0.0.0.1 24-25|0 21-22|0.0 20-21|0.0.2 19-20|0.0.2.0 16-17|0.0.1 13-14|0.0.0.2 12-13|0.0.0.2.1 10-11|0.0.0 7-8|0.0.0.2.0.0 6-7|0.0.0.2.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:17.113
(s / sac 
      :op3-of (a / and 
            :ARG0-of (f / find-01 
                  :ARG1 (e2 / expression 
                        :mod (m / mrna 
                              :mod (p2 / pendrin))) 
                  :ARG2 8 
                  :location (p / place 
                        :mod (i / inner 
                              :mod-of (e / ear)) 
                        :quant (s2 / several))) 
            :op1 (c / cochlea) 
            :op2 (l / labyrinth 
                  :mod (v / vestibular))))

# ::snt The precise location of pendrin protein expression , however , has not yet been determined .
# ::tok The precise location of pendrin protein expression , however , has not yet been determined .
# ::alignments 14-15|0.0.0 12-13|0.0.0.1 11-12|0.0.0.0 6-7|0.0 5-6|0 2-3|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:17.160
(p / protein 
      :ARG1-of (e / express-01 
            :ARG1-of (d / determined-02 
                  :polarity - 
                  :time (y / yet)) 
            :location (l / location 
                  :mod (p2 / precise))))

# ::snt The variability of deafness in Pendred syndrome and the observation that deafness is sometimes late in onset suggest that pendrin dysfunction may not be the direct cause of deafness .
# ::tok The variability of deafness in Pendred syndrome and the observation that deafness is sometimes late in onset suggest that pendrin dysfunction may not be the direct cause of deafness .
# ::alignments 28-29|0.1 26-27|0 25-26|0.3 22-23|0.3.1 21-22|0.2 20-21|0.0 19-20|0.0.0 17-18|0.2.1 16-17|0.2.0 14-15|0.3.0.0 13-14|0.3.0.0.0 11-12|0.3.0 9-10|0.2.1.0.1 7-8|0.2.1.0 6-7|0.2.1.0.0.0 5-6|0.2.1.0.0.0.0 3-4|0.2.1.0.0 1-2|0.2.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:17.447
(c / cause-01 
      :ARG0 (d3 / dysfunction 
            :mod (p2 / pendrin)) 
      :ARG1 (d / deafnes) 
      :ARG1-of (p / possible-01 
            :ARG0 (o / onset) 
            :ARG1-of (s / suggest-01 
                  :ARG0 (a / and 
                        :op1 (d5 / deafnes 
                              :location (s3 / syndrome 
                                    :mod (p3 / pendr))) 
                        :op2 (o2 / observation) 
                        :poss-of (v / variability)))) 
      :ARG1-of (d2 / direct-02 
            :ARG0 (d4 / deafnes 
                  :domain-of (l / late 
                        :time (s2 / sometimes))) 
            :polarity -))

# ::snt It is conceivable that pendrin dysfunction favors changes in the expression levels of proteins that are critical for the maintenance of the hearing function .
# ::tok It is conceivable that pendrin dysfunction favors changes in the expression levels of proteins that are critical for the maintenance of the hearing function .
# ::alignments 23-24|0.0.1.0.0.0 22-23|0.0.1.0.0.0.0 19-20|0.0.1.0.0 16-17|0.0.1.0 13-14|0.0.1 11-12|0.0 10-11|0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 2-3|0.0.0.0.0.1 0-1|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:17.896
(e / express-01 
      :ARG1 (l / level 
            :ARG1-of (c2 / change-01 
                  :ARG1-of (f2 / favor-01 
                        :ARG0 (d / dysfunction 
                              :mod (p2 / pendrin) 
                              :topic-of (c3 / conceive-01 
                                    :ARG1 (i / it))))) 
            :mod (p / protein 
                  :ARG0-of (c / critical-02 
                        :ARG1 (m / maintain-01 
                              :ARG1 (f / function-01 
                                    :ARG1 (h / hear-01)))))))

# ::snt Detailed studies aimed at identifying the direct cause of deafness in Pendred syndrome have recently become possible due to the generation of a pendrin-specific polyclonal antibody [ 9 ] and the development of Slc26a4 - / - mice , which bear a targeted disruption of the mouse Slc26a4 gene [ 14 ] .
# ::tok Detailed studies aimed at identifying the direct cause of deafness in Pendred syndrome have recently become possible due to the generation of a pendrin-specific polyclonal antibody [ 9 ] and the development of Slc26a4 - / - mice , which bear a targeted disruption of the mouse Slc26a4 gene [ 14 ] .
# ::alignments 50-51|0.0.0.0 48-49|0.0.0.2.0.1 46-47|0.0.0.2.0.0.0.0 43-44|0.0.0.2.0 42-43|0.0.0.2 40-41|0.0.0.2.0.0 37-38|0.0.0.2.0.0.0 35-36|0.0.0.3 33-34|0.0.0.1 31-32|0.0.0 29-30|0.0 27-28|0.4.0 25-26|0.2.0.0.0 20-21|0.2.0.0.0.0 16-17|0.3 15-16|0.2.0.0.2 14-15|0.2.0.0.2.0 12-13|0.2.1 11-12|0.2.1.0 9-10|0.1 7-8|0 6-7|0.4 4-5|0.2 2-3|0.2.0 1-2|0.2.0.0 0-1|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:20.204
(c / cause-01 
      :ARG0 (a / and 
            :op1 (d2 / develop-02 
                  :ARG0 14 
                  :ARG1 (s2 / Slc26a4) 
                  :ARG2-of (t / target-01 
                        :ARG0 (d / disruption 
                              :ARG1-of (b / bear-01 
                                    :ARG2 (m2 / mouse 
                                          :name-of (m / mouse))) 
                              :poss (g / gene))) 
                  :purpose (s / slash))) 
      :ARG1 (d3 / deafnes) 
      :ARG1-of (i / identify-01 
            :ARG2-of (a3 / aim-02 
                  :ARG1 (s4 / study-01 
                        :ARG1 (a2 / antibody 
                              :consist (g2 / generation)) 
                        :ARG1-of (d5 / detail-01) 
                        :ARG1-of (b2 / become-01 
                              :time (r / recent)))) 
            :manner (s3 / syndrome 
                  :mod (p2 / pendr))) 
      :ARG1-of (p / possible-01) 
      :ARG1-of (d4 / direct-02 
            :ARG0 9))

# ::snt The aim in the present study was to determine the location of pendrin and the cause of deafness in Slc26a4 - / - mice .
# ::tok The aim in the present study was to determine the location of pendrin and the cause of deafness in Slc26a4 - / - mice .
# ::alignments 23-24|0 21-22|0.0.1.0.0.0.0 17-18|0.0.0 15-16|0.0 13-14|0.0.1 12-13|0.0.1.1.0 10-11|0.0.1.1 8-9|0.0.1.0 5-6|0.0.1.0.0.0 4-5|0.0.1.0.0.0.1 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:20.792
(m / mouse 
      :location-of (c / cause-01 
            :ARG1 (d / deafnes) 
            :op2-of (a / and 
                  :ARG1-of (d2 / determine-01 
                        :ARG1-of (a2 / aim-01 
                              :ARG0 (s2 / study-01 
                                    :ARG0 (s / slash) 
                                    :time (p2 / present)))) 
                  :op1 (l / location 
                        :location-of (p / pendrin)))))

# ::snt The endocochlear potential and the endolymphatic and perilymphatic K + concentrations were measured in young adult mice ( 1 -- 4 month of age ) that either have ( Slc26a4 + / + ) or lack ( Slc26a4 - / - ) a functional gene for pendrin [ 14 ] .
# ::tok The endocochlear potential and the endolymphatic and perilymphatic K + concentrations were measured in young adult mice ( 1 -- 4 month of age ) that either have ( Slc26a4 + / + ) or lack ( Slc26a4 - / - ) a functional gene for pendrin [ 14 ] .
# ::alignments 48-49|0.0 44-45|0.2.1.0.0.1.1 43-44|0.2.1.0.0.1.1.0 39-40|0.2.1.1.2 35-36|0.2.1.0.0 34-35|0.2.1.0.0.1 31-32|0.2.1.1.1 26-27|0.2.1.0.0.1.0 23-24|0 21-22|0.1.1+0.1 20-21|0.1.0 18-19|0.2.1.0.0.0 16-17|0.2.0 15-16|0.2.1.2.0 14-15|0.2.0.0 12-13|0.2 10-11|0.2.1.2 8-9|0.2.1.1.0 6-7|0.2.1.1 3-4|0.2.1 2-3|0.2.1.0 1-2|0.2.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:21.534
(a / age-01 
      :ARG0 14 
      :duration (t / temporal-quantity 
            :quant 4 
            :unit (m / month)) 
      :purpose-of (m3 / measure-01 
            :ARG0 (m2 / mouse 
                  :mod (y / young)) 
            :ARG1 (a4 / and 
                  :op1 (p / potential 
                        :ARG1-of (l / lack-01 
                              :ARG0 1 
                              :op1-of (o / or 
                                    :mod (e / either) 
                                    :op2 (g / gene 
                                          :mod (f / functional)))) 
                        :mod (e2 / endocochlear)) 
                  :op2 (a3 / and 
                        :mod (k / k) 
                        :op1 (s2 / slash) 
                        :op2 (s / slash)) 
                  :op3 (c / concentration 
                        :location (a2 / adult)))))

# ::snt The mouse strain 129Sv/Ev ( Taconic , Germantown , NY ) was chosen as the source of Slc26a4 + / + controls , since Slc26a4 - / - mice were propagated in the this strain and generated using a stem cell line derived from 129Sv/Ev .
# ::tok The mouse strain 129Sv/Ev ( Taconic , Germantown , NY ) was chosen as the source of Slc26a4 + / + controls , since Slc26a4 - / - mice were propagated in the this strain and generated using a stem cell line derived from 129Sv/Ev .
# ::alignments 42-43|0.0.0.1.0 41-42|0.0.0.1 40-41|0.0.0.1.1 39-40|0.0.0.1.1.0 37-38|0.0.0 36-37|0.0.0.2 35-36|0.0.0.2.1 34-35|0.0.0.2.1.0.0.1+0.0.0.2.1.0.0 33-34|0.0.0.2.1.0.0.0 30-31|0.0.0.2.1.0 28-29|0.0.0.2.0 26-27|0.0.0.3.3 23-24|0.0.0.3.4 21-22|0.0.0.3 19-20|0.0.0.1.0.0 15-16|0.0 12-13|0 9-10|0.0.0.3.0.1+0.0.0.3.0.0.0+0.0.0.3.0.0+0.0.0.3.0 7-8|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 5-6|0.0.0.3.2.0.0+0.0.0.3.2.0+0.0.0.3.2 2-3|0.0.0.3.1.0.0+0.0.0.3.1.0 1-2|0.0.0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:22.589
(c3 / choose-01 
      :ARG1 (s6 / source 
            :ARG2-of (u / use-01 
                  :ARG0 (c4 / country 
                        :name (n2 / name 
                              :op1 "Germantown")) 
                  :ARG1 (l / line 
                        :ARG1-of (d / derive-01 
                              :ARG0 (s5 / slash)) 
                        :mod (c / cell 
                              :mod (s / stem))) 
                  :ARG1-of (g / generate-01 
                        :ARG0 (m / mouse) 
                        :op2-of (a / and 
                              :op1 (p / propagate-01 
                                    :ARG1 (s2 / strain 
                                          :mod (t / this) 
                                          :wiki "Influenza_A_virus_subtype_H5N1")))) 
                  :manner-of (c2 / control-01 
                        :ARG0 (s7 / state 
                              :name (n / name 
                                    :op1 "NY") 
                              :wiki "New_York") 
                        :ARG1 (m2 / mouse 
                              :mod-of (s8 / strain 
                                    :wiki "Influenza_A_virus_subtype_H5N1")) 
                        :location (c5 / country 
                              :name (n3 / name 
                                    :op1 "Taconic")) 
                        :op1-of (s3 / slash) 
                        :time (s4 / since)))))

# ::snt Slc26a4 + / + and Slc26a4 - / - were agouti .
# ::tok Slc26a4 + / + and Slc26a4 - / - were agouti .
# ::alignments 10-11|0.0.0.0 7-8|0.0.0 4-5|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:22.607
(s2 / slash 
      :mod (a2 / and 
            :domain-of (s / slash 
                  :mod-of (a / agouti))))

# ::snt They did not differ in coat color .
# ::tok They did not differ in coat color .
# ::alignments 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:22.630
(d / differ-02 
      :ARG0 (t / they) 
      :ARG1 (c / color 
            :mod (c2 / coat)) 
      :polarity -)

# ::snt Differences in pigmentation were verified using coisogenic age-matched Slc26a4 + / + and Slc26a4 - / - that were bred in parallel .
# ::tok Differences in pigmentation were verified using coisogenic age-matched Slc26a4 + / + and Slc26a4 - / - that were bred in parallel .
# ::alignments 21-22|0.0.0.0.0.1 19-20|0.0.0.0.0 17-18|0.0.0.0.0.0 15-16|0.0.2.0 12-13|0 10-11|0.0.0.0.0.1.0 8-9|0.0.1 7-8|0.0.1.0 5-6|0.0 4-5|0.0.2 2-3|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:22.790
(a / and 
      :op1 (u / use-01 
            :ARG0 (d / difference 
                  :location (p2 / pigmentation 
                        :ARG0-of (b / breed-01 
                              :ARG1 (t / that) 
                              :manner (p / parallel-01 
                                    :ARG1 (s2 / slash))))) 
            :ARG1 (s3 / Slc26a4 
                  :mod (a2 / age-match)) 
            :ARG1-of (v / verify-01 
                  :ARG0 (s / slash))))

# ::snt Expression of key proteins involved in the generation of the endocochlear potential and the transport of K + was studied using confocal immunocytochemistry and quantitative RT-PCR .
# ::tok Expression of key proteins involved in the generation of the endocochlear potential and the transport of K + was studied using confocal immunocytochemistry and quantitative RT-PCR .
# ::alignments 24-25|0.0.3.0.0.0.0.0.0.0.0 23-24|0.0.1 22-23|0.0.1.0 20-21|0.0 19-20|0.0.2 16-17|0 14-15|0.0.3.0 12-13|0.0.3 11-12|0.0.3.0.0.0 10-11|0.0.3.0.0 7-8|0.0.3.0.0.0.0 4-5|0.0.3.0.0.0.0.0 3-4|0.0.3.0.0.0.0.0.0 2-3|0.0.3.0.0.0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:23.959
(k / k 
      :mod-of (u / use-01 
            :ARG0 (e2 / expression) 
            :ARG1 (a / and 
                  :op1 (i / immunocytochemistry)) 
            :ARG1-of (s / study-01) 
            :op2-of (a2 / and 
                  :op1 (t / transport-01 
                        :ARG1 (e / endocochlear 
                              :mod-of (p / potential 
                                    :consist (g / generation 
                                          :ARG2-of (i2 / involve-01 
                                                :ARG1 (p2 / protein 
                                                      :ARG1-of (k2 / key-02 
                                                            :ARG0 (q / quantitative)))))))))))

# ::snt K + secretion and the generation of the endocochlear potential were measured using electrophysiological techniques .
# ::tok K + secretion and the generation of the endocochlear potential were measured using electrophysiological techniques .
# ::alignments 14-15|0.0.0.0.0.0.0 13-14|0.0.0.0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0 9-10|0.0 8-9|0 5-6|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:24.283
(e2 / endocochlear 
      :mod-of (p / potential 
            :consist (g / generation 
                  :op1-of (a / and 
                        :purpose-of (m / measure-01 
                              :ARG1 (u / use-01 
                                    :ARG1 (t / technique 
                                          :mod (e / electrophysiological 
                                                :poss-of (k / k))) 
                                    :ARG2 (s / secretion)))))))

# ::snt All experiments were approved by the Institutional Animal Care and Use Committee of Kansas State University .
# ::tok All experiments were approved by the Institutional Animal Care and Use Committee of Kansas State University .
# ::alignments 13-16|0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 10-12|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 9-10|0.0 6-9|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:24.668
(a2 / approve-01 
      :ARG0 (a / and 
            :op1 (o3 / organization 
                  :name (n3 / name 
                        :op1 "Institutional" 
                        :op2 "Animal" 
                        :op3 "Care")) 
            :op2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "Use" 
                        :op2 "Committee")) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "Kansas" 
                        :op2 "State" 
                        :op3 "University"))) 
      :ARG1 (e / experiment-01 
            :quant (a3 / all)))

# ::snt Animals were deeply anesthetized with sodium pentobarbital ( 100 mg/kg i.p. ) and transcardially perfused with a Cl -- free phosphate-buffered Na-gluconate solution containing 4 % paraformaldehyde .
# ::tok Animals were deeply anesthetized with sodium pentobarbital ( 100 mg/kg i.p. ) and transcardially perfused with a Cl -- free phosphate-buffered Na-gluconate solution containing 4 % paraformaldehyde .
# ::alignments 26-27|0.1 25-26|0.2.0.0.0 24-25|0.2.0.0 23-24|0 22-23|0.0 20-21|0.0.1 19-20|0.0.0 17-18|0.0.0.1 14-15|0.2.0.1.0 12-13|0.2.0.1.0.0 8-9|0.0.0.0 6-7|0.2.0.2 5-6|0.2.0.2.0 3-4|0.2.0 2-3|0.2 0-1|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:25.367
(c / contain-01 
      :ARG0 (s / solution 
            :ARG1-of (f / free-04 
                  :ARG0 100 
                  :ARG2 (c2 / cl)) 
            :mod (p3 / phosphate-buffer)) 
      :ARG1 (p / paraformaldehyde) 
      :ARG2-of (d / deep-02 
            :ARG1 (a2 / anesthetize-01 
                  :ARG0 (4 / 4 
                        :value-of (p2 / percentage-entity)) 
                  :ARG1 (a3 / animal 
                        :domain-of (p4 / perfuse 
                              :op1-of (a / and))) 
                  :ARG2 (p5 / pentobarbital 
                        :mod (s2 / sodium)))))

# ::snt Temporal bones were removed and cochleae fixed by perilymphatic perfusion , decalcified in EDTA , processed through a sucrose gradient and infiltrated with polyethylene glycol .
# ::tok Temporal bones were removed and cochleae fixed by perilymphatic perfusion , decalcified in EDTA , processed through a sucrose gradient and infiltrated with polyethylene glycol .
# ::alignments 24-25|0.2.2.0 23-24|0.2.2.0.0 21-22|0.2.2 20-21|0.2 19-20|0.2.1.0 18-19|0.2.1.0.0 15-16|0.2.1 13-14|0.2.0.0.0+0.2.0.0+0.2.0 9-10|0.1.0 6-7|0.1 5-6|0.1.1 4-5|0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:25.490
(a2 / and 
      :op1 (r / remove-01 
            :ARG1 (b / bone 
                  :mod (t / temporal))) 
      :op2 (f / fix-03 
            :ARG0 (p3 / perfusion) 
            :manner (c2 / cochlea)) 
      :op3 (a / and 
            :location (c / country 
                  :name (n / name 
                        :op1 "EDTA")) 
            :op1 (p2 / process-01 
                  :ARG1 (g2 / gradient 
                        :mod (s / sucrose))) 
            :op2 (i / infiltrate-01 
                  :ARG1 (g / glycol 
                        :mod (p / polyethylene)))))

# ::snt Mid-modiolar cryosections ( 12 m , CM3050S , Leica , Nussloch , Germany ) were blocked in PBS with 0.2 % Triton-X ( PBS-TX ) and 10 % bovine serum albumin .
# ::tok Mid-modiolar cryosections ( 12 m , CM3050S , Leica , Nussloch , Germany ) were blocked in PBS with 0.2 % Triton-X ( PBS-TX ) and 10 % bovine serum albumin .
# ::alignments 30-31|0.0.4 29-30|0.0.4.0 28-29|0.0.4.1 27-28|0.0.0.1.0.0 26-27|0.0.0.1.0 25-26|0.0 20-21|0.0.0.1 19-20|0.0.0.1.0.0.1 17-18|0.0.0.2 15-16|0.0.0 12-13|0.0.3.1+0.0.3.0.0+0.0.3.0+0.0.3 10-11|0.0.2.0.0+0.0.2.0+0.0.2 8-9|0.0.1.0.0+0.0.1.0+0.0.1 6-7|0.0.0.1.0.0.0 4-5|0 3-4|0.1 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:26.040
(m / m 
      :mod-of (a2 / and 
            :ARG0-of (b2 / block-01 
                  :ARG1 (c4 / cryosection) 
                  :duration (p2 / percentage-entity 
                        :value (1 / 10 
                              :value-of (p / percentage-entity 
                                    :mod-of (c3 / cm3050) 
                                    :value 0.2))) 
                  :location (p3 / pb)) 
            :op1 (o / organization 
                  :name (n3 / name 
                        :op1 "Leica")) 
            :op2 (c2 / country 
                  :name (n2 / name 
                        :op1 "Nussloch")) 
            :op3 (c / country 
                  :name (n / name 
                        :op1 "Germany") 
                  :wiki "Germany") 
            :op4 (a / albumin 
                  :mod (s / serum) 
                  :mod (b / bovine))) 
      :quant 12)

# ::snt Slides were incubated overnight at 4 C with primary antibodies in PBS-TX with 1 -- 3 % BSA [ rabbit anti-pendrin , 1:500 ( h766 -- 780 ) ; rat anti-ZO-1 , 1:100 ( Chemicon , Temecula , CA ) ; goat anti-KCNQ1 , 1:200 ( C20 , Santa Cruz Biotechnology , Santa Cruz , CA ) , rabbit anti-KCNE1 , 1:200 ( Alomone , Jerusalem , Israel ) ; rabbit anti-KCNJ10 , 1:300 ( Alomone ) ; rabbit anti-SLC12A2 , 1:100 ( Chemicon ) ; and rabbit anti-connexin 26 , 1:100 ( Zymed , San Francisco , CA ) ] .
# ::tok Slides were incubated overnight at 4 C with primary antibodies in PBS-TX with 1 -- 3 % BSA [ rabbit anti-pendrin , 1:500 ( h766 -- 780 ) ; rat anti-ZO-1 , 1:100 ( Chemicon , Temecula , CA ) ; goat anti-KCNQ1 , 1:200 ( C20 , Santa Cruz Biotechnology , Santa Cruz , CA ) , rabbit anti-KCNE1 , 1:200 ( Alomone , Jerusalem , Israel ) ; rabbit anti-KCNJ10 , 1:300 ( Alomone ) ; rabbit anti-SLC12A2 , 1:100 ( Chemicon ) ; and rabbit anti-connexin 26 , 1:100 ( Zymed , San Francisco , CA ) ] .
# ::alignments 98-99|0.0.2.0.2+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 95-97|0.0.2.0.1.1.1+0.0.2.0.1.1.0.1+0.0.2.0.1.1.0.0+0.0.2.0.1.1.0+0.0.2.0.1.1 93-94|0.0.2.0.1.0 89-90|0.0.4.0.1 87-89|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 86-87|0 78-79|0.0.2 70-71|0.0.2.0.1 67-68|0.0.4.0.2.1+0.0.4.0.2.0.0+0.0.4.0.2.0+0.0.4.0.2 65-66|0.0.4.0.4.1.0.1+0.0.4.0.4.1.0.0.0+0.0.4.0.4.1.0.0+0.0.4.0.4.1.0 58-59|0.0.4.0.4 55-56|0.0.4.0.3.1+0.0.4.0.3.0.0+0.0.4.0.3.0+0.0.4.0.3 52-54|0.0.1.1+0.0.1.0+0.0.1+0.0 48-51|0.0.4.2.0.2+0.0.4.2.0.1+0.0.4.2.0.0+0.0.4.2.0+0.0.4.2 41-42|0.0.4.0.0.3 38-39|0.0.4.0.4.1.2+0.0.4.0.4.1.1.0+0.0.4.0.4.1.1+0.0.4.0.4.1 36-37|0.0.4.0.4.0.0.0+0.0.4.0.4.0.0+0.0.4.0.4.0 29-30|0.0.4.0.0.5 28-29|0.0.3 26-27|0.0.4.0.0.4 19-20|0.0.4.0 17-18|0.0.4.1.0+0.0.4.1+0.0.4 16-17|0.0.4.0.0.2 15-16|0.0.4.0.0.2.0 13-14|0.0.4.0.0.1.1 11-12|0.0.4.0.0.0.0.0.0+0.0.4.0.0.0.0.0+0.0.4.0.0.0.0 9-10|0.0.4.0.0.1 8-9|0.0.4.0.0.1.0 6-7|0.0.4.0.0.1.0.0 5-6|0.0.4.0.0.7 3-4|0.0.4.0.0.6 2-3|0.0.4.0.0 0-1|0.0.4.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:28.278
(a2 / and 
      :op1 (o / organization 
            :domain-of (t / thing 
                  :name (n3 / name 
                        :op1 (r / rabbit) 
                        :op2 (a / anti-connexin))) 
            :name (n7 / name 
                  :op1 "Santa" 
                  :op2 "Cruz") 
            :op1 (r2 / rabbit-01 
                  :op2-of (s / state 
                        :name (n / name 
                              :op1 "CA") 
                        :op1 (r3 / rabbit-01 
                              :op1-of (z / zym) 
                              :op1-of (c / city 
                                    :name (n2 / name 
                                          :op1 "San" 
                                          :op2 "Francisco") 
                                    :wiki "San_Francisco")) 
                        :wiki "California")) 
            :op1-of (a3 / and) 
            :part (o3 / organization 
                  :ARG1-of (r6 / rabbit-01 
                        :ARG2 (i / incubate-01 
                              :ARG1 (s4 / slide-01 
                                    :ARG0 (t2 / thing 
                                          :name (n12 / name 
                                                :op1 "PBS-TX"))) 
                              :ARG2 (a4 / antibodi 
                                    :mod (p2 / primary 
                                          :mod (c5 / C)) 
                                    :mod 1) 
                              :op1-of (p / percentage-entity 
                                    :value 3) 
                              :op1-of (g / goat) 
                              :op1-of 780 
                              :op1-of (r5 / rat) 
                              :time (o4 / overnight) 
                              :time 4) 
                        :op1-of 26 
                        :op1-of (c2 / country 
                              :name (n4 / name 
                                    :op1 "Israel") 
                              :wiki "Israel") 
                        :op1-of (s2 / state 
                              :name (n6 / name 
                                    :op1 "CA") 
                              :wiki "California") 
                        :purpose-of (r4 / rabbit-01 
                              :ARG2 (c4 / country 
                                    :name (n10 / name 
                                          :op1 "Temecula")) 
                              :op1-of (s3 / state 
                                    :location-of (c3 / city 
                                          :name (n5 / name 
                                                :op1 "Jerusalem") 
                                          :wiki "Jerusalem") 
                                    :name (n9 / name 
                                          :op1 "CA") 
                                    :wiki "California"))) 
                  :name (n11 / name 
                        :op1 "BSA") 
                  :part (o2 / organization 
                        :name (n8 / name 
                              :op1 "Santa" 
                              :op2 "Cruz" 
                              :op3 "Biotechnology")))))

# ::snt Slides were washed in PBS-TX and incubated for 1 h at 25 C with appropriate secondary antibodies at a 1:1000 dilution in PBS-TX with 1 -- 3 % BSA [ donkey anti-rabbit Alexa 488 , chicken anti-rat Alexa 594 , and chicken anti-goat Alexa 594 ( Molecular Probes , Eugene , OR ) ] .
# ::tok Slides were washed in PBS-TX and incubated for 1 h at 25 C with appropriate secondary antibodies at a 1:1000 dilution in PBS-TX with 1 -- 3 % BSA [ donkey anti-rabbit Alexa 488 , chicken anti-rat Alexa 594 , and chicken anti-goat Alexa 594 ( Molecular Probes , Eugene , OR ) ] .
# ::alignments 51-52|0.2.6.0.0+0.2.6.0+0.2.6 49-50|0.2.3.2.0.0+0.2.3.2.0+0.2.3.2 46-48|0.2.5.0.1+0.2.5.0.0+0.2.5.0+0.2.5 41-42|0.1 40-41|0 37-39|0.0.0.1+0.0.0.0+0.0.0+0.0 35-36|0.2.1.2.0.0.0 32-34|0.2.4.0.1+0.2.4.0.0+0.2.4.0+0.2.4 30-31|0.2.1.0 28-29|0.2.3.1.0+0.2.3.1+0.2.3 27-28|0.2.3.0 26-27|0.2.3.0.0 24-25|0.2.0.0 20-21|0.2.1.2.0.0.2 16-17|0.2.1.2.0 15-16|0.2.1.1.1 14-15|0.2.1.2.0.0 12-13|0.2.2 11-12|0.2.1.2.0.0.1 9-10|0.2.1.2 8-9|0.2.1.1.0 6-7|0.2.1 5-6|0.2 4-5|0.2.0.1.0.0+0.2.0.1.0+0.2.0.1 2-3|0.2.0 0-1|0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:29.733
(a / and 
      :op1 (t / thing 
            :name (n4 / name 
                  :op1 (a2 / Alexa) 
                  :op2 594)) 
      :op2 (c2 / chicken) 
      :op6-of (a6 / and 
            :op1 (w / wash-01 
                  :ARG0 1 
                  :location (c5 / country 
                        :name (n7 / name 
                              :op1 "PBS-TX"))) 
            :op2 (i / incubate-01 
                  :ARG0 (d / donkey) 
                  :ARG1 (s2 / slide-01 
                        :ARG0 1 
                        :ARG2 (s / secondary)) 
                  :ARG2 (h / h 
                        :mod-of (a4 / antibodi 
                              :ARG1-of (a5 / appropriate-02 
                                    :ARG0 (c3 / chicken) 
                                    :ARG2 25 
                                    :prep-for (d2 / dilution))))) 
            :op3 (c4 / C) 
            :op4 (o3 / organization 
                  :mod (p / percentage-entity 
                        :value 3) 
                  :name (n6 / name 
                        :op1 "BSA") 
                  :part-of (o / organization 
                        :name (n2 / name 
                              :op1 "Eugene"))) 
            :op5 (t2 / thing 
                  :name (n5 / name 
                        :op1 (a3 / Alexa) 
                        :op2 488)) 
            :op7 (o2 / organization 
                  :name (n3 / name 
                        :op1 "Molecular" 
                        :op2 "Probes")) 
            :op8 (c / country 
                  :name (n / name 
                        :op1 "OR"))))

# ::snt Actin filaments were visualized by staining with Alexa 488 conjugated phalloidin ( Molecular Probes ) .
# ::tok Actin filaments were visualized by staining with Alexa 488 conjugated phalloidin ( Molecular Probes ) .
# ::alignments 12-14|0.0.0.1+0.0.0.0+0.0.0+0.0 10-11|0.1.0.0.0 9-10|0.1.0.0 7-8|0.2.0.0.0+0.2.0.0+0.2.0 5-6|0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:29.858
(v / visualize-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "Molecular" 
                  :op2 "Probes")) 
      :ARG1 (f / filament 
            :mod (a / actin 
                  :ARG0-of (c / conjugate-01 
                        :ARG1 (p / phalloidin)))) 
      :ARG2 (s / stain-01 
            :ARG0 (p2 / person 
                  :name (n2 / name 
                        :op1 "Alexa"))))

# ::snt After incubation , slides were washed with PBS-TX , mounted with FluorSave ( Calbiochem , La Jolla , CA ) , and viewed by confocal microscopy ( LSM 5 Pascal or LSM 510 Meta , Carl Zeiss , Jena or Gttingen , Germany ) .
# ::tok After incubation , slides were washed with PBS-TX , mounted with FluorSave ( Calbiochem , La Jolla , CA ) , and viewed by confocal microscopy ( LSM 5 Pascal or LSM 510 Meta , Carl Zeiss , Jena or Gttingen , Germany ) .
# ::alignments 42-43|0.1.0.0.3.1+0.1.0.0.3.0.0+0.1.0.0.3.0+0.1.0.0.3 40-41|0.1.0.0.2.1.1.0.0+0.1.0.0.2.1.1.0+0.1.0.0.2.1.1 39-40|0.1.0.0.2.1 38-39|0.1.0.0.2.1.0.0.0+0.1.0.0.2.1.0.0+0.1.0.0.2.1.0 35-37|0.1.0.0.2.0.1+0.1.0.0.2.0.0+0.1.0.0.2.0+0.1.0.0.2 32-34|0.1.0.0.1.0.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 30-31|0.1.0.0 29-30|0.1.0.0.0.2+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 28-29|0.1.0.0.0.1 27-28|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 25-26|0.1.0 22-23|0.1 21-22|0 18-19|0.2.1.1.1+0.2.1.1.0.0+0.2.1.1.0+0.2.1.1 15-17|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 11-12|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 9-10|0.1.1.2 7-8|0.0.0.0+0.0.0+0.0 5-6|0.2.1 3-4|0.1.1 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:30.877
(a / and 
      :op1 (c4 / country 
            :name (n11 / name 
                  :op1 "PBS-TX")) 
      :op2 (v / view-02 
            :ARG0 (m2 / microscopy 
                  :op1-of (o2 / or 
                        :op2 (p3 / person 
                              :name (n6 / name 
                                    :op1 "Pascal") 
                              :quant 5 
                              :wiki "Blaise_Pascal") 
                        :op3 (t / thing 
                              :name (n5 / name 
                                    :op1 510 
                                    :op2 (m / Meta))) 
                        :op4 (p2 / person 
                              :name (n4 / name 
                                    :op1 "Carl" 
                                    :op2 "Zeiss") 
                              :op1-of (o / or 
                                    :op2 (p / person 
                                          :name (n3 / name 
                                                :op1 "Jena")) 
                                    :op3 (c2 / country 
                                          :name (n2 / name 
                                                :op1 "Gttingen")))) 
                        :op5 (c / country 
                              :name (n / name 
                                    :op1 "Germany") 
                              :wiki "Germany"))) 
            :ARG1 (s2 / slide-01 
                  :ARG0 (o3 / organization 
                        :name (n7 / name 
                              :op1 "LSM")) 
                  :ARG1 (c3 / country 
                        :name (n9 / name 
                              :op1 "La" 
                              :op2 "Jolla")) 
                  :ARG1-of (m3 / mount-01))) 
      :time (a2 / after 
            :op1 (i / incubation) 
            :time-of (w / wash-01 
                  :ARG0 (p4 / person 
                        :name (n10 / name 
                              :op1 "FluorSave")) 
                  :ARG1 (s / state 
                        :name (n8 / name 
                              :op1 "CA") 
                        :wiki "California"))))

# ::snt Laser scanning brightfield images were collected to document structural preservation , for morphometric analysis and for analysis of pigmentation .
# ::tok Laser scanning brightfield images were collected to document structural preservation , for morphometric analysis and for analysis of pigmentation .
# ::alignments 18-19|0.2.0.0.1 16-17|0.2.0.0 14-15|0.2.0 13-14|0.2 9-10|0.2.0.0.0 8-9|0.2.0.0.0.0 7-8|0.1 5-6|0 3-4|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:31.033
(c / collect-01 
      :ARG1 (i / image 
            :ARG1-of (s2 / scan-01) 
            :mod (l / las)) 
      :ARG2 (d / document) 
      :purpose (a3 / analyze-01 
            :op1-of (a2 / and 
                  :op2 (a / analyze-01 
                        :ARG0 (p2 / preservation 
                              :mod (s / structure)) 
                        :ARG1 (p / pigmentation)))))

# ::snt Animals were deeply anesthetized with sodium pentobarbital ( 100 mg/kg i.p. ) .
# ::tok Animals were deeply anesthetized with sodium pentobarbital ( 100 mg/kg i.p. ) .
# ::alignments 8-9|0.1.0 6-7|0.2 5-6|0.2.0 3-4|0 2-3|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:31.090
(a / anesthetize-01 
      :ARG1 (a2 / animal) 
      :ARG1-of (d / deep-02 
            :ARG0 100) 
      :ARG2 (p / pentobarbital 
            :mod (s / sodium)))

# ::snt Kidneys and brain were removed and pulverized in liquid N2 .
# ::tok Kidneys and brain were removed and pulverized in liquid N2 .
# ::alignments 8-9|0.0.1 6-7|0.1 5-6|0 4-5|0.0 2-3|0.0.0.0 1-2|0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:31.149
(a / and 
      :op1 (r / remove-01 
            :ARG1 (a2 / and 
                  :op1 (b / brain)) 
            :ARG2 (l / liquid)) 
      :op2 (p / pulverize-01 
            :ARG1 (k / kidney)))

# ::snt Temporal bones were removed and two preparations of inner ear tissues were obtained by microdissection : ( 1 ) stria vascularis without spiral ligament , and ( 2 ) spiral ganglia including the surrounding bone and the organ of Corti .
# ::tok Temporal bones were removed and two preparations of inner ear tissues were obtained by microdissection : ( 1 ) stria vascularis without spiral ligament , and ( 2 ) spiral ganglia including the surrounding bone and the organ of Corti .
# ::alignments 39-40|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 37-38|0.1.0 35-36|0.1 34-35|0 33-34|0.0 30-31|0.1.1.2.1 29-30|0.1.1.2.1.0 27-28|0.1.1.2.1.0.0 25-26|0.1.1.2 23-24|0.1.1.2.0 22-23|0.1.1.2.0.0 20-21|0.1.1.1.1.0 19-20|0.1.1.1.1.0.1 17-18|0.1.1.1.1.0.0 14-15|0.1.1.1.0 12-13|0.1.1.1 10-11|0.1.1.1.1.1 9-10|0.1.1.1.1.1.0.0 8-9|0.1.1.1.1.1.0 6-7|0.1.1.1.1 5-6|0.1.1.1.1.2 4-5|0.1.1 3-4|0.1.1.0 1-2|0.1.1.0.0 0-1|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:31.714
(b / bone 
      :ARG1-of (s / surround-01) 
      :op1-of (a / and 
            :op2 (o / organ 
                  :poss (c / country 
                        :name (n / name 
                              :op1 "Corti"))) 
            :op4-of (a3 / and 
                  :op1 (r / remove-01 
                        :ARG1 (b2 / bone 
                              :mod (t2 / temporal))) 
                  :op2 (o2 / obtain-01 
                        :ARG0 (m / microdissection) 
                        :ARG1 (p / prepare-02 
                              :ARG0 (v / vasculari 
                                    :li 1 
                                    :mod (s4 / stria)) 
                              :ARG1 (t / tissue 
                                    :mod (i / inner 
                                          :mod-of (e / ear))) 
                              :quant 2)) 
                  :op3 (a2 / and 
                        :op1 (l / ligament 
                              :ARG1-of (s3 / spiral-01)) 
                        :op2 (g / ganglion 
                              :ARG0-of (s2 / spiral-01 
                                    :ARG1 2))))))

# ::snt The dissection medium was changed twice during the microdissection and isolated tissues were washed three times to minimize cross-contamination .
# ::tok The dissection medium was changed twice during the microdissection and isolated tissues were washed three times to minimize cross-contamination .
# ::alignments 17-18|0.1.1 14-15|0.1.0 13-14|0.1 11-12|0.1.1.0 10-11|0.1.1.0.0 9-10|0 8-9|0.0.1 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:31.808
(a / and 
      :ARG0-of (c / change-01 
            :ARG1 (m3 / medium 
                  :mod (d / dissection)) 
            :time (m2 / microdissection)) 
      :op1 (w / wash-01 
            :ARG1 3 
            :purpose (m / minimize-01 
                  :ARG0 (t / tissue 
                        :ARG1-of (i / isolate-01)))))

# ::snt The Slc26a4 - / - genotype was verified by the observation of large otoconia in the utricular macula [ 14 ] .
# ::tok The Slc26a4 - / - genotype was verified by the observation of large otoconia in the utricular macula [ 14 ] .
# ::alignments 19-20|0.1.0 17-18|0.0.0.0 16-17|0.0.0.0.0 13-14|0.0.0 12-13|0.0.0.1 10-11|0.0 7-8|0 5-6|0.1 3-4|0.2 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:32.167
(v / verify-01 
      :ARG0 (o2 / observation 
            :mod (o / otoconia 
                  :location (m / macula 
                        :mod (u / utricular)) 
                  :mod (l / large))) 
      :ARG1 (g / genotype 
            :mod-of (1 / 14 
                  :poss (s2 / Slc26a4))) 
      :ARG2 (s / slash))

# ::snt Total RNA was isolated and residual DNA contamination was removed by enzymatic digestion ( RNeasy micro , Qiagen , Valencia , CA ) .
# ::tok Total RNA was isolated and residual DNA contamination was removed by enzymatic digestion ( RNeasy micro , Qiagen , Valencia , CA ) .
# ::alignments 21-22|0.1.1.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 19-20|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 17-18|0.0.0.0.0+0.0.0.0+0.0.0 15-16|0.0.1.0.0 12-13|0.1.0 11-12|0.1.0.0 9-10|0.1 7-8|0.1.1 6-7|0.1.1.1 5-6|0.1.1.2 4-5|0 3-4|0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:32.439
(a / and 
      :op1 (i / isolate-01 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "Qiagen") 
                  :part-of (p / province 
                        :name (n2 / name 
                              :op1 "Valencia") 
                        :wiki "Province_of_Valencia")) 
            :ARG1 (r3 / rna 
                  :ARG2-of (t / total-01 
                        :ARG0 (m / micro)))) 
      :op2 (r / remove-01 
            :ARG0 (d / digestion 
                  :mod (e / enzymatic)) 
            :ARG1 (c / contaminate-01 
                  :ARG0 (s / state 
                        :name (n / name 
                              :op1 "CA") 
                        :wiki "California") 
                  :ARG1 (d2 / DNA) 
                  :mod (r2 / residual))))

# ::snt Quality and quantity of 18S rRNA obtained from kidneys and brain were determined ( Nano Assay , 2100 Bioanalyzer , Agilent , Palo Alto , CA ) .
# ::tok Quality and quantity of 18S rRNA obtained from kidneys and brain were determined ( Nano Assay , 2100 Bioanalyzer , Agilent , Palo Alto , CA ) .
# ::alignments 25-26|0.2.0.1.2+0.2.0.1.1.0+0.2.0.1.1+0.2.0.1 22-24|0.2.4.0.1+0.2.4.0.0+0.2.4.0+0.2.4 20-21|0.2.3.0.0+0.2.3.0+0.2.3 17-19|0.2.2.0.1+0.2.2.0.0+0.2.2.0+0.2.2 14-16|0.1.0.1+0.1.0.0+0.1.0+0.1 12-13|0 10-11|0.2.1 9-10|0.2 8-9|0.2.0.2 6-7|0.2.0 5-6|0.2.0.0 4-5|0.2.0.1.0 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:33.135
(d / determined-02 
      :ARG1 (a2 / and 
            :op1 (q2 / quality) 
            :op2 (q / quantity)) 
      :ARG2 (p / person 
            :name (n5 / name 
                  :op1 "Nano" 
                  :op2 "Assay")) 
      :manner (a / and 
            :ARG0-of (o2 / obtain-01 
                  :ARG1 (r / rRNA) 
                  :ARG2 (s / state 
                        :mod 18 
                        :name (n / name 
                              :op1 "CA") 
                        :wiki "California") 
                  :source (k / kidney)) 
            :op1 (b2 / brain) 
            :op2 (t / thing 
                  :name (n4 / name 
                        :op1 2100 
                        :op2 (b / Bioanalyzer))) 
            :op3 (o / organization 
                  :name (n3 / name 
                        :op1 "Agilent")) 
            :op4 (c / country 
                  :name (n2 / name 
                        :op1 "Palo" 
                        :op2 "Alto"))))

# ::snt Further , the quality of RNA preparations obtained from stria vascularis and spiral ganglia was assessed ( Pico Assay , 2100 Bioanalyzer ) .
# ::tok Further , the quality of RNA preparations obtained from stria vascularis and spiral ganglia was assessed ( Pico Assay , 2100 Bioanalyzer ) .
# ::alignments 20-22|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 17-19|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 15-16|0.0 13-14|0.3 12-13|0.1.1.1 11-12|0 10-11|0.2 9-10|0.2.0 7-8|0.1 6-7|0.1.1 5-6|0.1.1.2 3-4|0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:33.499
(a2 / and 
      :ARG0-of (a / assess-01 
            :ARG1 (q / quality) 
            :ARG2 (p / person 
                  :name (n2 / name 
                        :op1 "Pico" 
                        :op2 "Assay"))) 
      :ARG2-of (o / obtain-01 
            :ARG0 (f / further) 
            :ARG1 (p2 / prepare-02 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 2100 
                              :op2 (b / Bioanalyzer))) 
                  :ARG1 (s / spiral-01) 
                  :quant (r / rna))) 
      :op1 (v / vasculari 
            :mod (s2 / stria)) 
      :op2 (g / ganglion))

# ::snt Real time RT-PCR was performed on RNA obtained from individual animals ( OneStep RT-PCR , Qiagen ; Smart Cycler , Cepheid , Sunnyvale , CA ) in the presence of 0.2  SYBR green I ( Molecular Probes ) .
# ::tok Real time RT-PCR was performed on RNA obtained from individual animals ( OneStep RT-PCR , Qiagen ; Smart Cycler , Cepheid , Sunnyvale , CA ) in the presence of 0.2  SYBR green I ( Molecular Probes ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:33.503
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Transcripts of 18S rRNA and mRNA for the K + channels KCNJ10 , KCNQ1 and KCNQ4 were amplified using gene-specific primers ( Table 1 ) .
# ::tok Transcripts of 18S rRNA and mRNA for the K + channels KCNJ10 , KCNQ1 and KCNQ4 were amplified using gene-specific primers ( Table 1 ) .
# ::alignments 23-24|0.1.0.0 22-23|0.1.0.0.0 20-21|0.1.1 18-19|0.1 17-18|0.1.2 15-16|0.0.0.0+0.0.0+0.0 14-15|0 10-11|0.1.2.0.2.0 8-9|0.1.2.0.0 5-6|0.1.2.0.2 4-5|0.1.2.0 3-4|0.1.2.0.1 2-3|0.1.0 0-1|0.1.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:34.079
(a2 / and 
      :op1 (t2 / thing 
            :name (n / name 
                  :op1 "KCNQ4")) 
      :op2 (u / use-01 
            :ARG0 (12 / 18 
                  :mod-of (1 / 1 
                        :mod-of (t / table))) 
            :ARG1 (p / primer) 
            :ARG1-of (a / amplify-01 
                  :ARG0 (a3 / and 
                        :example (k / k) 
                        :op1 (r / rRNA) 
                        :op2 (m / mrna 
                              :poss (c / channel))) 
                  :ARG2 (t3 / transcript))))

# ::snt RT was performed for 30 min at 50 C and 15 min at 95 C .
# ::tok RT was performed for 30 min at 50 C and 15 min at 95 C .
# ::alignments 13-15|0.3.0.1+0.3.0.0+0.3.0+0.3 11-12|0.2 10-11|0.2.0 9-10|0 8-9|0.1 7-8|0.1.0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:34.192
(a / and 
      :ARG0-of (p / perform-02 
            :ARG1 (m2 / min 
                  :quant 30)) 
      :op1 (c2 / C 
            :quant 50) 
      :op2 (m / min 
            :quant 15) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 95 
                  :op2 (c / C))))

# ::snt PCR consisted of 50 cycles of 1 min at 60 C , 1 min at 72 C , 7s heating to hot-measurement temperature , 13s hot-measurement at 3 -- 5 C below product melting temperature ( Table 1 ) and 1 min at 94 C .
# ::tok PCR consisted of 50 cycles of 1 min at 60 C , 1 min at 72 C , 7s heating to hot-measurement temperature , 13s hot-measurement at 3 -- 5 C below product melting temperature ( Table 1 ) and 1 min at 94 C .
# ::alignments 43-45|0.0.5.0.1+0.0.5.0.0+0.0.5.0+0.0.5 41-42|0.0.4 40-41|0.0.3.3.2 39-40|0.0 37-38|0.0.3.0 36-37|0.0.3.0.0 34-35|0.0.3.3.3 33-34|0.0.3.3 32-33|0.0.3.3.1 31-32|0.1.5 30-31|0.1.1 29-30|0.1.3 27-28|0.1.4 24-25|0.1.2 22-23|0.0.3.1 19-20|0.0.3 18-19|0.0.3.2 15-17|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 13-14|0.0.1 12-13|0.0.3.3.0 10-11|0.0.0 9-10|0.0.0.0 7-8|0.1.0 6-7|0.0.2.1 4-5|0.1 3-4|0.1.6 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:35.470
(c6 / consist-01 
      :ARG1 (a / and 
            :op1 (c4 / C 
                  :mod-of 60) 
            :op2 (m3 / min) 
            :op3 (t5 / thing 
                  :name (n2 / name 
                        :op1 72 
                        :op2 (c3 / C)) 
                  :quant 1) 
            :op4 (h / heat-01 
                  :ARG1 (12 / 1 
                        :mod-of (t2 / table)) 
                  :ARG2 (t4 / temperature) 
                  :mod 7 
                  :purpose (m2 / melt-01 
                        :ARG0 1 
                        :ARG1 (p / product) 
                        :ARG2 1 
                        :mod-of (t3 / temperature))) 
            :op5 (m / min) 
            :op6 (t / thing 
                  :name (n / name 
                        :op1 94 
                        :op2 (c / C)))) 
      :ARG2 (c5 / cycle-02 
            :ARG1 (m4 / min) 
            :op1-of (c2 / C) 
            :op1-of 13 
            :op1-of 5 
            :op1-of 3 
            :op1-of (b / below) 
            :quant 50))

# ::snt Hot-measurements were performed to eliminate the detection of primer-dimers that had melting temperatures between 72 and 75 C [ 15 ] .
# ::tok Hot-measurements were performed to eliminate the detection of primer-dimers that had melting temperatures between 72 and 75 C [ 15 ] .
# ::alignments 19-20|0.0.2.0 17-18|0.1 16-17|0.0.1.1.0 15-16|0 14-15|0.0.0 12-13|0.0.2.1 11-12|0.0.2 8-9|0.0.1.1.1 6-7|0.0.1.1 4-5|0.0.1 2-3|0.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:35.603
(a / and 
      :op1 (p2 / perform-02 
            :ARG0 72 
            :ARG1 (e / eliminate-01 
                  :ARG0 (h / hot-measurement) 
                  :ARG1 (d / detect-01 
                        :ARG0 75 
                        :ARG1 (p / primer-dimer))) 
            :purpose (m / melt-01 
                  :ARG0 15 
                  :ARG1 (t / temperature))) 
      :op2 (c / C))

# ::snt PCR was followed by a melt ( 60 to 95 C ) .
# ::tok PCR was followed by a melt ( 60 to 95 C ) .
# ::alignments 10-11|0.1.0 9-10|0.0 7-8|0.2 5-6|0.1 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:35.637
(f / follow-01 
      :ARG0 95 
      :ARG1 (m / melt-01 
            :ARG1 (c / C)) 
      :ARG2 60)

# ::snt The generation of a single product of appropriate size was routinely checked by the presence of a single melt peak and by agarose gel-electrophoresis .
# ::tok The generation of a single product of appropriate size was routinely checked by the presence of a single melt peak and by agarose gel-electrophoresis .
# ::alignments 23-24|0.0 22-23|0 20-21|0.0.0 19-20|0.0.0.0.0.1 18-19|0.0.0.0.0.0 17-18|0.0.0.0.0.1.0 14-15|0.0.0.0.0 11-12|0.0.0.0 10-11|0.0.0.0.2 8-9|0.0.0.0.1.0.1 7-8|0.0.0.0.1.0.1.0 5-6|0.0.0.0.1.0 4-5|0.0.0.0.1.0.0 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:35.927
(a / agarose 
      :mod-of (g / gel-electrophoresi 
            :op1-of (a2 / and 
                  :time-of (c / check-01 
                        :ARG0 (p2 / presence 
                              :ARG0-of (m / melt-01) 
                              :ARG1-of (p / peak-01 
                                    :ARG1-of (s / single-02))) 
                        :ARG1 (g2 / generation 
                              :consist-of (p3 / product 
                                    :ARG1-of (s3 / single-02) 
                                    :mod (s2 / size 
                                          :ARG1-of (a3 / appropriate-02)))) 
                        :manner (r / routine)))))

# ::snt Product identity was confirmed by sequencing .
# ::tok Product identity was confirmed by sequencing .
# ::alignments 5-6|0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:35.944
(c / confirm-01 
      :ARG0 (s / sequence) 
      :ARG1 (i / identity 
            :mod (p / product)))

# ::snt Template molecules ( T ) were quantified according to T = P / ( F ^ Ct ) where P is the number of product molecules , F is the fidelity of the reaction and Ct is the cycle at which the number of product molecules reaches a chosen threshold [ 15 ] .
# ::tok Template molecules ( T ) were quantified according to T = P / ( F ^ Ct ) where P is the number of product molecules , F is the fidelity of the reaction and Ct is the cycle at which the number of product molecules reaches a chosen threshold [ 15 ] .
# ::alignments 51-52|0.2.1.1 49-50|0.2.3.1 48-49|0.2.3.1.0 46-47|0.2.3 45-46|0.2.3.0.0 44-45|0.2.3.0.0.0 42-43|0.2.3.0 38-39|0.2.2 34-35|0.2 33-34|0.2.1 30-31|0.2.0 27-28|0.2.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 25-26|0.2.1.2.1 24-25|0.2.3.1.0.0 22-23|0.2.1.2 19-20|0.2.1.2.0 16-17|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 14-15|0.2.2.0.1+0.2.2.0.0.0+0.2.2.0.0+0.2.2.0 12-13|0.0 11-12|0.0.0 9-10|0.3.1+0.3.0.0+0.3.0+0.3 7-8|0 6-7|0.1 3-4|0.2.1.3.1+0.2.1.3.0.0+0.2.1.3.0+0.2.1.3 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.022
(s2 / say-01 
      :ARG0 (s / slash 
            :mod (p4 / P60)) 
      :ARG0-of (q / quantify-01 
            :ARG1 (m3 / molecule 
                  :mod (t2 / template))) 
      :ARG1 (a / and 
            :op1 (f / fidelity 
                  :domain (a2 / aircraft-type 
                        :name (n2 / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor")) 
            :op2 (r2 / react-01 
                  :ARG0 (c3 / country 
                        :name (n4 / name 
                              :op1 "Ct")) 
                  :ARG1 15 
                  :mod (n3 / number 
                        :domain (p3 / P60) 
                        :quant-of (m2 / molecule)) 
                  :op1-of (a5 / aircraft-type 
                        :name (n7 / name 
                              :op1 "T50") 
                        :wiki "Sukhoi_PAK_FA")) 
            :op3 (c2 / cycle-02 
                  :ARG0 (a3 / aircraft-type 
                        :name (n5 / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor")) 
            :op4 (r / reach-01 
                  :ARG0 (n / number 
                        :quant-of (m / molecule 
                              :mod (p / product))) 
                  :ARG1 (t / threshold 
                        :ARG1-of (c / choose-01 
                              :ARG0 (p2 / product))))) 
      :ARG2 (a4 / aircraft-type 
            :name (n6 / name 
                  :op1 "T50") 
            :wiki "Sukhoi_PAK_FA"))

# ::snt Fidelity ( F ) was obtained from the slope ( S ) of the log-linear phase of the growth curve via a best-fit fifth-order polynomial : F = 7.39 + 3.80  S + 1.05  S2 + 0.15  S3 + 11.38  10-3 * S4 + 3.39  10-4  S5 .
# ::tok Fidelity ( F ) was obtained from the slope ( S ) of the log-linear phase of the growth curve via a best-fit fifth-order polynomial : F = 7.39 + 3.80  S + 1.05  S2 + 0.15  S3 + 11.38  10-3 * S4 + 3.39  10-4  S5 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.026
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The number of product molecules at threshold ( PCt ) was determined by amplification of known amounts of 18S rRNA according to PCt = T  F ^ Ct. .
# ::tok The number of product molecules at threshold ( PCt ) was determined by amplification of known amounts of 18S rRNA according to PCt = T  F ^ Ct. .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.036
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Quantifications of 18S rRNA were used to compare tissue amounts .
# ::tok Quantifications of 18S rRNA were used to compare tissue amounts .
# ::alignments 9-10|0.1.1 8-9|0.1.1.0 7-8|0.1 5-6|0 2-4|0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.076
(u / use-01 
      :ARG1 (t2 / thing 
            :name (n / name 
                  :op1 18S 
                  :op2 (r / rRNA))) 
      :ARG2 (c / compare-01 
            :ARG0 (q / quantification) 
            :ARG1 (a / amount 
                  :quant-of (t / tissue))))

# ::snt Genomic contamination of inner ear samples was assessed to be < 0.02 % by omission of the RT step .
# ::tok Genomic contamination of inner ear samples was assessed to be < 0.02 % by omission of the RT step .
# ::alignments 18-19|0.0.0 14-15|0.0.0.0 12-13|0.1 7-8|0 5-6|0.0.1.0+0.0.1 4-5|0.0.1.1.0 3-4|0.0.1.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.234
(a / assess-01 
      :ARG1 (c / contaminate-01 
            :ARG0 (s / step 
                  :poss-of (o / omission)) 
            :ARG1 (t / thing 
                  :ARG1-of (s2 / sample-01) 
                  :mod (i / inner 
                        :mod-of (e / ear)))) 
      :ARG2 (p / percentage-entity))

# ::snt Animals were deeply anesthetized with sodium pentobarbital ( 100 mg/kg i.p. ) .
# ::tok Animals were deeply anesthetized with sodium pentobarbital ( 100 mg/kg i.p. ) .
# ::alignments 8-9|0.1.0 6-7|0.2 5-6|0.2.0 3-4|0 2-3|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.287
(a / anesthetize-01 
      :ARG1 (a2 / animal) 
      :ARG1-of (d / deep-02 
            :ARG0 100) 
      :ARG2 (p / pentobarbital 
            :mod (s / sodium)))

# ::snt Stria vascularis without spiral ligament was obtained by microdissection .
# ::tok Stria vascularis without spiral ligament was obtained by microdissection .
# ::alignments 6-7|0.1 4-5|0.0 3-4|0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.355
(s / spiral-01 
      :ARG0 (l / ligament) 
      :ARG1 (o / obtain-01 
            :ARG1 (v / vasculari 
                  :mod (s2 / stria))))

# ::snt Currents generated by the stria marginal epithelium were recorded [ 16 ] .
# ::tok Currents generated by the stria marginal epithelium were recorded [ 16 ] .
# ::alignments 10-11|0.0.0.1 8-9|0 6-7|0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.1 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:39.440
(r / record-01 
      :ARG1 (c / current 
            :ARG1-of (g / generate-01 
                  :ARG0 (e / epithelium 
                        :mod (m / marginal) 
                        :mod (s / stria)) 
                  :ARG2 16)))

# ::snt A Pt-Ir wire microelectrode with a Pt-black tip was positioned 20 -- 30 m from the apical surface of the epithelium and vibrated at 200 -- 400 Hz by piezo-electric bimorph elements ( Applicable Electronics , Forest Dale , MA ; ASET version 1.05 , Science Wares , East Falmouth , MA ) .
# ::tok A Pt-Ir wire microelectrode with a Pt-black tip was positioned 20 -- 30 m from the apical surface of the epithelium and vibrated at 200 -- 400 Hz by piezo-electric bimorph elements ( Applicable Electronics , Forest Dale , MA ; ASET version 1.05 , Science Wares , East Falmouth , MA ) .
# ::alignments 48-50|0.5.0.1+0.5.0.0+0.5.0+0.5 45-47|0.4.0.1+0.4.0.0+0.4.0+0.4 42-43|0.3.2 40-41|0.3 39-40|0.3.1.0.0+0.3.1.0+0.3.1 37-38|0.2.2+0.2.0.0+0.2.0+0.2 33-35|0.1.0.1+0.1.0.0+0.1.0+0.1 31-32|0.3.0.0 30-31|0.3.0.0.0 27-28|0.3.0.0.0.1 26-27|0.3.0.0.0.0 24-25|0.3.0.1.0.0 22-23|0.0 21-22|0 20-21|0.0.1 17-18|0.0.1.0 16-17|0.0.1.0.0 12-13|0.2.1 10-11|0.0.0 9-10|0.3.0 7-8|0.0.2 3-4|0.3.0.1 2-3|0.3.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.265
(a3 / and 
      :op1 (v2 / vibrate-01 
            :ARG0 20 
            :ARG1 (e3 / epithelium 
                  :poss-of (s / surface 
                        :mod (a4 / apical))) 
            :ARG2 (t2 / tip)) 
      :op2 (t / thing 
            :name (n5 / name 
                  :op1 (a2 / Applicable) 
                  :op2 (e / Electronics))) 
      :op3 (p2 / person 
            :name (n4 / name 
                  :op1 "Dale") 
            :quant 30 
            :wiki -) 
      :op4 (a / and 
            :ARG2-of (p3 / position-01 
                  :ARG0 (e2 / element 
                        :mod (b / bimorph 
                              :quant 400 
                              :source-of (h / hz))) 
                  :ARG1 (m / microelectrode 
                        :ARG1-of (w / wire-01 
                              :op1-of 200))) 
            :op1 (c2 / country 
                  :name (n3 / name 
                        :op1 "MA")) 
            :op2 (v / version)) 
      :op5 (p / person 
            :name (n2 / name 
                  :op1 "Science" 
                  :op2 "Wares")) 
      :op6 (c / country 
            :name (n / name 
                  :op1 "East" 
                  :op2 "Falmouth")))

# ::snt A Pt-black electrode ( 26-gauge ) served as reference in the bath chamber .
# ::tok A Pt-black electrode ( 26-gauge ) served as reference in the bath chamber .
# ::alignments 12-13|0.1.0 11-12|0.1.0.0 8-9|0.1 6-7|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.294
(s / serve-01 
      :ARG0 (e / electrode) 
      :ARG1 (r / reference-04 
            :location (c / chamber 
                  :ARG1-of (b / bathe-01))))

# ::snt The signals from the phase-sensitive detectors were digitized ( 16 bit ) at a rate of 0.5 Hz .
# ::tok The signals from the phase-sensitive detectors were digitized ( 16 bit ) at a rate of 0.5 Hz .
# ::alignments 17-18|0.1 16-17|0.2 14-15|0.1.0 10-11|0.0 9-10|0.0.0 5-6|0.3 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.333
(s / signal 
      :domain-of (b / bit 
            :quant 16) 
      :mod-of (h / hz 
            :mod-of (r / rate)) 
      :mod-of 0.5 
      :source (d / detector))

# ::snt The output was expressed as current density at the electrode .
# ::tok The output was expressed as current density at the electrode .
# ::alignments 9-10|0.0.0 6-7|0.0 5-6|0.0.1 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.386
(e2 / express-01 
      :ARG0 (d / density 
            :quant-of (e / electrode) 
            :time (c / current)) 
      :ARG1 (o / output))

# ::snt Animals were anesthetized with inactin ( thiobutabarbital sodium salt , 140 mg/kg ip ) .
# ::tok Animals were anesthetized with inactin ( thiobutabarbital sodium salt , 140 mg/kg ip ) .
# ::alignments 12-13|0 10-11|0.0 8-9|0.0.0.0 7-8|0.0.0.0.0 4-5|0.0.0.2 2-3|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.509
(i / ip 
      :quant (1 / 140 
            :op1 (a / anesthetize-01 
                  :ARG0 (s / salt 
                        :mod (s2 / sodium)) 
                  :ARG1 (a2 / animal) 
                  :ARG2 (i2 / inactin))))

# ::snt The endocochlear potential and the endolymphatic [ K + ] were measured with double-barreled microelectrodes [ 17 ] .
# ::tok The endocochlear potential and the endolymphatic [ K + ] were measured with double-barreled microelectrodes [ 17 ] .
# ::alignments 16-17|0.0.1 14-15|0.0.0.0 13-14|0.0.0.0.0 11-12|0 7-8|0.0.0.0.1 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.549
(m2 / measure-01 
      :ARG1 (a / and 
            :op1 (p / potential 
                  :part (m / microelectrod 
                        :mod (d / double-barrel) 
                        :mod (k / k))) 
            :poss 17))

# ::snt Measurements were made in the basal turn by a round-window approach through the basilar membrane and in the apical turn after thinning the bone over the stria vascularis and picking a small hole ( ~ 30 m ) .
# ::tok Measurements were made in the basal turn by a round-window approach through the basilar membrane and in the apical turn after thinning the bone over the stria vascularis and picking a small hole ( ~ 30 m ) .
# ::alignments 36-37|0.0.0.0.0 35-36|0.0.0.0 32-33|0.0.2.2.0 31-32|0.0.2.2.0.0 29-30|0.0.2.2 28-29|0.0.2 27-28|0.0.2.1 26-27|0.0.2.1.0 23-24|0 21-22|0.0 20-21|0.0.1 18-19|0.0.2.0.0.0 15-16|0.0.0.1 14-15|0.0.0.2 13-14|0.0.0.2.0 10-11|0.0.0 6-7|0.0.2.0 5-6|0.0.2.0.1 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.818
(b / bone 
      :ARG1-of (t / thin-01 
            :condition (a5 / approach-02 
                  :ARG0 (3 / 30 
                        :quant-of (m / m)) 
                  :ARG1 (a4 / and) 
                  :ARG2 (m2 / membrane 
                        :mod (b2 / basilar))) 
            :op1-of (a2 / after) 
            :op1-of (a / and 
                  :ARG1-of (t2 / turn-01 
                        :ARG0 (m3 / measurement 
                              :poss-of (a3 / apical)) 
                        :mod (b3 / basal)) 
                  :op2 (v / vasculari 
                        :mod (s2 / stria)) 
                  :op3 (p / pick-01 
                        :ARG1 (h / hole 
                              :mod (s / small))))))

# ::snt K + - selective electrodes were calibrated in solutions of constant cation ( K + and Na + ) concentration of 150 mM .
# ::tok K + - selective electrodes were calibrated in solutions of constant cation ( K + and Na + ) concentration of 150 mM .
# ::alignments 22-23|0.0.0 21-22|0.0.0.0 19-20|0.0 16-17|0.1.0.0+0.1.0+0.1 15-16|0 11-12|0.2.0.1.1 10-11|0.0.1 8-9|0.2 6-7|0.2.0 4-5|0.2.0.1 3-4|0.2.0.1.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:40.996
(a / and 
      :ARG0-of (c / concentrate-02 
            :ARG2 (m / mm 
                  :quant 150) 
            :frequency (c3 / constant)) 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Na")) 
      :poss-of (s / solution 
            :location-of (c4 / calibrate-01 
                  :ARG0 (k / k) 
                  :ARG1 (e / electrod 
                        :mod (s2 / selective) 
                        :part-of (c2 / cation)))))

# ::snt The minor selectivity of the K + electrodes for Na + produced a nonlinearity in the calibration curve , which was closely fitted by the Nicolski equation using nonlinear curve-fitting software ( OriginLab , Northampton , MA ) : V = Vi + S  log ( [ K + ] + A  [ Na + ] ) , where Vi is an offset term , S is slope , A is selectivity , and [ Na + ] is Na + concentration .
# ::tok The minor selectivity of the K + electrodes for Na + produced a nonlinearity in the calibration curve , which was closely fitted by the Nicolski equation using nonlinear curve-fitting software ( OriginLab , Northampton , MA ) : V = Vi + S  log ( [ K + ] + A  [ Na + ] ) , where Vi is an offset term , S is slope , A is selectivity , and [ Na + ] is Na + concentration .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:41.001
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Calibrations were made immediately after withdrawal of the electrodes from the cochlea .
# ::tok Calibrations were made immediately after withdrawal of the electrodes from the cochlea .
# ::alignments 11-12|0.0.1.1 8-9|0.0.1.0 5-6|0.0.1 4-5|0.0 3-4|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:41.066
(c2 / calibration 
      :domain-of (a / after 
            :mod (i / immediate) 
            :op1 (w / withdraw-01 
                  :ARG1 (e / electrod) 
                  :ARG2 (c / cochlea))))

# ::snt Plasma K + concentrations were obtained using a blood analyzer ( Stat Profile M , Nova Biomedical , Waltham , MA ) .
# ::tok Plasma K + concentrations were obtained using a blood analyzer ( Stat Profile M , Nova Biomedical , Waltham , MA ) .
# ::alignments 20-21|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 18-19|0.0.0.0+0.0.0+0.0 15-17|0.1.1.0.1.0.1+0.1.1.0.1.0.0+0.1.1.0.1.0+0.1.1.0.1 11-14|0.1.0.0.0.2+0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 9-10|0.1.0 8-9|0.1.0.1 6-7|0.1 5-6|0 3-4|0.1.1 0-2|0.1.1.0.2.1+0.1.1.0.2.0+0.1.1.0.2+0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:42.092
(o3 / obtain-01 
      :ARG0 (c2 / country 
            :name (n2 / name 
                  :op1 "Waltham")) 
      :ARG1 (u / use-01 
            :ARG1 (a / analyze-01 
                  :ARG0 (o2 / organization 
                        :name (n4 / name 
                              :op1 "Stat" 
                              :op2 "Profile" 
                              :op3 "M")) 
                  :ARG1 (b / blood)) 
            :ARG2 (c3 / concentration 
                  :mod (t / thing 
                        :domain (c / country 
                              :name (n / name 
                                    :op1 "MA")) 
                        :domain (o / organization 
                              :name (n3 / name 
                                    :op1 "Nova" 
                                    :op2 "Biomedical")) 
                        :name (n5 / name 
                              :op1 (p / Plasma) 
                              :op2 (k / K))))))

# ::snt Data are presented as mean  sem ; n denotes the number of experiments .
# ::tok Data are presented as mean  sem ; n denotes the number of experiments .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:42.094
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Differences were considered significant when p < 0.05 .
# ::tok Differences were considered significant when p < 0.05 .
# ::alignments 5-6|0.0 3-4|0.1 2-3|0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:42.131
(c / consider-01 
      :ARG0 (p / p) 
      :ARG1 (s / significant-02 
            :ARG1 (d / difference)))

# ::snt In situ hybridization in the cochlea has suggested that pendrin mRNA is expressed in cells that reside immediately beneath the spiral prominence on the lateral wall of the external sulcus [ 8 ] .
# ::tok In situ hybridization in the cochlea has suggested that pendrin mRNA is expressed in cells that reside immediately beneath the spiral prominence on the lateral wall of the external sulcus [ 8 ] .
# ::alignments 31-32|0.3 29-30|0.1.2.0.0.1 28-29|0.2 25-26|0.1.0.0 24-25|0.1.0 21-22|0.1.2.0.0 20-21|0.1.2.0.0.0 18-19|0.1.2.0.0.2 17-18|0.1.2.0.1 16-17|0.1.2.0 14-15|0.1.2 12-13|0.1 10-11|0.1.1 9-10|0.1.1.0 7-8|0 5-6|0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:42.486
(s3 / suggest-01 
      :ARG0 (h / hybridization 
            :location (c2 / cochlea)) 
      :ARG1 (e2 / express-01 
            :ARG0 (l / lateral 
                  :mod-of (w / wall)) 
            :ARG1 (m / mrna 
                  :mod (p2 / pendrin)) 
            :manner (c / cell 
                  :ARG0-of (r / reside-01 
                        :ARG1 (p / prominence 
                              :ARG0-of (s2 / spiral-01) 
                              :location-of (s / sulcu) 
                              :op1-of (b / beneath)) 
                        :time (i / immediate)))) 
      :ARG2 (e / external) 
      :op1-of 8)

# ::snt To determine the location of pendrin protein expression , we performed confocal immunocytochemistry on cryosections prepared from temporal bones of normal ( Slc26a4 + / + ) mice using an established antibody [ 3 ] .
# ::tok To determine the location of pendrin protein expression , we performed confocal immunocytochemistry on cryosections prepared from temporal bones of normal ( Slc26a4 + / + ) mice using an established antibody [ 3 ] .
# ::alignments 33-34|0.0.1.0.0.3.0.0 31-32|0.1 30-31|0 28-29|0.0.1.0.0.3 27-28|0.0.1.0.0.3.0 24-25|0.0.0.0.0.1 20-21|0.0.1.0.0.1 18-19|0.0.1.0.0.2 17-18|0.0.1.0.0.2.0 15-16|0.0.1.0.0 14-15|0.0.1.0.0.0 12-13|0.0.1.0 10-11|0.0.1 9-10|0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:42.831
(e / establish-01 
      :ARG0 (w / we 
            :ARG0-of (d / determine-01 
                  :ARG1 (l / location 
                        :location-of (e2 / express-01 
                              :ARG0 (p3 / protein) 
                              :ARG1 (s / slash)))) 
            :ARG0-of (p2 / perform-02 
                  :ARG1 (i / immunocytochemistry 
                        :ARG0-of (p / prepare-02 
                              :ARG1 (c / cryosection) 
                              :ARG1-of (n / normal-02) 
                              :ARG2 (b / bone 
                                    :mod (t / temporal)) 
                              :manner (u / use-01 
                                    :ARG1 (m / mouse 
                                          :prep-against-of 3)))))) 
      :ARG1 (a / antibody))

# ::snt Staining was absent when the primary antibody was pre-absorbed with the antigenic peptide ( data not shown ) .
# ::tok Staining was absent when the primary antibody was pre-absorbed with the antigenic peptide ( data not shown ) .
# ::alignments 16-17|0 15-16|0.2 14-15|0.0 12-13|0.1.0.0 11-12|0.1.0 6-7|0.1.1.0 5-6|0.1.1.0.0 2-3|0.1.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:42.946
(s / show-01 
      :ARG1 (d / data) 
      :ARG1-of (s2 / stain-01 
            :ARG0 (a / antigenic 
                  :mod-of (p / peptide)) 
            :ARG1-of (a3 / absent-01 
                  :ARG0 (a2 / antibody 
                        :mod (p2 / primary)))) 
      :polarity -)

# ::snt Strong expression of pendrin was observed not only in outer sulcus epithelial cells , as predicted from in situ hybridization data , but also in root cells , in apical membranes of spiral prominence surface epithelial cells and in apical membranes of spindle-shaped cells that are part of stria vascularis ( Fig. 1a ,1 b ,1 c ) .
# ::tok Strong expression of pendrin was observed not only in outer sulcus epithelial cells , as predicted from in situ hybridization data , but also in root cells , in apical membranes of spiral prominence surface epithelial cells and in apical membranes of spindle-shaped cells that are part of stria vascularis ( Fig. 1a ,1 b ,1 c ) .
# ::alignments 56-57|0.1.1.1.1 54-55|0.1.1.1.3 52-53|0.2.1.0 51-52|0.2.1.1.0+0.2.1.1+0.2.1 49-50|0.0.0 48-49|0.0 43-44|0.2.0.0 42-43|0.2.0.0.0 40-41|0.2.0 39-40|0.2.0.1 37-38|0.2 36-37|0.1.1.1.0.0 35-36|0.1.1.1.0.0.2 34-35|0.1.1.1.0 33-34|0.1.1.1.0.0.1 32-33|0.1.1.1 30-31|0.1.1.1.0.0.0 29-30|0.1.1.1.0.0.0.0 26-27|0.1.1.1.2 25-26|0.1.1.1.2.0 23-24|0.3.0 22-23|0 20-21|0.1.2.0 19-20|0.1.2 15-16|0.3 12-13|0.3.1 11-12|0.3.1.1 10-11|0.3.1.2 9-10|0.3.1.0 7-8|0.1.1.0 6-7|0.1.1.0.0 5-6|0.1.1 3-4|0.1.0 1-2|0.1 0-1|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:44.313
(c6 / contrast-01 
      :ARG0 (s / stria 
            :mod-of (v / vasculari)) 
      :ARG1 (e3 / express-01 
            :ARG1 (p3 / pendrin) 
            :ARG1-of (o3 / observe-01 
                  :ARG0 (o2 / only 
                        :polarity -) 
                  :ARG2 (s4 / spiral-01 
                        :ARG1 (s3 / surface 
                              :mod-of (c4 / cell 
                                    :domain-of (m2 / membran 
                                          :mod (a3 / apical)) 
                                    :location (p / prominence) 
                                    :mod (e / epithelial))) 
                        :op1-of (c / c) 
                        :op1-of (c5 / cell 
                              :mod (r / root)) 
                        :op1-of (b / b))) 
            :ARG2 (h / hybridization 
                  :source-of (d / data)) 
            :mod (s6 / strong)) 
      :ARG2 (a2 / and 
            :op1 (m / membran 
                  :domain (c3 / cell 
                        :mod (s2 / spindle-shap)) 
                  :mod (a / apical)) 
            :op2 (c2 / country 
                  :mod-of 1a 
                  :name (n / name 
                        :op1 "Fig."))) 
      :ARG2-of (p2 / predict-01 
            :ARG0 (a4 / also) 
            :ARG1 (c7 / cell 
                  :mod (o / outer) 
                  :mod (e2 / epithelial) 
                  :mod (s5 / sulcu))))

# ::snt The presence of pendrin in spindle-shaped cells suggests that these cells secrete HCO3 - into endolymph .
# ::tok The presence of pendrin in spindle-shaped cells suggests that these cells secrete HCO3 - into endolymph .
# ::alignments 15-16|0.0.2 11-12|0.1 10-11|0.1.0 9-10|0.1.0.0 7-8|0 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:44.380
(s2 / suggest-01 
      :ARG0 (p2 / presence 
            :location (c2 / cell 
                  :mod (s3 / spindle-shap)) 
            :mod (p / pendrin) 
            :mod (e / endolymph)) 
      :ARG1 (s / secrete-01 
            :ARG0 (c / cell 
                  :mod (t / this))))

# ::snt Pendrin-mediated HCO3 - transport has previously been shown in the kidney [ 9 ] .
# ::tok Pendrin-mediated HCO3 - transport has previously been shown in the kidney [ 9 ] .
# ::alignments 12-13|0.1.0 10-11|0.0.0.1 7-8|0.0.0 5-6|0.0.0.0 3-4|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:44.415
(h / HCO3 
      :ARG1-of (t / transport-01 
            :ARG1-of (s / show-01 
                  :time (p / previous) 
                  :time (k / kidney))) 
      :mod (p2 / pendrin-mediat 
            :poss-of 9))

# ::snt HCO3 - in the cochlea may be generated from CO2 by carbonic anhydrase located in strial intermediate cells [ 18,19 ] .
# ::tok HCO3 - in the cochlea may be generated from CO2 by carbonic anhydrase located in strial intermediate cells [ 18,19 ] .
# ::alignments 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 13-14|0.0.0.0 12-13|0.0.0 11-12|0.0.0.1 9-10|0.0.2 7-8|0.0 5-6|0 4-5|0.0.1.0 0-2|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:44.576
(p / possible-01 
      :ARG1 (g / generate-01 
            :ARG0 (a / anhydrase 
                  :ARG1-of (l / locate-01 
                        :location (c / cell 
                              :mod (i / intermediate))) 
                  :mod (c2 / carbonic)) 
            :ARG1 (t / thing 
                  :location (c4 / cochlea) 
                  :name (n / name 
                        :op1 (h / HCO3) 
                        :op2 -)) 
            :ARG2 (c3 / co2)))

# ::snt CO2 may be supplied by the metabolically highly active stria marginal cells .
# ::tok CO2 may be supplied by the metabolically highly active stria marginal cells .
# ::alignments 11-12|0.0.2 10-11|0.0.2.1 9-10|0.0.2.2 8-9|0.0.2.0 7-8|0.0.2.0.0 6-7|0.0.0 3-4|0.0 1-2|0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:44.828
(p / possible-01 
      :ARG1 (s2 / supply-01 
            :ARG0 (m2 / metabolically) 
            :ARG1 (c2 / co2) 
            :ARG2 (c / cell 
                  :ARG1-of (a / activity-06 
                        :degree (h / high)) 
                  :mod (m / marginal) 
                  :mod (s / stria))))

# ::snt It is conceivable that pendrin dysfunction interrupts HCO3 - secretion and leads to an accumulation of HCO3 - in stria vascularis .
# ::tok It is conceivable that pendrin dysfunction interrupts HCO3 - secretion and leads to an accumulation of HCO3 - in stria vascularis .
# ::alignments 20-21|0.2.0.0 19-20|0.2.0 14-15|0.2.1 11-12|0.2 10-11|0 9-10|0.1 6-7|0.0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.087
(a2 / and 
      :ARG1-of (i / interrupt-01 
            :ARG0 (d / dysfunction 
                  :mod (p / pendrin) 
                  :topic-of (c / conceive-01 
                        :ARG1 (i2 / it)))) 
      :op1 (s2 / secretion) 
      :op2 (l / lead-03 
            :ARG0 (s / stria 
                  :mod-of (v / vasculari)) 
            :ARG1 (a / accumulation)))

# ::snt Preliminary data ( Wangemann et al. , unpublished ) support a role for pendrin in HCO3 - secretion into endolymph .
# ::tok Preliminary data ( Wangemann et al. , unpublished ) support a role for pendrin in HCO3 - secretion into endolymph .
# ::alignments 19-20|0.0 17-18|0.0.0.2 13-14|0.0.0.1.0 11-12|0.0.0.1 9-10|0.0.0 7-8|0 3-6|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.1.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.346
(u / unpublish 
      :poss (e / endolymph 
            :ARG2-of (s2 / support-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 "Wangemann" 
                              :op2 "et" 
                              :op3 "al.")) 
                  :ARG1 (r / role 
                        :mod (p / pendrin)) 
                  :concession (s / secretion)) 
            :poss-of (p2 / preliminary 
                  :mod-of (d / data))))

# ::snt Protein localization of pendrin , KCNQ1 , ZO-1 and F actin in cochlea and vestibular labyrinth of Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Protein localization of pendrin , KCNQ1 , ZO-1 and F actin in cochlea and vestibular labyrinth of Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 26-27|0.1.4.2.0 24-25|0.0 21-22|0 19-20|0.1.5 15-16|0.1.4.2 14-15|0.1.4.1 13-14|0.1.4 12-13|0.1.4.0 9-10|0.1.3.1+0.1.3.0.0+0.1.3.0+0.1.3 8-9|0.1 5-6|0.1.2 3-4|0.1.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.454
(a / and 
      :domain-of (s / slash) 
      :op1 (a4 / and 
            :op1 (l2 / localization 
                  :mod (p2 / protein)) 
            :op2 (p / pendrin) 
            :op3 (k / KCNQ1) 
            :op4 (a3 / aircraft-type 
                  :name (n / name 
                        :op1 "F22") 
                  :wiki "Lockheed_Martin_F-22_Raptor") 
            :op5 (a2 / and 
                  :op1 (c / cochlea) 
                  :op2 (v / vestibular) 
                  :op3 (l / labyrinth 
                        :mod (m / mouse))) 
            :op6 (s2 / slash)))

# ::snt a : Overview of cochlea ; bar = 100 m .
# ::tok a : Overview of cochlea ; bar = 100 m .
# ::alignments 9-10|0.0.2 8-9|0.0.1 6-7|0.0 5-6|0 4-5|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.480
(a / and 
      :op1 (b / bar-01 
            :ARG0 (c / cochlea 
                  :mod-of (o / overview)) 
            :ARG1 100 
            :domain-of (m / m)))

# ::snt b-f : Detail of cochlear lateral wall ; bar = 10 m .
# ::tok b-f : Detail of cochlear lateral wall ; bar = 10 m .
# ::alignments 11-12|0.1 10-11|0.0 8-9|0 7-8|0.2 6-7|0.2.0.0 5-6|0.2.0.0.0 4-5|0.2.0.0.1 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.552
(b / bar-01 
      :ARG0 10 
      :ARG1 (m / m) 
      :op2-of (a / and 
            :op1 (d / detail-01 
                  :ARG1 (w / wall 
                        :mod (l / lateral) 
                        :mod (c / cochlear)))))

# ::snt g : Detail of utricle ; bar = 10 m .
# ::tok g : Detail of utricle ; bar = 10 m .
# ::alignments 9-10|0.1 8-9|0.0 6-7|0 5-6|0.2 4-5|0.1.0.0 2-3|0.1.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.580
(b / bar-01 
      :ARG1 10 
      :domain-of (m / m 
            :ARG0-of (d / detail-01 
                  :ARG1 (u / utricle))) 
      :op2-of (a / and 
            :op1 (g / g)))

# ::snt h-i : Detail of ampulla ; bar = 10 m .
# ::tok h-i : Detail of ampulla ; bar = 10 m .
# ::alignments 9-10|0.1 8-9|0.0 6-7|0 5-6|0.2 4-5|0.1.0.0 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:45.603
(b / bar-01 
      :ARG1 10 
      :domain-of (m / m 
            :ARG0-of (d / detail-01 
                  :ARG1 (a2 / ampulla))) 
      :op1-of (a / and))

# ::snt RM , Reissner 's membrane ; SC , spindle-shaped cells , SMC , strial marginal cells ; SV , stria vascularis ; SL , spiral ligament ; LIM , spiral limbus .
# ::tok RM , Reissner 's membrane ; SC , spindle-shaped cells , SMC , strial marginal cells ; SV , stria vascularis ; SL , spiral ligament ; LIM , spiral limbus .
# ::alignments 30-31|0.1.2.1 29-30|0.1.2 27-28|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 25-26|0.1.0.0 24-25|0.1.0 22-23|0.1.0.1.1.3.1+0.1.0.1.1.3.0.0+0.1.0.1.1.3.0+0.1.0.1.1.3 20-21|0.0 19-20|0 17-18|0.1.0.1.1.2.0.0+0.1.0.1.1.2.0+0.1.0.1.1.2 15-16|0.1.4.0 14-15|0.1.4 11-12|0.1.5.0.0+0.1.5.0+0.1.5 9-10|0.1.2.0.0 8-9|0.1.2.0 6-7|0.1.0.1.1.1.1+0.1.0.1.1.1.0.0+0.1.0.1.1.1.0+0.1.0.1.1.1 5-6|0.1.0.1.1 4-5|0.1.3 2-3|0.1.1.0+0.1.1+0.1 0-1|0.1.0.1.1.0.0.0+0.1.0.1.1.0.0+0.1.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:46.205
(s3 / stria 
      :mod-of (v / vasculari) 
      :poss (p / person 
            :ARG0-of (s2 / spiral-01 
                  :ARG1 (l2 / ligament) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "LIM") 
                        :op5-of (a / and 
                              :op1 (o4 / organization 
                                    :name (n7 / name 
                                          :op1 "RM")) 
                              :op2 (s5 / state 
                                    :name (n5 / name 
                                          :op1 "SC") 
                                    :wiki "South_Carolina") 
                              :op3 (o2 / organization 
                                    :name (n3 / name 
                                          :op1 "SV")) 
                              :op4 (c / country 
                                    :name (n2 / name 
                                          :op1 "SL") 
                                    :wiki "Sri_Lanka")))) 
            :name (n6 / name 
                  :op1 "Reissner") 
            :op1 (s / spiral-01 
                  :ARG0 (s4 / spindle-shap 
                        :mod-of (c3 / cell)) 
                  :ARG1 (l / limbu)) 
            :poss-of (m2 / membrane) 
            :poss-of (m / marginal 
                  :mod-of (c2 / cell)) 
            :poss-of (o3 / organization 
                  :name (n4 / name 
                        :op1 "SMC"))))

# ::snt BC , basal cells ; SP , spiral prominence epithelial cells ; RC , root cells ; OS , outer sulcus epithelial cells ; VHC , vestibular hair cells ; VTC , vestibular transitional cells ; VDC , vestibular dark cells ; arrows , basal cells at the top and bottom of stria vascularis form tight junctions with surface epithelial cells .
# ::tok BC , basal cells ; SP , spiral prominence epithelial cells ; RC , root cells ; OS , outer sulcus epithelial cells ; VHC , vestibular hair cells ; VTC , vestibular transitional cells ; VDC , vestibular dark cells ; arrows , basal cells at the top and bottom of stria vascularis form tight junctions with surface epithelial cells .
# ::alignments 60-61|0.4.5.0.0.0 59-60|0.4.5.0.0.0.1 58-59|0.4.5.0.0.0.0 56-57|0.4.5.0.0.0.1.0.1 55-56|0.4.5.0.0.0.1.0 54-55|0.4.5.0.0 53-54|0.4.5.0 52-53|0.4.5.0.1 50-51|0.4.5 49-50|0.4 48-49|0.4.4 45-46|0.4.0 44-45|0.4.0.0 42-43|0.4.5.0.0.0.1.0.6.2 40-41|0.4.5.0.0.0.1.0.6.1 39-40|0.4.5.0.0.0.1.0.6 38-39|0.4.5.0.0.0.1.0.6.1.0 36-37|0.4.3.0.0+0.4.3.0+0.4.3 34-35|0.4.5.0.0.0.1.0.0.0 33-34|0.4.5.0.0.0.1.0.0 32-33|0.4.5.0.0.0.1.0.0.0.0 30-31|0.4.2.0.0+0.4.2.0+0.4.2 28-29|0.4.5.0.0.0.1.0.4.1 27-28|0.4.5.0.0.0.1.0.4 26-27|0.4.5.0.0.0.1.0.4.0 24-25|0.4.1.0.0+0.4.1.0+0.4.1 22-23|0.4.5.0.0.0.1.0.5.0 21-22|0.4.5.0.0.0.1.0.5 20-21|0.4.5.0.0.0.1.0.5.0.1 19-20|0.4.5.0.0.0.1.0.5.0.0 17-18|0.4.5.0.0.0.1.0.6.0 15-16|0.4.5.0.0.0.1.0.3.0 14-15|0.4.5.0.0.0.1.0.3 12-13|0.3.0.0+0.3.0+0.3 10-11|0.2.0 9-10|0.2.0.0 8-9|0.2.0.0.0 7-8|0.2 5-6|0.1 4-5|0 3-4|0.4.5.0.0.0.1.0.2.0 2-3|0.4.5.0.0.0.1.0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:48.314
(a3 / and 
      :op1 "BC" 
      :op2 (s5 / SP) 
      :op3 (s4 / spiral-01 
            :ARG1 (c8 / cell 
                  :mod (e3 / epithelial 
                        :mod (p / prominence)))) 
      :op4 (o6 / organization 
            :name (n4 / name 
                  :op1 "RC")) 
      :op5 (a / and 
            :location-of (c2 / cell 
                  :mod (b2 / basal)) 
            :op1 (o3 / organization 
                  :name (n3 / name 
                        :op1 "VHC")) 
            :op2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "VTC")) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "VDC")) 
            :op4 (t2 / top) 
            :op5 (b / bottom 
                  :poss (v / vasculari 
                        :consist (f / form 
                              :prep-with (c / cell 
                                    :mod (s / surface) 
                                    :mod (e / epithelial 
                                          :ARG2-of (t / tight-05 
                                                :ARG0 (t3 / transitional 
                                                      :mod-of (c4 / cell 
                                                            :mod (v3 / vestibular))) 
                                                :ARG1 (j / junction) 
                                                :op1-of (b3 / basal 
                                                      :mod-of (c9 / cell)) 
                                                :op1-of (r / root 
                                                      :mod-of (c7 / cell)) 
                                                :op1-of (h / hair 
                                                      :mod (v4 / vestibular) 
                                                      :mod-of (c5 / cell)) 
                                                :op1-of (e2 / epithelial 
                                                      :mod-of (c6 / cell 
                                                            :mod (o4 / outer) 
                                                            :mod (s3 / sulcu))) 
                                                :purpose (d / dark-02 
                                                      :ARG0 (o5 / o) 
                                                      :ARG1 (c3 / cell 
                                                            :mod (v2 / vestibular)) 
                                                      :ARG2 (a2 / arrow)))))) 
                        :mod (s2 / stria)))))

# ::snt The extent of pendrin expression in spiral prominence cells and stria vascularis was determined by labeling KCNQ1 , a K + channel that is expressed in strial marginal cells , and ZO-1 , a tight junction protein that labels basal cells and thereby delineates the boundaries of stria vascularis .
# ::tok The extent of pendrin expression in spiral prominence cells and stria vascularis was determined by labeling KCNQ1 , a K + channel that is expressed in strial marginal cells , and ZO-1 , a tight junction protein that labels basal cells and thereby delineates the boundaries of stria vascularis .
# ::alignments 48-49|0.0.1.0.0.0 47-48|0.0.1.0.0.0.0 45-46|0.0.1.0.0 43-44|0.0.1.0 42-43|0.0.1.0.1 41-42|0.0.1 40-41|0.0.0 39-40|0.0.0.0 38-39|0.0 36-37|0 35-36|0.2 34-35|0.1 30-31|0.0.1.1.0.0 28-29|0.0.1.1.0.0.0.1 27-28|0.0.1.1.0.0.0.1.0 24-25|0.0.1.1.0.0.0 21-22|0.0.1.1.0.0.0.0 19-20|0.0.1.1.0.0.0.0.0 15-16|0.0.1.1.0 13-14|0.0.1.1.0.1 11-12|0.0.1.1.2 10-11|0.0.1.1.2.0 9-10|0.0.1.1 8-9|0.0.1.1.1.1 7-8|0.0.1.1.1.1.1 6-7|0.0.1.1.1.1.0 4-5|0.0.1.1.1 3-4|0.0.1.1.1.0 1-2|0.0.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:49.228
(p / protein 
      :ARG0-of (l / label-01 
            :ARG1 (c / cell 
                  :mod (b2 / basal)) 
            :op1-of (a / and 
                  :op2 (d / delineate-01 
                        :ARG1 (b / boundary 
                              :mod (v / vasculari 
                                    :mod (s / stria))) 
                        :manner (t / thereby)) 
                  :op2-of (a3 / and 
                        :ARG0-of (l2 / label-01 
                              :ARG1 (a2 / and 
                                    :ARG1-of (e / express-01 
                                          :ARG0 (c3 / channel 
                                                :mod (k / k)) 
                                          :manner (c2 / cell 
                                                :mod (m / marginal)))) 
                              :ARG1-of (d2 / determined-02 
                                    :ARG0 (e3 / extent))) 
                        :ARG1-of (e2 / express-01 
                              :ARG0 (p3 / pendrin) 
                              :location (c4 / cell 
                                    :ARG1-of (s3 / spiral-01) 
                                    :mod (p2 / prominence))) 
                        :op1 (v2 / vasculari 
                              :mod (s2 / stria))))) 
      :ARG1-of (t2 / tight-05) 
      :mod (j / junction))

# ::snt Dual labeling experiments demonstrated that pendrin is expressed in spindle-shaped cells , which are surface epithelial cells in stria vascularis adjacent to strial marginal cells near the borders of both the spiral prominence and Reissner 's membrane ( Fig. 1c ) .
# ::tok Dual labeling experiments demonstrated that pendrin is expressed in spindle-shaped cells , which are surface epithelial cells in stria vascularis adjacent to strial marginal cells near the borders of both the spiral prominence and Reissner 's membrane ( Fig. 1c ) .
# ::alignments 38-40|0.3.0.1+0.3.0.0+0.3.0+0.3 36-37|0.2.2 34-35|0.2.1.0+0.2.1+0.2 33-34|0 32-33|0.1 31-32|0.2.0.2.0 29-30|0.2.0.2.0.0 27-28|0.0 25-26|0.0.0 24-25|0.0.0.0 23-24|0.0.0.0.0 20-21|0.0.0.0.1 19-20|0.2.0.2.1.1 18-19|0.2.0.2.1.1.0 16-17|0.2.0.2.1 15-16|0.2.0.2.1.0 14-15|0.2.0.2 10-11|0.2.0.3 9-10|0.2.0.3.0 7-8|0.2.0 5-6|0.2.0.0 3-4|0.2.0.1 2-3|0.2.0.1.0 1-2|0.2.0.1.0.0 0-1|0.2.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:50.117
(a / and 
      :op1 (b2 / border 
            :ARG2-of (n3 / near-02 
                  :ARG1 (c / cell 
                        :mod (m2 / marginal) 
                        :prep-to-of (a2 / adjacent)))) 
      :op2 (p2 / prominence) 
      :op3 (p / person 
            :ARG0-of (e2 / express-01 
                  :ARG1 (p3 / pendrin) 
                  :ARG1-of (d / demonstrate-01 
                        :ARG0 (e3 / experiment-01 
                              :ARG1 (l / label-01) 
                              :mod (d2 / dual))) 
                  :ARG2 (s3 / surface 
                        :ARG0-of (s / spiral-01 
                              :ARG1 (b / both)) 
                        :mod-of (c2 / cell 
                              :mod (e / epithelial) 
                              :part-of (v / vasculari 
                                    :mod (s2 / stria)))) 
                  :manner (c3 / cell 
                        :mod (s4 / spindle-shap))) 
            :name (n2 / name 
                  :op1 "Reissner") 
            :poss-of (m / membrane)) 
      :op4 (t / thing 
            :name (n / name 
                  :op1 (f / Fig.) 
                  :op2 1c)))

# ::snt In situ hybridization in the vestibular labyrinth suggested that pendrin mRNA is expressed in non-sensory cells [ 8 ] .
# ::tok In situ hybridization in the vestibular labyrinth suggested that pendrin mRNA is expressed in non-sensory cells [ 8 ] .
# ::alignments 17-18|0.2 15-16|0.1.2 12-13|0.1 10-11|0.1.1 9-10|0.1.1.0 7-8|0 6-7|0.1.0 5-6|0.1.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:50.232
(s / suggest-01 
      :ARG0 (h / hybridization) 
      :ARG1 (e / express-01 
            :ARG0 (l / labyrinth 
                  :mod (v / vestibular)) 
            :ARG1 (m / mrna 
                  :mod (p / pendrin)) 
            :manner (c / cell)) 
      :ARG2 8)

# ::snt Using confocal immunocytochemistry on cryosections , we observed strong expression of the pendrin protein in the apical membrane of vestibular transitional cells in the utricle and ampullae ( Fig. 1g ,1 h ,1 i ) .
# ::tok Using confocal immunocytochemistry on cryosections , we observed strong expression of the pendrin protein in the apical membrane of vestibular transitional cells in the utricle and ampullae ( Fig. 1g ,1 h ,1 i ) .
# ::alignments 33-34|0.0.2.1.3 31-32|0 28-30|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 26-27|0.0.2.1.2 25-26|0.0.2.1 24-25|0.0.2.1.1 21-22|0.0.2.1.0 20-21|0.0.2.1.0.0 19-20|0.0.2.1.0.1 17-18|0.0.2.1.0.2 16-17|0.0.2.1.0.2.0 13-14|0.0.0 9-10|0.0 8-9|0.0.1 7-8|0.0.2 6-7|0.0.2.0 4-5|0.0.1.1 2-3|0.0.2.0.0.0 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:50.877
(h / h 
      :ARG0-of (e / express-01 
            :ARG1 (p / protein) 
            :ARG1-of (s / strong-02 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (f / Fig.) 
                              :op2 1g)) 
                  :concession (c2 / cryosection)) 
            :ARG1-of (o / observe-01 
                  :ARG0 (w / we 
                        :ARG0-of (u2 / use-01 
                              :ARG1 (i2 / immunocytochemistry))) 
                  :manner (a2 / and 
                        :location-of (c / cell 
                              :mod (t2 / transitional) 
                              :mod (v / vestibular) 
                              :poss-of (m / membrane 
                                    :mod (a3 / apical))) 
                        :op1 (u / utricle) 
                        :op2 (a / ampulla) 
                        :op3 (i / i)))))

# ::snt Dual labeling with KCNQ1 demonstrated that pendrin expression was clearly limited to vestibular transitional cells and did not extend to other non-sensory cells such as vestibular dark cells , which were clearly identified by the expression of KCNQ1 and KCNE1 in their apical membranes .
# ::tok Dual labeling with KCNQ1 demonstrated that pendrin expression was clearly limited to vestibular transitional cells and did not extend to other non-sensory cells such as vestibular dark cells , which were clearly identified by the expression of KCNQ1 and KCNE1 in their apical membranes .
# ::alignments 43-44|0.1.2 42-43|0.1.2.0 38-39|0.0 35-36|0 32-33|0.1 31-32|0.1.1 27-28|0.1.0 26-27|0.1.0.0 25-26|0.1.0.1 23-24|0.0.0.0.0.0 22-23|0.0.0.3.1 20-21|0.0.0.3.1.0 18-19|0.0.0.3 17-18|0.0.0.3.2 15-16|0.0.0 14-15|0.0.0.2 13-14|0.0.0.2.0 10-11|0.0.0.1 9-10|0.0.0.1.0 7-8|0.0.0.3.0 6-7|0.0.0.3.0.0 4-5|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:52.207
(e / express-01 
      :ARG1 (a2 / and 
            :op1 (a3 / and 
                  :ARG1-of (d2 / demonstrate-01 
                        :ARG0 (l2 / label-01 
                              :ARG1 (s / such) 
                              :mod (d3 / dual))) 
                  :op1 (l / limit-01 
                        :ARG1-of (c5 / clear-06)) 
                  :op2 (c4 / cell 
                        :mod (t / transitional)) 
                  :op3 (e2 / extend-01 
                        :ARG1 (e3 / express-01 
                              :ARG1 (p / pendrin)) 
                        :ARG4 (c3 / cell 
                              :mod (o / other)) 
                        :polarity -))) 
      :manner-of (i / identify-01 
            :ARG1 (c2 / cell 
                  :ARG1-of (d / dark-02) 
                  :mod (v / vestibular)) 
            :ARG1-of (c / clear-06) 
            :time (m / membran 
                  :mod (a / apical))))

# ::snt The onset of pendrin expression during development of the mouse inner ear has been determined to be embryonic day ( ED ) 13 [ 14 ] .
# ::tok The onset of pendrin expression during development of the mouse inner ear has been determined to be embryonic day ( ED ) 13 [ 14 ] .
# ::alignments 24-25|0.1.0.2.0.0 22-23|0.1.0.1 20-21|0.1.0.2.0.1.0.0+0.1.0.2.0.1.0+0.1.0.2.0.1 18-19|0.1 17-18|0.1.1 14-15|0 11-12|0.1.0.2 10-11|0.1.0.2.1 9-10|0.1.0.0 6-7|0.1.0.2.0 4-5|0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:52.392
(d2 / determined-02 
      :ARG0 (o2 / onset) 
      :ARG1 (d / day 
            :ARG0-of (e3 / express-01 
                  :ARG1 (m / mouse) 
                  :ARG2 13 
                  :location (e2 / ear 
                        :ARG1-of (d3 / develop-02 
                              :ARG2 14 
                              :op1-of (o / organization 
                                    :name (n / name 
                                          :op1 "ED"))) 
                        :mod (i / inner))) 
            :mod (e / embryonic)))

# ::snt Morphologically detectable differences in the inner ears of Slc26a4 + / + and Slc26a4 - / - mice become evident as early as ED 15 , when Slc26a4 - / - mice start to develop an enlarged endolymphatic space that persists into adulthood [ 14 ] .
# ::tok Morphologically detectable differences in the inner ears of Slc26a4 + / + and Slc26a4 - / - mice become evident as early as ED 15 , when Slc26a4 - / - mice start to develop an enlarged endolymphatic space that persists into adulthood [ 14 ] .
# ::alignments 44-45|0.1 42-43|0.0.1.2.1.3 40-41|0 38-39|0.0 36-37|0.0.0 34-35|0.0.1 32-33|0.0.1.1 31-32|0.0.1.0 29-30|0.0.1.2.2 24-25|0.0.1.2.1.1.0 23-24|0.0.1.1.0.1.0+0.0.1.1.0.1+0.0.1.1.0 21-22|0.0.1.1.0.0 19-20|0.0.1.2.1.2 18-19|0.0.1.2.1 17-18|0.0.1.2.1.0 15-16|0.0.1.2.0 12-13|0.0.1.2 10-11|0.0.1.1.1 6-7|0.0.1.2.1.1.2 5-6|0.0.1.2.1.1.2.0 2-3|0.0.1.2.1.1 1-2|0.0.1.2.1.1.1 0-1|0.0.1.2.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:54.242
(p / persist-01 
      :ARG0 (s / space 
            :ARG1-of (e / enlarge-01) 
            :ARG1-of (d / develop-02 
                  :ARG0 (m / mouse) 
                  :ARG1-of (s2 / start-01 
                        :ARG0 (o / organization 
                              :mod (e2 / early) 
                              :name (n / name 
                                    :op1 "ED")) 
                        :ARG2 (s5 / slash)) 
                  :op3-of (a2 / and 
                        :domain-of (s4 / slash) 
                        :op1 (b / become-01 
                              :ARG0 (m2 / mouse) 
                              :ARG1 (d2 / differ-01 
                                    :ARG0 15 
                                    :ARG1 (d3 / detectable 
                                          :mod (m3 / morphologically)) 
                                    :ARG2 (e4 / ear 
                                          :mod (i / inner))) 
                              :ARG2 (e3 / evident) 
                              :op1-of (a / adulthood)) 
                        :op2 (s3 / slash)))) 
      :ARG1 14)

# ::snt Interestingly , sensory hair cells in the cochlea appear normal until postnatal day ( PD ) 7 but show clear evidence of degeneration by PD 15 [ 14 ] .
# ::tok Interestingly , sensory hair cells in the cochlea appear normal until postnatal day ( PD ) 7 but show clear evidence of degeneration by PD 15 [ 14 ] .
# ::alignments 27-28|0.2.1.0.1 25-26|0.0 22-23|0.2.1.0 20-21|0.2.1 19-20|0.2.1.1 18-19|0.2 17-18|0 16-17|0.2.1.1.0 14-15|0.2.1.0.0 12-13|0.1.1.0 11-12|0.1.1.0.0 10-11|0.1.1.1 9-10|0.1.1 8-9|0.1 7-8|0.1.0 4-5|0.2.0 3-4|0.2.0.1 2-3|0.2.0.0 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:54.630
(c2 / contrast-01 
      :ARG0 15 
      :ARG1 (a / appear-02 
            :ARG0 (c3 / cochlea) 
            :ARG1 (n / normal-02 
                  :ARG1 (d2 / day 
                        :mod (p2 / postnatal)) 
                  :location (u / until)) 
            :manner (i / interesting)) 
      :ARG2 (s / show-01 
            :ARG0 (c4 / cell 
                  :mod (s2 / sensory) 
                  :mod (h / hair)) 
            :ARG1 (e / evidence-01 
                  :ARG1 (d / degenerate-01 
                        :ARG0 (p / pd) 
                        :ARG1 14) 
                  :ARG1-of (c / clear-06 
                        :ARG0 7))))

# ::snt These observations suggest that the cochlear environment supports the survival of sensory hair cells in spite of the enlargement of the endolymphatic duct .
# ::tok These observations suggest that the cochlear environment supports the survival of sensory hair cells in spite of the enlargement of the endolymphatic duct .
# ::alignments 22-23|0.1.1.1.0.0 18-19|0.1.1.1.0 15-16|0.1.1.1 13-14|0.1.1.0 12-13|0.1.1.0.1 11-12|0.1.1.0.0 9-10|0.1.1 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:54.885
(s5 / suggest-01 
      :ARG0 (o / observation 
            :mod (t / this)) 
      :ARG1 (s4 / support-01 
            :ARG0 (e2 / environment 
                  :mod (c2 / cochlear)) 
            :ARG1 (s3 / survive-01 
                  :ARG1 (c / cell 
                        :mod (s2 / sensory) 
                        :mod (h / hair)) 
                  :location (s / spite 
                        :poss (e / enlargement 
                              :poss (d / duct))))))

# ::snt A normal endolymphatic K + concentration , which is critical for hair cell survival [ 20 ] , is established at PD 3 [ 21 ] and may persist in Slc26a4 - / - at least until PD 7 .
# ::tok A normal endolymphatic K + concentration , which is critical for hair cell survival [ 20 ] , is established at PD 3 [ 21 ] and may persist in Slc26a4 - / - at least until PD 7 .
# ::alignments 38-39|0.0.1.1.1.1 36-37|0.1.1.1 32-33|0.0.1.0 30-31|0.1.1.0 28-29|0.1.1 27-28|0.1 26-27|0 24-25|0.0.1.1.1.0 22-23|0.0.0.1.0 21-22|0.0.2 19-20|0.0 15-16|0.1.0 13-14|0.0.1.1.1 12-13|0.0.1.1 11-12|0.0.1.1.0 9-10|0.0.1 5-6|0.0.0 3-4|0.0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:55.185
(a / and 
      :op1 (e / establish-01 
            :ARG1 (c3 / concentrate-02 
                  :ARG1 (k / k) 
                  :ARG1-of (n / normal-02 
                        :ARG0 3)) 
            :concession (c2 / critical-02 
                  :ARG0 (s / slash) 
                  :ARG1 (c / cell 
                        :mod (h / hair) 
                        :mod-of (s3 / survive-01 
                              :ARG0 21 
                              :ARG1 7))) 
            :location (p3 / pd)) 
      :op2 (p2 / possible-01 
            :ARG0 20 
            :ARG1 (p / persist-01 
                  :ARG1 (s2 / Slc26a4) 
                  :time (u / until))))

# ::snt The time period between PD 7 and 15 is the time when the endocochlear potential develops at the onset of hearing [ 22 ] .
# ::tok The time period between PD 7 and 15 is the time when the endocochlear potential develops at the onset of hearing [ 22 ] .
# ::alignments 22-23|0.0.2 20-21|0.0.1.0 18-19|0.0.1 15-16|0.0 14-15|0.0.0 13-14|0.0.0.0 10-11|0.0.3 7-8|0.0.1.0.1 6-7|0 5-6|0.0.1.0.2 4-5|0.0.1.0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:55.369
(a / and 
      :op1 (d / develop-02 
            :ARG0 (p / potential 
                  :mod (e / endocochlear)) 
            :ARG1 (o / onset 
                  :mod (h / hear-01 
                        :ARG0 (p2 / pd) 
                        :ARG1 15 
                        :ARG2 7)) 
            :ARG2 22 
            :time (t / time)) 
      :time (p3 / period 
            :mod (t2 / time)))

# ::snt We hypothesized that a lack of a normal endocochlear potential or an alteration of the endolymphatic K + concentration could account for deafness in Slc26a4 - / - mice .
# ::tok We hypothesized that a lack of a normal endocochlear potential or an alteration of the endolymphatic K + concentration could account for deafness in Slc26a4 - / - mice .
# ::alignments 28-29|0.0.2.0.0 26-27|0.0.0.0 22-23|0.0.1.1.0.0 20-21|0.0.1.1.0 19-20|0.0.1.1 18-19|0.1 16-17|0.1.0 12-13|0 10-11|0.0 9-10|0.0.2 8-9|0.0.2.1 7-8|0.0.2.0 4-5|0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:55.654
(a2 / alteration 
      :op2-of (o / or 
            :ARG1-of (l / lack-01 
                  :ARG0 (s / slash)) 
            :ARG2-of (h / hypothesize-01 
                  :ARG0 (w / we) 
                  :ARG1 (p / possible-01 
                        :ARG1 (a / account-01 
                              :ARG1 (d / deafnes)))) 
            :op1 (p2 / potential 
                  :ARG1-of (n / normal-02 
                        :ARG0 (m / mouse)) 
                  :mod (e / endocochlear))) 
      :poss (c / concentrate-02 
            :ARG1 (k / k)))

# ::snt Measurements revealed that the endocochlear potential was absent but that the endolymphatic K + concentration was normal in adult Slc26a4 - / - ( Fig. 2a ) .
# ::tok Measurements revealed that the endocochlear potential was absent but that the endolymphatic K + concentration was normal in adult Slc26a4 - / - ( Fig. 2a ) .
# ::alignments 25-26|0.0 21-22|0.1.0 19-20|0.1.1.0.2 18-19|0.1.1.0.1 16-17|0.1.1.0 14-15|0.1.1.0.0 12-13|0.1.1.0.0.0 8-9|0 7-8|0.1 5-6|0.1.1 4-5|0.1.1.1 1-2|0.1.2 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:55.880
(c2 / contrast-01 
      :ARG0 2a 
      :ARG1 (a2 / absent-01 
            :ARG0 (s / slash) 
            :ARG1 (p / potential 
                  :ARG0-of (n / normal-02 
                        :ARG1 (c / concentrate-02 
                              :ARG1 (k / k)) 
                        :ARG2 (a / adult) 
                        :manner (s2 / Slc26a4)) 
                  :mod (e / endocochlear)) 
            :ARG1-of (r / reveal-01 
                  :ARG0 (m / measurement))))

# ::snt No significant differences between Slc26a4 + / + and Slc26a4 - / - mice were found in perilymphatic ( Fig. 2a ) or plasma K + concentrations ( Slc26a4 + / + , 4.9  0.3 mM , n = 6 ; Slc26a4 - / - , 5.1  0.3 mM , n = 6 ) .
# ::tok No significant differences between Slc26a4 + / + and Slc26a4 - / - mice were found in perilymphatic ( Fig. 2a ) or plasma K + concentrations ( Slc26a4 + / + , 4.9  0.3 mM , n = 6 ; Slc26a4 - / - , 5.1  0.3 mM , n = 6 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:55.883
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt These observations suggest that a primary event leading to deafness in Slc26a4 - / - mice , and potentially in patients suffering from Pendred syndrome , is the loss of the endocochlear potential .
# ::tok These observations suggest that a primary event leading to deafness in Slc26a4 - / - mice , and potentially in patients suffering from Pendred syndrome , is the loss of the endocochlear potential .
# ::alignments 32-33|0.1.0.1.0 31-32|0.1.0.1 28-29|0.1.0.1.0.0 24-25|0.1.0.0.1.0 23-24|0.1.0.0.1.0.0 21-22|0.1.0.0.1 20-21|0.1.0.0.0.1+0.1.0.0.0+0.1.0.0 18-19|0.3 17-18|0.2 15-16|0.4 13-14|0.1.0.0.0.0 9-10|0.1.0.2 7-8|0.1.0 6-7|0.1 5-6|0.1.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.384
(s4 / suggest-01 
      :ARG0 (o / observation 
            :mod (t / this)) 
      :ARG1 (e2 / event 
            :ARG1-of (l2 / lead-01 
                  :ARG0 (p3 / person 
                        :ARG0-of (h / have-rel-role-91 
                              :ARG1 (s3 / slash) 
                              :ARG2 (p4 / patient)) 
                        :ARG0-of (s2 / suffer-01 
                              :ARG1 (s / syndrome 
                                    :mod (p2 / pendr)))) 
                  :ARG2 (e / endocochlear 
                        :mod-of (p / potential 
                              :poss-of (l / loss))) 
                  :ARG4 (d / deafnes)) 
            :mod (p6 / primary)) 
      :op1-of (a / and) 
      :op1-of (p5 / potential) 
      :op1-of (m / mouse))

# ::snt Degeneration of hair cells is probably a response to the loss of the endocochlear potential .
# ::tok Degeneration of hair cells is probably a response to the loss of the endocochlear potential .
# ::alignments 14-15|0.0.0 13-14|0.0.0.0 10-11|0.0 7-8|0 5-6|0.2 3-4|0.1.0 2-3|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.423
(r / respond-01 
      :ARG1 (l / loss 
            :poss (p / potential 
                  :mod (e / endocochlear))) 
      :ARG2 (d / degeneration 
            :domain (c / cell 
                  :mod (h / hair))) 
      :time (p2 / probable))

# ::snt Potential , K + concentrations and pigmentation of stria vascularis in Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Potential , K + concentrations and pigmentation of stria vascularis in Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 20-21|0.0.3 18-19|0.0.3.0 15-16|0 13-14|0.1 9-10|0.0.1.1 8-9|0.0.1.1.0 6-7|0.0.2 5-6|0.0 4-5|0.0.1 2-3|0.0.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.487
(a / and 
      :op1 (a2 / and 
            :op1 (k / k) 
            :op2 (c / concentration 
                  :mod (p2 / potential) 
                  :part (v / vasculari 
                        :mod (s3 / stria))) 
            :op3 (p / pigmentation) 
            :op4 (m / mouse 
                  :mod (s / slash))) 
      :op2 (s2 / slash))

# ::snt a : Endocochlear potential and K + concentrations in endolymph and perilymph at the apex ( A ) and base ( B ) of the cochlea .
# ::tok a : Endocochlear potential and K + concentrations in endolymph and perilymph at the apex ( A ) and base ( B ) of the cochlea .
# ::alignments 25-26|0.4.1.0 21-22|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 19-20|0.4.1 18-19|0.4 14-15|0.4.0 11-12|0.0.1 10-11|0.0 9-10|0.0.0 7-8|0.3 5-6|0.2 4-5|0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.584
(a4 / and 
      :location (a3 / and 
            :op1 (e / endolymph) 
            :op2 (p / perilymph) 
            :op3 (l / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -)) 
      :op1 (p2 / potential) 
      :op2 (k / k) 
      :op3 (c2 / concentration) 
      :op4 (a / and 
            :op1 (a2 / apex) 
            :op2 (b / base 
                  :poss (c / cochlea))))

# ::snt Numbers adjacent to symbols denote number of measurements .
# ::tok Numbers adjacent to symbols denote number of measurements .
# ::alignments 7-8|0.0.2 5-6|0.0 4-5|0 3-4|0.0.0.0+0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.613
(d / denote-01 
      :mod-of (n / number 
            :mod (t / thing 
                  :ARG1-of (s / symbolize-01)) 
            :prep-to-of (a / adjacent 
                  :ARG1-of (n2 / number-01)) 
            :quant-of (m / measure-01)))

# ::snt b-d : Pigmentation of stria vascularis in Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok b-d : Pigmentation of stria vascularis in Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 16-17|0.0.2 14-15|0.1 11-12|0 9-10|0.0.2.0 5-6|0.0 4-5|0.0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.650
(a / and 
      :location-of (v / vasculari 
            :mod (s3 / stria) 
            :mod-of (p / pigmentation) 
            :poss (m / mouse 
                  :mod (s2 / slash))) 
      :op1 (s / slash))

# ::snt b : View of stria vascularis through the bony capsule of the cochlea .
# ::tok b : View of stria vascularis through the bony capsule of the cochlea .
# ::alignments 12-13|0.0.0 9-10|0.0 8-9|0 5-6|0.0.0.1.0 4-5|0.0.0.1.0.0 2-3|0.0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.720
(b / bony 
      :mod-of (c2 / capsule 
            :poss (c / cochlea 
                  :poss (b2 / b) 
                  :topic-of (v2 / view-01 
                        :ARG1 (v / vasculari 
                              :mod (s / stria))))))

# ::snt OW , oval window , RW , round window ; arrows , stria vascularis .
# ::tok OW , oval window , RW , round window ; arrows , stria vascularis .
# ::alignments 13-14|0.0 12-13|0 10-11|0.2.0 9-10|0.2.0.0 8-9|0.2.1 7-8|0.2 3-4|0.1.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.759
(s / stria 
      :mod-of (v / vasculari) 
      :mod-of (o / oval 
            :mod-of (w2 / window)) 
      :op1-of (r / round 
            :location (a / arrow 
                  :op1-of (a2 / and)) 
            :mod-of (w / window)))

# ::snt c-d : Whole-mounts of stria vascularis isolated from age-matched mice .
# ::tok c-d : Whole-mounts of stria vascularis isolated from age-matched mice .
# ::alignments 9-10|0.0 8-9|0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.812
(a / age-match 
      :mod-of (m / mouse 
            :ARG1-of (i / isolate-01 
                  :ARG0 (v / vasculari 
                        :mod (s / stria) 
                        :mod-of (w / whole-mount)))))

# ::snt c : Laser-scanning images , bar = 10 m , d : Quantification of pigmentation based on optical density .
# ::tok c : Laser-scanning images , bar = 10 m , d : Quantification of pigmentation based on optical density .
# ::alignments 18-19|0.2 17-18|0.2.0 15-16|0 14-15|0.1 12-13|0.1.0 10-11|0.3.1 8-9|0.3.0 7-8|0.0 5-6|0.3 3-4|0.4.0 2-3|0.4 0-1|0.5 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:56.942
(b / base-02 
      :ARG0 10 
      :ARG1 (p / pigmentation 
            :mod-of (q / quantification)) 
      :ARG2 (d / density 
            :mod (o / optics)) 
      :ARG2-of (b2 / bar-01 
            :ARG0 (m / m) 
            :ARG1 (d2 / d)) 
      :op1-of (l / laser-scann 
            :mod-of (i / image)) 
      :op1-of (c / c))

# ::snt The endocochlear potential is generated by stria vascularis in the lateral wall of the cochlea [ 17,23 ] .
# ::tok The endocochlear potential is generated by stria vascularis in the lateral wall of the cochlea [ 17,23 ] .
# ::alignments 14-15|0.3 11-12|0.2 10-11|0.2.0 7-8|0.0 6-7|0.0.0 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:57.027
(g / generate-01 
      :ARG0 (v / vasculari 
            :mod (s / stria)) 
      :ARG1 (p / potential 
            :mod (e / endocochlear)) 
      :location (w / wall 
            :mod (l / lateral)) 
      :op1-of (c / cochlea))

# ::snt The potential is generated across the basal cell barrier of stria vascularis by the K + channel KCNJ10 located in intermediate cells [ 24 ] , which are connected to basal cells by a high density of gap junctions [ 25 ] .
# ::tok The potential is generated across the basal cell barrier of stria vascularis by the K + channel KCNJ10 located in intermediate cells [ 24 ] , which are connected to basal cells by a high density of gap junctions [ 25 ] .
# ::alignments 40-41|0.1.4.0 38-39|0.0.1 37-38|0.0.1.0 35-36|0.0 34-35|0.0.0 31-32|0.2 30-31|0.2.0 28-29|0 23-24|0.1.0 21-22|0.1.4.2 20-21|0.1.4.2.0 18-19|0.1.4 17-18|0.1.4.1.0.1+0.1.4.1.0+0.1.4.1 16-17|0.1.4.1.0.0 14-15|0.0.0.0 11-12|0.1.2.1 10-11|0.1.2.1.0 8-9|0.1.2 7-8|0.1.2.0 6-7|0.1.2.2 4-5|0.1.3 3-4|0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:57.656
(c2 / connect-01 
      :ARG0 (d / density 
            :ARG1-of (h / high-02 
                  :ARG0 (k / k)) 
            :mod (j / junction 
                  :mod (g / gap))) 
      :ARG1 (g2 / generate-01 
            :ARG0 24 
            :ARG1 (p / potential) 
            :ARG2 (b2 / barrier 
                  :mod (c5 / cell) 
                  :mod (v / vasculari 
                        :mod (s / stria)) 
                  :mod (b3 / basal)) 
            :location (a / across) 
            :manner (l / locate-01 
                  :ARG0 25 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :name-of (c4 / channel) 
                              :op1 "KCNJ10")) 
                  :location (c3 / cell 
                        :mod (i / intermediate)))) 
      :ARG2 (c / cell 
            :mod (b / basal)))

# ::snt Marginal cells of stria vascularis , which form the barrier toward endolymph , transport K + from the intrastrial space into endolymph and keep the K + concentration low adjacent to the KCNJ10 K + channel [ 26 ] .
# ::tok Marginal cells of stria vascularis , which form the barrier toward endolymph , transport K + from the intrastrial space into endolymph and keep the K + concentration low adjacent to the KCNJ10 K + channel [ 26 ] .
# ::alignments 37-38|0.2.0 35-36|0.2.1.0.1 32-34|0.2.1.0.1.0.0.1+0.2.1.0.1.0.0.0+0.2.1.0.1.0.0+0.2.1.0.1.0 29-30|0.2.1.0 28-29|0.2.1.0.0 27-28|0.2.1 23-24|0.2 22-23|0 21-22|0.1.2 19-20|0.1.3 14-15|0.1.1 13-14|0.1 11-12|0.1.0 9-10|0.0.1 7-8|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:58.270
(a2 / and 
      :op1 (f / form-01 
            :ARG0 (v / vasculari 
                  :mod (s2 / stria) 
                  :part (c3 / cell 
                        :mod (m / marginal))) 
            :ARG1 (b / barrier)) 
      :op2 (t2 / transport-01 
            :ARG0 (e2 / endolymph) 
            :ARG1 (k4 / k) 
            :ARG2 (e / endolymph) 
            :ARG4 (s / space)) 
      :op3 (k3 / keep-01 
            :ARG0 26 
            :ARG1 (c2 / concentrate-02 
                  :domain-of (a / adjacent 
                        :ARG1-of (l / low-04) 
                        :prep-to (c / channel 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 (k / KCNJ10) 
                                          :op2 (k2 / K))))))))

# ::snt To determine the cause of the loss of the endocochlear potential in Slc26a4 - / - mice , we first determined whether intermediate cells are present in stria vascularis , since a loss of intermediate cells is known to lead to a loss of the endocochlear potential [ 27,28 ] .
# ::tok To determine the cause of the loss of the endocochlear potential in Slc26a4 - / - mice , we first determined whether intermediate cells are present in stria vascularis , since a loss of intermediate cells is known to lead to a loss of the endocochlear potential [ 27,28 ] .
# ::alignments 46-47|0.2 39-40|0.1.0.0.0 37-38|0.1.0.0 35-36|0.1.0.0.0.0 34-35|0.1.0.0.0.0.0 30-31|0.1.0.0.1 28-29|0.1.1 27-28|0.1.1.0 25-26|0.1 23-24|0.1.0 22-23|0.1.0.1 20-21|0 18-19|0.0 16-17|0.3.1.1 14-15|0.3.0 10-11|0.3.1.0.0 9-10|0.3.1.0.0.0 6-7|0.3.1.0 3-4|0.3.1 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:58.628
(d / determine-01 
      :ARG0 (w / we) 
      :ARG1 (p2 / present 
            :domain (c2 / cell 
                  :ARG0-of (k / know-02 
                        :ARG1 (l / lead-03 
                              :ARG1 (c / cell 
                                    :mod (i / intermediate))) 
                        :op1-of (s / since)) 
                  :mod (i2 / intermediate)) 
            :topic (v / vasculari 
                  :mod (s2 / stria))) 
      :ARG2 (p / potential) 
      :time (d2 / determine-01 
            :ARG0 (s3 / slash) 
            :ARG1 (c3 / cause-01 
                  :ARG1 (l2 / loss 
                        :poss (p3 / potential 
                              :mod (e / endocochlear))) 
                  :location (m / mouse))))

# ::snt Intermediate cells of stria vascularis were visualized by their pigmentation .
# ::tok Intermediate cells of stria vascularis were visualized by their pigmentation .
# ::alignments 9-10|0.0 6-7|0 4-5|0.1 3-4|0.1.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:58.657
(v / visualize-01 
      :ARG0 (p / pigmentation) 
      :ARG1 (v2 / vasculari 
            :consist (c / cell 
                  :mod (i / intermediate)) 
            :mod (s / stria)))

# ::snt Pigmentation was present in stria vascularis of Slc26a4 - / - mice ( Fig. 2b ) , which suggests that intermediate cells are present .
# ::tok Pigmentation was present in stria vascularis of Slc26a4 - / - mice ( Fig. 2b ) , which suggests that intermediate cells are present .
# ::alignments 23-24|0.0.0 21-22|0.0 20-21|0 18-19|0.0.0.0 13-15|0.0.0.0.1.0.1.0.1+0.0.0.0.1.0.1.0.0+0.0.0.0.1.0.1.0+0.0.0.0.1.0.1 11-12|0.0.0.0.0 9-10|0.0.0.0.1.1.1 7-8|0.0.0.0.1 5-6|0.0.0.0.1.1 4-5|0.0.0.0.1.1.0 2-3|0.0.0.0.1.0.0 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:59.026
(i / intermediate 
      :mod-of (c / cell 
            :domain-of (p / present 
                  :ARG1-of (s / suggest-01 
                        :ARG0 (m / mouse) 
                        :ARG2 (s3 / Slc26a4 
                              :mod-of (p3 / pigmentation 
                                    :domain-of (p2 / present) 
                                    :poss-of (t / thing 
                                          :name (n / name 
                                                :op1 (f / Fig.) 
                                                :op2 2b))) 
                              :mod-of (v / vasculari 
                                    :mod (s4 / stria) 
                                    :purpose (s2 / slash)))))))

# ::snt Interestingly , pigmentation of stria vascularis was much stronger in Slc26a4 - / - than in Slc26a4 + / + mice .
# ::tok Interestingly , pigmentation of stria vascularis was much stronger in Slc26a4 - / - than in Slc26a4 + / + mice .
# ::alignments 20-21|0.1.1 18-19|0.1 12-13|0.1.0.0 10-11|0.1.0.1 8-9|0.1.0 7-8|0.1.0.3 5-6|0.0 4-5|0 2-3|0.0.0 0-1|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:47:59.139
(s5 / stria 
      :mod-of (v / vasculari 
            :mod-of (p / pigmentation)) 
      :mod-of (s / slash 
            :op1 (s4 / strong-02 
                  :ARG1 (s2 / slash) 
                  :ARG2 (s3 / Slc26a4) 
                  :manner (i / interesting) 
                  :mod (m2 / much)) 
            :op2 (m / mouse)))

# ::snt To determine in greater detail the cause of the loss of the endocochlear potential in Slc26a4 - / - mice , we isolated total RNA from stria vascularis and spiral ganglia of young ( 1 -- 4 month ) Slc26a4 + / + and both young and old ( ~ 12 month ) Slc26a4 - / - mice , assessed amounts of isolated tissues by quantification of 18S rRNA , and quantified the expression of KCNJ10 mRNA .
# ::tok To determine in greater detail the cause of the loss of the endocochlear potential in Slc26a4 - / - mice , we isolated total RNA from stria vascularis and spiral ganglia of young ( 1 -- 4 month ) Slc26a4 + / + and both young and old ( ~ 12 month ) Slc26a4 - / - mice , assessed amounts of isolated tissues by quantification of 18S rRNA , and quantified the expression of KCNJ10 mRNA .
# ::alignments 76-77|0.1 75-76|0.2.1.4.0.0+0.2.1.4.0+0.2.1.4 73-74|0 71-72|0.2 70-71|0.2.1 68-69|0.2.1.1.0 67-68|0.0 65-66|0.2.1.2 63-64|0.2.1.1.1 62-63|0.2.1.1.1.0 60-61|0.2.1.1.1.1 59-60|0.2.1.1 57-58|0.2.0 55-56|0.2.1.1.1.0.0 51-52|0.2.1.3.3.1.1.0.0.0.1+0.2.1.3.3.1.1.0.0.0 50-51|0.2.1.3.3.1.1.0.0 47-48|0.2.1.3.1 46-47|0.2.1.3 45-46|0.2.1.3.0 44-45|0.2.1.0 43-44|0.2.1.3.2 41-42|0.2.1.3.2.0 37-38|0.2.1.3.3.1.1.0.1.1+0.2.1.3.3.1.1.0.1 36-37|0.2.1.3.3.1.1.0.1.0 34-35|0.2.1.3.3.1.1.0.0.0.0 32-33|0.2.1.3.3.0.1.0.0 30-31|0.2.1.3.3.4 29-30|0.2.1.3.3.4.0 28-29|0.2.1.3.3 27-28|0.2.1.3.3.3 26-27|0.2.1.3.3.3.0 24-25|0.2.1.3.3.1.1 23-24|0.2.1.3.3.1.1.0 22-23|0.2.1.3.3.1 21-22|0.2.1.3.3.1.0 19-20|0.2.1.3.3.2 17-18|0.2.1.3.3.0.1.0.1 15-16|0.2.1.3.3.0.0.0.0 13-14|0.2.1.3.3.0.0.0 12-13|0.2.1.3.3.0.0.0.1 9-10|0.2.1.3.3.0.0 6-7|0.2.1.3.3.0 4-5|0.2.1.3.3.0.1.0 3-4|0.2.1.3.3.0.1.0.2 1-2|0.2.1.3.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:03.206
(e / express-01 
      :ARG0 18 
      :ARG1 (m / mrna) 
      :ARG1-of (q / quantify-01 
            :ARG0 (m2 / mouse) 
            :op3-of (a / and 
                  :mod (b / both) 
                  :op1 (a3 / assess-01 
                        :ARG0 (r / rRNA) 
                        :ARG1 (t2 / tissue 
                              :ARG1-of (i / isolate-01 
                                    :ARG0 (s / slash)) 
                              :quant (a2 / amount))) 
                  :op2 (q2 / quantification) 
                  :op3-of (a4 / and 
                        :op1 (y / young) 
                        :op2 (o / old) 
                        :op2-of (a5 / and 
                              :op1 (s2 / slash)) 
                        :op4-of (a6 / and 
                              :ARG0-of (c / cause-01 
                                    :ARG1 (l / loss 
                                          :poss (p / potential 
                                                :location (s6 / Slc26a4) 
                                                :mod (e2 / endocochlear))) 
                                    :ARG1-of (d2 / determine-01 
                                          :ARG2 (d / detail-01 
                                                :ARG0 (y2 / young) 
                                                :ARG1 (s5 / slash) 
                                                :mod (g2 / great)))) 
                              :ARG3-of (i2 / isolate-01 
                                    :ARG0 (w / we) 
                                    :ARG1 (r2 / rna 
                                          :ARG2-of (t5 / total-01 
                                                :ARG0 (12 / 12 
                                                      :quant-of (t3 / temporal-quantity 
                                                            :quant 1 
                                                            :unit (m3 / month))) 
                                                :ARG1 (t4 / temporal-quantity 
                                                      :quant 4 
                                                      :unit (m4 / month))))) 
                              :op1 (m5 / mouse) 
                              :op2 (v / vasculari 
                                    :mod (s4 / stria)) 
                              :op3 (g / ganglion 
                                    :ARG1-of (s3 / spiral-01)))) 
                  :op4 (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10")))))

# ::snt Quantities of stria vascularis isolated from these different mice were similar , since no significant differences were found in the numbers of 18S rRNA molecules ( log ( rRNA ) = 9.46  0.08 , n = 17 , pooled data ) .
# ::tok Quantities of stria vascularis isolated from these different mice were similar , since no significant differences were found in the numbers of 18S rRNA molecules ( log ( rRNA ) = 9.46  0.08 , n = 17 , pooled data ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:03.210
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In contrast , quantities of spiral ganglia isolated from young and old Slc26a4 - / - mice ( log ( rRNA ) = 9.04  0.18 , n = 4 and 9.29  0.15 , n = 6 ) were significantly smaller than in Slc26a4 + / + mice ( log ( rRNA ) = 9.48  0.19 , n = 7 ) , consistent with morphometric data ( see below ) .
# ::tok In contrast , quantities of spiral ganglia isolated from young and old Slc26a4 - / - mice ( log ( rRNA ) = 9.04  0.18 , n = 4 and 9.29  0.15 , n = 6 ) were significantly smaller than in Slc26a4 + / + mice ( log ( rRNA ) = 9.48  0.19 , n = 7 ) , consistent with morphometric data ( see below ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:03.220
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Expression of KCNJ10 mRNA was normal in stria vascularis and spiral ganglia of young Slc26a4 - / - mice but significantly reduced in old Slc26a4 - / - mice ( Fig. 3 ) .
# ::tok Expression of KCNJ10 mRNA was normal in stria vascularis and spiral ganglia of young Slc26a4 - / - mice but significantly reduced in old Slc26a4 - / - mice ( Fig. 3 ) .
# ::alignments 31-32|0.1.0 28-29|0.1.1.0 26-27|0.1.2.1.0 23-24|0.1.2.0.0.0 21-22|0.1 20-21|0.1.1 19-20|0 18-19|0.0 16-17|0.1.2.0.1.1 14-15|0.1.2.3.0 13-14|0.1.2.3.0.0 11-12|0.1.2.3 10-11|0.1.2.0.0 9-10|0.1.2 8-9|0.1.2.2 7-8|0.1.2.2.0 5-6|0.1.2.1 3-4|0.1.2.0 2-3|0.1.2.0.1.0.0+0.1.2.0.1.0+0.1.2.0.1 0-1|0.1.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:03.802
(c / contrast-01 
      :ARG1 (m2 / mouse) 
      :ARG2 (r / reduce-01 
            :ARG0 3 
            :ARG1-of (s2 / significant-02 
                  :ARG0 (m / mouse)) 
            :op5-of (a / and 
                  :op1 (m3 / mrna 
                        :ARG0-of (s5 / spiral-01 
                              :ARG1 (o / old)) 
                        :mod (t / thing 
                              :name (n2 / name 
                                    :op1 "KCNJ10") 
                              :op1-of (s3 / slash))) 
                  :op2 (n / normal-02 
                        :ARG0 (s / slash) 
                        :ARG1 (e / expression)) 
                  :op3 (v / vasculari 
                        :mod (s6 / stria)) 
                  :op4 (g / ganglion 
                        :mod (s4 / Slc26a4 
                              :mod (y / young))))))

# ::snt Quantifications of KCNQ1 and KCNQ4 mRNA were used to assess possible cross-contamination between the stria vascularis and spiral ganglia preparations based on the assumptions that ( 1 ) KCNQ1 is expressed in cells of the stria vascularis but not the spiral ganglia preparation and ( 2 ) KCNQ4 is expressed in cells of the spiral ganglia but not the stria vascularis preparation .
# ::tok Quantifications of KCNQ1 and KCNQ4 mRNA were used to assess possible cross-contamination between the stria vascularis and spiral ganglia preparations based on the assumptions that ( 1 ) KCNQ1 is expressed in cells of the stria vascularis but not the spiral ganglia preparation and ( 2 ) KCNQ4 is expressed in cells of the spiral ganglia but not the stria vascularis preparation .
# ::alignments 61-62|0.1.0.0.1.0.0.2.1.0 60-61|0.1.0.0.1.0.0.2.1.0.2 59-60|0.1.0.0.1.0.0.2.1.0.1 57-58|0.1.0.0.1.0.0.2.1.0.0 56-57|0.1.0.0.1.0.0.2.1.1 55-56|0.1.0.0.1.0.0.2.1.3.0 54-55|0.1.0.0.1.0.0.2.1.3.0.0 51-52|0.1.0.0.1.0.0.2.1.3 49-50|0.1.0.0.1.0.0.2.1 45-46|0.1.0.0.1.0.0.2.1.2 43-44|0.1.0.0.1.0.0.2 42-43|0.1.0.0.1.0.0.2.0 41-42|0.1.0.0.1.0.0.2.0.2 40-41|0.1.0.0.1.0.0.2.0.1 38-39|0.1.0.0.1.0.0.2.0.0 37-38|0 36-37|0.1.0.0.1.0.0.1.0 35-36|0.1.0.0.1.0.0.1.0.0 32-33|0.1.0.0.1.0.0.1 30-31|0.1.0.0.1.0.0 26-27|0.1.0.0.1.0.0.0 23-24|0.1.0.0.1.0.1+0.1.0.0.1.0 20-21|0.1.0.0.1 19-20|0.1.1 18-19|0.1.1.1 17-18|0.1.1.0 16-17|0.1 15-16|0.1.0 14-15|0.1.0.0.2.0 10-11|0.0 9-10|0.1.0.0 7-8|0.1.0.0.2 4-6|0.1.0.0.2.1.0.0.1+0.1.0.0.2.1.0.0.0+0.1.0.0.2.1.0.0+0.1.0.0.2.1.0 3-4|0.1.0.0.2.1 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:05.252
(c3 / contrast-01 
      :ARG1 (p4 / possible-01) 
      :ARG2 (a3 / and 
            :op1 (v3 / vasculari 
                  :ARG0-of (a4 / assess-01 
                        :ARG1 (q / quantification) 
                        :ARG1-of (b / base-02 
                              :ARG2 (t / thing 
                                    :ARG1-of (e2 / express-01 
                                          :li 1 
                                          :manner (c4 / cell 
                                                :part-of (v2 / vasculari 
                                                      :mod (s4 / stria))) 
                                          :op1-of (a / and 
                                                :op2 (p2 / prepare-02 
                                                      :ARG1 - 
                                                      :ARG1-of (s3 / spiral-01) 
                                                      :ARG2 (g2 / ganglion)) 
                                                :op3 (e / express-01 
                                                      :ARG1 (p / prepare-02 
                                                            :ARG0 - 
                                                            :ARG1 (s / stria) 
                                                            :ARG2 (v / vasculari)) 
                                                      :ARG1-of (c / contrast-01) 
                                                      :li 2 
                                                      :manner (c2 / cell 
                                                            :part-of (g / ganglion 
                                                                  :ARG1-of (s2 / spiral-01)))))) 
                                    :ARG1-of (a2 / assume-02))) 
                        :ARG2-of (u / use-01 
                              :ARG0 (s6 / stria) 
                              :ARG1 (a5 / and 
                                    :op1 (t2 / thing 
                                          :name (n / name 
                                                :op1 (k / KCNQ4) 
                                                :op2 (m / mRNA))))))) 
            :op2 (p3 / prepare-02 
                  :ARG1-of (s5 / spiral-01) 
                  :ARG2 (g3 / ganglion))))

# ::snt The number of KCNQ1 mRNA molecules in stria vascularis was 24-fold greater than in spiral ganglia , and the number of KCNQ4 mRNA molecules in spiral ganglia was 5-fold greater than in stria vascularis .
# ::tok The number of KCNQ1 mRNA molecules in stria vascularis was 24-fold greater than in spiral ganglia , and the number of KCNQ4 mRNA molecules in spiral ganglia was 5-fold greater than in stria vascularis .
# ::alignments 33-34|0.0 32-33|0.0.0 29-30|0.1.1.0.0.0 26-27|0.1.1.0.0.1.1 25-26|0.1.1.0.0.1 23-24|0.1.1.0.0.1.1.0 22-23|0.1.1.0.0.1.1.0.0 19-20|0.1.1.0.0.1.1.0.1 17-18|0 15-16|0.1.1.0 14-15|0.1.1.0.0 11-12|0.1.1.0.0.1.0 8-9|0.1.1.1 7-8|0.1.1.1.0 5-6|0.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:05.562
(a / and 
      :op1-of (v / vasculari 
            :mod (s / stria)) 
      :poss (m3 / molecule 
            :mod (m4 / mrna 
                  :mod (k / KCNQ1)) 
            :quant (n2 / number 
                  :poss-of (g3 / ganglion 
                        :ARG1-of (s3 / spiral-01 
                              :ARG0 (g / great) 
                              :purpose (s2 / spiral-01 
                                    :ARG0 (g4 / great) 
                                    :ARG1 (g2 / ganglion 
                                          :location-of (m / molecule 
                                                :mod (m2 / mrna) 
                                                :quant (n / number)))))) 
                  :quant-of (v2 / vasculari 
                        :mod (s4 / stria)))))

# ::snt These observations validate our measurements of KCNJ10 and KCNQ1 by demonstrating that the microdissected preparations of stria vascularis and spiral ganglia were 98 % and 78 % pure , respectively .
# ::tok These observations validate our measurements of KCNJ10 and KCNQ1 by demonstrating that the microdissected preparations of stria vascularis and spiral ganglia were 98 % and 78 % pure , respectively .
# ::alignments 29-30|0.0 27-28|0.1.0.0.0.0.0.2 26-27|0.1.0.0.0.0.0.2.0 25-26|0.1.0.0.0.0.0.2.0.0 24-25|0 23-24|0.2 22-23|0.2.0 20-21|0.1.0.2 19-20|0.1.0.0.0.0.0.3 18-19|0.1.0 17-18|0.1.0.1 16-17|0.1.0.1.0 14-15|0.1 13-14|0.1.0.3 10-11|0.1.0.0 7-8|0.1.0.0.0 6-7|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 4-5|0.1.0.0.0.0.0 3-4|0.1.0.0.0.0.0.1 2-3|0.1.0.0.0.0 1-2|0.1.0.0.0.0.0.0 0-1|0.1.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:06.647
(a / and 
      :mod (r / respective) 
      :op1 (p4 / prepare-02 
            :ARG1 (a2 / and 
                  :ARG0-of (d / demonstrate-01 
                        :ARG1 (a3 / and 
                              :ARG0-of (v2 / validate-01 
                                    :ARG1 (m2 / measure-01 
                                          :ARG0 (o / observation 
                                                :mod (t2 / this)) 
                                          :ARG1 (w / we) 
                                          :ARG2-of (p / pure-02 
                                                :ARG1 (p2 / percentage-entity 
                                                      :value 78)) 
                                          :ARG2-of (s / spiral-01))) 
                              :op1 (t / thing 
                                    :name (n / name 
                                          :op1 "KCNJ10")))) 
                  :op1 (v / vasculari 
                        :mod (s2 / stria)) 
                  :op2 (g / ganglion) 
                  :quant (m / microdissect))) 
      :op2 (p3 / percentage-entity 
            :value 98))

# ::snt Quantification of KCNJ10 and KCNQ1 mRNA expression in stria vascularis and spiral ganglia of Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Quantification of KCNJ10 and KCNQ1 mRNA expression in stria vascularis and spiral ganglia of Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 23-24|0.0.1.1.0 21-22|0.0.1.1.2.2 18-19|0 16-17|0.0.1.2.0 12-13|0.0.1.1.2.1 11-12|0.0.1.2 10-11|0.0.1.1.2 9-10|0.0.1.1.1 8-9|0.0.1.1.1.0 6-7|0.0.1.1 4-6|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 3-4|0.0.1 2-3|0.0.0.0+0.0.0+0.0 0-1|0.0.1.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:06.837
(a / and 
      :op1 (t2 / thing 
            :name (n2 / name 
                  :op1 "KCNJ10") 
            :op1-of (a3 / and 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 (k / KCNQ1) 
                              :op2 (m2 / mRNA))) 
                  :op3 (e / express-01 
                        :ARG0 (m / mouse) 
                        :ARG1 (v / vasculari 
                              :mod (s4 / stria)) 
                        :op1-of (a2 / and 
                              :consist (q / quantification) 
                              :op2 (g / ganglion) 
                              :op3 (s / slash))) 
                  :op4 (s3 / spiral-01 
                        :ARG1 (s2 / slash)))))

# ::snt a : Electropherogram of total RNA isolated from stria vascularis microdissected from one mouse .
# ::tok a : Electropherogram of total RNA isolated from stria vascularis microdissected from one mouse .
# ::alignments 13-14|0.0.0.0.0.0 9-10|0.0 8-9|0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:06.889
(s / stria 
      :mod-of (v / vasculari 
            :ARG2-of (i / isolate-01 
                  :ARG1 (r / rna 
                        :ARG2-of (t / total-01 
                              :ARG0 (m / mouse)) 
                        :part (o / organization 
                              :name (n / name 
                                    :op1 "Electropherogram"))))))

# ::snt The amount of total RNA was obtained from the total integral ( shaded ) and the amount of 18S rRNA was obtained from the integral of the 18S peak .
# ::tok The amount of total RNA was obtained from the total integral ( shaded ) and the amount of 18S rRNA was obtained from the integral of the 18S peak .
# ::alignments 28-29|0.1.1.0 24-25|0.1.1 21-22|0.1 19-20|0.0.1.0 18-19|0.0.0 16-17|0.0.1 14-15|0 12-13|0.1.0.0.0.0.0 10-11|0.1.0.0.0.0.0.0 9-10|0.1.0.0.0.0 6-7|0.0 4-5|0.1.0.0 3-4|0.1.0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:07.058
(a2 / and 
      :op1 (o2 / obtain-01 
            :ARG0 18 
            :ARG1 (a / amount 
                  :quant-of (r / rRNA))) 
      :op2 (o / obtain-01 
            :ARG1 (a3 / amount 
                  :quant-of (r2 / rna 
                        :ARG2-of (t2 / total-01 
                              :ARG1 (t / total-01 
                                    :ARG1 (s / shade-01 
                                          :ARG1 (i2 / integral)))))) 
            :ARG2 (i / integral 
                  :ARG1-of (p / peak-01))))

# ::snt Sharp peaks representing 18S and 28S rRNA demonstrate the high quality of RNA .
# ::tok Sharp peaks representing 18S and 28S rRNA demonstrate the high quality of RNA .
# ::alignments 12-13|0.0.0.1.0.1 10-11|0.0.0.1.0 9-10|0.0.0.1.0.0 7-8|0.0.0.1 6-7|0.0.0.2 5-6|0.0.0.0 4-5|0 3-4|0.0.0.1.0.0.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:07.640
(a / and 
      :ARG1-of (r3 / represent-01 
            :ARG0 (p / peak-01 
                  :ARG0 28 
                  :ARG0-of (d / demonstrate-01 
                        :ARG1 (q / quality 
                              :ARG1-of (h / high-02 
                                    :ARG0 18) 
                              :poss (r / rna))) 
                  :ARG1 (r2 / rRNA) 
                  :mod (s / sharp))))

# ::snt Insert : Genotype of Slc26a4 - / - mice was verified by the observation of one or few very large rhomboedric otoconia in the utricular macula ( arrow ) .
# ::tok Insert : Genotype of Slc26a4 - / - mice was verified by the observation of one or few very large rhomboedric otoconia in the utricular macula ( arrow ) .
# ::alignments 27-28|0.0.2.0 25-26|0.1.0 24-25|0.1.0.0 21-22|0.1 19-20|0.1.1 18-19|0.1.1.0 17-18|0.1.1.0.0 16-17|0 13-14|0.0.0 10-11|0.0 8-9|0.0.1 6-7|0.0.1.0 4-5|0.1.0.1 2-3|0.1.0.1.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.084
(o2 / or 
      :op1 (v2 / verify-01 
            :ARG0 (o3 / observation) 
            :ARG1 (m2 / mouse 
                  :mod (s / slash)) 
            :ARG1-of (i / insert-01 
                  :ARG0 (a / arrow))) 
      :op2 (o / otoconia 
            :location (m / macula 
                  :mod (u / utricular) 
                  :mod-of (s2 / Slc26a4 
                        :mod-of (g / genotype))) 
            :mod (l / large 
                  :degree (v / very 
                        :degree-of (f / few)))))

# ::snt A , crista ampullaris ; U , utricular macula .
# ::tok A , crista ampullaris ; U , utricular macula .
# ::alignments 8-9|0.0.0.0 5-6|0.1 4-5|0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.101
(a / and 
      :op1 (a2 / ampullari 
            :mod (c / crista 
                  :mod-of (m / macula))) 
      :op2 (u / u))

# ::snt Scale bar : 100 m .
# ::tok Scale bar : 100 m .
# ::alignments 4-5|0.0 3-4|0.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.119
(b / bar-01 
      :ARG0 (m / m 
            :quant 100) 
      :ARG1 (s / scale))

# ::snt b : Example of real-time RT-PCR data used for quantification of 18S , KCNJ10 , KCNQ1 and KCNQ4 .
# ::tok b : Example of real-time RT-PCR data used for quantification of 18S , KCNJ10 , KCNQ1 and KCNQ4 .
# ::alignments 16-17|0 13-14|0.2.0.0+0.2.0+0.2 11-12|0.1 9-10|0.0.2 7-8|0.0 6-7|0.0.1 4-5|0.0.1.0 2-3|0.0.1.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.204
(a / and 
      :op1 (u / use-01 
            :ARG0 (b / b) 
            :ARG1 (d / data 
                  :mod (r / real-time) 
                  :mod-of (e / example)) 
            :ARG2 (q / quantification)) 
      :op2 18 
      :op3 (t / thing 
            :name (n / name 
                  :op1 "KCNJ10")))

# ::snt Known quantities of 18S rRNA were used to calibrate the threshold .
# ::tok Known quantities of 18S rRNA were used to calibrate the threshold .
# ::alignments 10-11|0.1.1 8-9|0.1 6-7|0 3-5|0.0.0.1+0.0.0.0+0.0.0+0.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.245
(u / use-01 
      :ARG1 (t2 / thing 
            :name (n / name 
                  :op1 18S 
                  :op2 (r / rRNA))) 
      :ARG2 (c / calibrate-01 
            :ARG0 (q / quantity 
                  :ARG1-of (k / know-01)) 
            :ARG1 (t / threshold)))

# ::snt SV , stria vascularis ; SG , spiral ganglia .
# ::tok SV , stria vascularis ; SG , spiral ganglia .
# ::alignments 8-9|0.1 7-8|0 5-6|0.0.0.1.0 4-5|0.0.0.1 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.292
(s / spiral-01 
      :ARG0 (o / organization 
            :mod-of (v / vasculari 
                  :mod (s3 / stria) 
                  :op1-of (a / and 
                        :op2 (s2 / sg))) 
            :name (n / name 
                  :op1 "SV")) 
      :ARG1 (g / ganglion))

# ::snt c : Quantification of KCNJ10 and KCNQ1 mRNA in young Slc26a4 + / + and young and old Slc26a4 - / - mice .
# ::tok c : Quantification of KCNJ10 and KCNQ1 mRNA in young Slc26a4 + / + and young and old Slc26a4 - / - mice .
# ::alignments 22-23|0.0.3 20-21|0.0.4.2 17-18|0.0.2 16-17|0.0 15-16|0.0.0 14-15|0 12-13|0.0.4.2.0 9-10|0.0.1 6-8|0.0.4.1.0.1+0.0.4.1.0.0+0.0.4.1.0+0.0.4.1 5-6|0.0.4 4-5|0.0.4.0.0.0+0.0.4.0.0+0.0.4.0 2-3|0.0.4.1.1 0-1|0.0.4.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.414
(a2 / and 
      :op1 (a / and 
            :op1 (y / young) 
            :op1-of (y2 / young) 
            :op2 (o / old) 
            :op3 (m / mouse) 
            :op3-of (a3 / and 
                  :op1 (t2 / thing 
                        :name (n2 / name 
                              :op1 "KCNJ10")) 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 (k / KCNQ1) 
                              :op2 (m2 / mRNA)) 
                        :poss-of (q / quantification)) 
                  :op4 (s / slash 
                        :op1-of (s2 / slash) 
                        :poss-of (c / c)))))

# ::snt The presence of KCNJ10 mRNA in stria vascularis of Slc26a4 - / - mice supports the finding that intermediate cells are present .
# ::tok The presence of KCNJ10 mRNA in stria vascularis of Slc26a4 - / - mice supports the finding that intermediate cells are present .
# ::alignments 21-22|0.0.1 19-20|0.0 18-19|0 16-17|0.0.0.1.0 14-15|0.0.0.1.0.1 13-14|0.0.0.1.0.1.0 11-12|0.0.0.1.0.0 7-8|0.0.0.1.1 6-7|0.0.0.1.1.0 4-5|0.0.0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.715
(i / intermediate 
      :mod-of (c / cell 
            :domain (m2 / mrna 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10")) 
                  :mod-of (p2 / presence 
                        :ARG1-of (f / find-01 
                              :ARG0 (s2 / slash) 
                              :ARG1-of (s / support-01 
                                    :ARG0 (m / mouse))) 
                        :location (v / vasculari 
                              :mod (s3 / stria)))) 
            :domain-of (p / present)))

# ::snt Expression of the KCNJ10 protein was assessed in young Slc26a4 - / - mice by confocal immunocytochemistry .
# ::tok Expression of the KCNJ10 protein was assessed in young Slc26a4 - / - mice by confocal immunocytochemistry .
# ::alignments 16-17|0.0 13-14|0.2 11-12|0.1.0.0.1 8-9|0.2.0 6-7|0 4-5|0.1.0 3-4|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:08.810
(a / assess-01 
      :ARG0 (i / immunocytochemistry) 
      :ARG1 (e / expression 
            :poss (p / protein 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10") 
                        :op1-of (s / slash)))) 
      :location (m / mouse 
            :mod (y / young)))

# ::snt Interestingly , expression of the KCNJ10 protein was absent in stria vascularis but normal in spiral ganglia ( Fig. 4 ) .
# ::tok Interestingly , expression of the KCNJ10 protein was absent in stria vascularis but normal in spiral ganglia ( Fig. 4 ) .
# ::alignments 19-20|0.0.0.0 18-19|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 16-17|0.0.1.0.1 15-16|0.0.0 13-14|0.0.1.0 12-13|0 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1 6-7|0.0 5-6|0.0.2.0.0+0.0.2.0+0.0.2 2-3|0.0.1 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:09.113
(c2 / contrast-01 
      :ARG0 (p / protein 
            :ARG0-of (s / spiral-01 
                  :ARG1 4 
                  :ARG2 (i / interesting)) 
            :ARG1-of (e / express-01 
                  :ARG0-of (n2 / normal-02 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "Fig.")) 
                        :manner (g / ganglion))) 
            :mod (t / thing 
                  :name (n3 / name 
                        :op1 "KCNJ10"))) 
      :ARG1 (a / absent-01 
            :ARG1 (v / vasculari 
                  :mod (s2 / stria))))

# ::snt The absence of the KCNJ10 K + channel in stria vascularis is sufficient to explain the loss of the endocochlear potential [ 17 ] .
# ::tok The absence of the KCNJ10 K + channel in stria vascularis is sufficient to explain the loss of the endocochlear potential [ 17 ] .
# ::alignments 22-23|0.0.0.0.0 20-21|0.0.0.2.0 16-17|0.0.0.1 14-15|0.0.0 12-13|0.0.0.2 10-11|0.0 9-10|0 7-8|0.0.0.0.1 4-6|0.0.0.0.1.0.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:09.558
(s2 / stria 
      :mod-of (v / vasculari 
            :ARG2-of (e / explain-01 
                  :ARG0 (a / absent-01 
                        :ARG0 17 
                        :ARG1 (c / channel 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 (k / KCNJ10) 
                                          :op2 (k2 / K))))) 
                  :ARG1 (l / loss) 
                  :ARG1-of (s / suffice-01 
                        :ARG0 (p / potential)))))

# ::snt Protein localization of KCNJ10 in the cochlea of Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Protein localization of KCNJ10 in the cochlea of Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 17-18|0.0.0 15-16|0.0 12-13|0 10-11|0.1.1 6-7|0.1.2.0 3-4|0.1.0.0+0.1.0+0.1 1-2|0.1.2 0-1|0.1.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:09.608
(a / and 
      :domain-of (s / slash 
            :mod-of (m / mouse)) 
      :op1 (t / thing 
            :name (n / name 
                  :op1 "KCNJ10") 
            :op1-of (s2 / slash) 
            :poss-of (l / localization 
                  :location (c / cochlea) 
                  :mod (p / protein))))

# ::snt a : Overview of cochlea ; bar = 100 m .
# ::tok a : Overview of cochlea ; bar = 100 m .
# ::alignments 9-10|0.0.2 8-9|0.0.1 6-7|0.0 5-6|0 4-5|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:09.630
(a / and 
      :op1 (b / bar-01 
            :ARG0 (c / cochlea 
                  :mod-of (o / overview)) 
            :ARG1 100 
            :domain-of (m / m)))

# ::snt Compare to Fig. 1a to note the enlarged scala media and the distended Reissner 's membrane .
# ::tok Compare to Fig. 1a to note the enlarged scala media and the distended Reissner 's membrane .
# ::alignments 15-16|0.0.0.0 12-14|0+0.0.1+0.0+0.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0.0 8-9|0.0.0.0.0.0.0.1 7-8|0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0 2-3|0.0.0.0.0.0.1.0.0.0+0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:10.021
(r / Reissner 
      :op2-of (n / name 
            :name-of (t / thing 
                  :poss-of (m / membrane 
                        :op1-of (a / and 
                              :ARG1-of (n2 / note-01 
                                    :ARG0 (m2 / media 
                                          :ARG1-of (e / enlarge-01) 
                                          :mod (s / scala)) 
                                    :ARG1-of (c2 / compare-01 
                                          :ARG2 (c / country 
                                                :name (n3 / name 
                                                      :op1 "Fig."))))))) 
            :op1 (d / distended)))

# ::snt b-c : Detail of lateral wall and spiral ganglia ( insert ) ; main bar : 10 m , insert : 5 m .
# ::tok b-c : Detail of lateral wall and spiral ganglia ( insert ) ; main bar : 10 m , insert : 5 m .
# ::alignments 21-22|0.0.1.1.0.0 19-20|0.0.1.1.0.1 17-18|0.1.0 16-17|0.0.0 14-15|0.1 13-14|0.1.1 12-13|0 10-11|0.0.1.1.0.1.0 8-9|0.0.1.1 7-8|0.0.1.1.0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.1.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:10.164
(a / and 
      :op1 (d / detail-01 
            :ARG0 10 
            :ARG1 (a2 / and 
                  :op1 (w / wall 
                        :mod (l / lateral)) 
                  :op2 (g / ganglion 
                        :ARG1-of (s / spiral-01 
                              :ARG0 5 
                              :ARG1-of (i / insert-01 
                                    :ARG1-of (i2 / insert-01)))))) 
      :op2 (b / bar-01 
            :ARG1 (m / m) 
            :mod (m2 / main)))

# ::snt Expression of KCNJ10 in Slc26a4 - / - mice was absent in stria vascularis but unchanged in spiral ganglion cells .
# ::tok Expression of KCNJ10 in Slc26a4 - / - mice was absent in stria vascularis but unchanged in spiral ganglion cells .
# ::alignments 19-20|0.0.0.0 18-19|0.0.0.0.0 17-18|0.0.0 15-16|0.1.0.0.0+0.1.0.0 14-15|0 13-14|0.1.1 12-13|0.1.1.0 10-11|0.1 8-9|0.0 6-7|0.1.0.1.1 2-3|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:10.428
(c3 / contrast-01 
      :ARG0 (m / mouse 
            :ARG0-of (s / spiral-01 
                  :ARG1 (c / cell 
                        :mod (g / ganglion)))) 
      :ARG1 (a / absent-01 
            :ARG1 (e / expression 
                  :ARG1-of (c2 / change-01 
                        :polarity -) 
                  :poss (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10") 
                        :op1-of (s3 / slash))) 
            :manner (v / vasculari 
                  :mod (s2 / stria))))

# ::snt RM , Reissner 's membrane , SV , stria vascularis ; SP , spiral prominence ; SL , spiral ligament ; LIM , spiral limbus ; SG , spiral ganglion .
# ::tok RM , Reissner 's membrane , SV , stria vascularis ; SP , spiral prominence ; SL , spiral ligament ; LIM , spiral limbus ; SG , spiral ganglion .
# ::alignments 29-30|0.2.0.1.2 28-29|0.2.0.1 26-27|0.2.0.1.1.2 24-25|0.2.0.1.1.1 23-24|0.2.0.1.1 21-22|0.3.1.0+0.3.1+0.3 19-20|0.3.0.0 18-19|0.3.0 16-17|0.2.2+0.2.1.0+0.2.1+0.2 14-15|0.2.0.0 13-14|0.2.0 11-12|0.1 10-11|0 9-10|0.2.0.1.0.0 8-9|0.2.0.1.0 6-7|0.2.0.1.1.0.0.0.0+0.2.0.1.1.0.0.0+0.2.0.1.1.0.0 4-5|0.2.0.1.1.0.2 2-3|0.2.0.1.1.0.1.0+0.2.0.1.1.0.1+0.2.0.1.1.0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:10.970
(a / and 
      :op1 (o3 / organization 
            :name (n5 / name 
                  :op1 "RM")) 
      :op2 (s6 / SP) 
      :op3 (c / country 
            :ARG2-of (s5 / spiral-01 
                  :ARG1 (p / prominence) 
                  :ARG2-of (s / spiral-01 
                        :ARG0 (s7 / stria 
                              :mod-of (v / vasculari)) 
                        :ARG1 (s3 / spiral-01 
                              :ARG0 (p2 / person 
                                    :location (o2 / organization 
                                          :name (n3 / name 
                                                :op1 "SV")) 
                                    :name (n4 / name 
                                          :op1 "Reissner") 
                                    :poss-of (m / membrane)) 
                              :ARG1 (l / limbu) 
                              :ARG2 (s2 / sg)) 
                        :mod-of (g / ganglion))) 
            :name (n2 / name 
                  :op1 "SL") 
            :wiki "Sri_Lanka") 
      :op4 (o / organization 
            :ARG2-of (s4 / spiral-01 
                  :ARG1 (l2 / ligament)) 
            :name (n / name 
                  :op1 "LIM")))

# ::snt Histological evaluation of cryosections revealed an enlargement of scala media with a large bulging of Reissner 's membrane and an apparent degeneration of the organ of Corti , as described earlier [ 14 ] .
# ::tok Histological evaluation of cryosections revealed an enlargement of scala media with a large bulging of Reissner 's membrane and an apparent degeneration of the organ of Corti , as described earlier [ 14 ] .
# ::alignments 32-33|0.2.2.0 30-31|0.0.0.0 29-30|0.0.0 26-27|0.2.2.1.0.0.0+0.2.2.1.0.0+0.2.2.1.0 24-25|0.2.2.1 21-22|0.2.2 20-21|0.2.2.2 18-19|0.2 17-18|0.2.1.0 15-16|0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 13-14|0.2.1 12-13|0.2.0 9-10|0.1.0 8-9|0.1.0.0 6-7|0.1 4-5|0 3-4|0.0.1 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:11.442
(r / reveal-01 
      :ARG0 (e3 / evaluate-01 
            :ARG0-of (d / describe-01 
                  :time (e / early)) 
            :ARG1 (c2 / cryosection) 
            :manner (h / histological)) 
      :ARG1 (e2 / enlargement 
            :mod (m2 / media 
                  :mod (s / scala))) 
      :op1-of (a2 / and 
            :op2 (l / large) 
            :op3 (b / bulge-01 
                  :ARG1 (m / membrane 
                        :poss (p / person 
                              :name (n2 / name 
                                    :op1 "Reissner")))) 
            :op4 (d2 / degenerate-01 
                  :ARG0 14 
                  :ARG1 (o / organ 
                        :poss (c / country 
                              :name (n / name 
                                    :op1 "Corti"))) 
                  :mod (a / apparent))))

# ::snt Tissue height of stria vascularis was normal ( Fig. 5 ) , consistent with the similar numbers of 18S rRNA molecules in isolated preparations ( see above ) .
# ::tok Tissue height of stria vascularis was normal ( Fig. 5 ) , consistent with the similar numbers of 18S rRNA molecules in isolated preparations ( see above ) .
# ::alignments 26-27|0.0.0.1.1 25-26|0.0.0.1 23-24|0.0.1.0 22-23|0.0.1.0.1 20-21|0.0.1 19-20|0.0.1.1 18-19|0.0.0.1.0 16-17|0.0 15-16|0 12-13|0.0.0 9-10|0.0.1.0.0 6-7|0.0.0.0.0 4-5|0.0.0.0.2 3-4|0.0.0.0.2.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:11.792
(r2 / resemble-01 
      :ARG1 (n / number 
            :ARG2-of (c / consistent-01 
                  :ARG1 (h / height 
                        :ARG1-of (n2 / normal-02) 
                        :mod (t / tissue) 
                        :mod (v / vasculari 
                              :mod (s2 / stria))) 
                  :ARG2-of (s / see-01 
                        :ARG1 18 
                        :location (a / above))) 
            :quant-of (m / molecule 
                  :ARG1-of (p / prepare-02 
                        :ARG0 5 
                        :ARG1-of (i / isolate-01)) 
                  :mod (r / rRNA))))

# ::snt The absence of a change in tissue height is consistent with the presence of intermediate cells [ 28 ] .
# ::tok The absence of a change in tissue height is consistent with the presence of intermediate cells [ 28 ] .
# ::alignments 17-18|0.0 15-16|0.2.0 14-15|0.2.0.0 12-13|0.2 9-10|0 7-8|0.1.0.0 6-7|0.1.0.0.0 4-5|0.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:11.886
(c2 / consistent-01 
      :ARG0 28 
      :ARG1 (a / absent-01 
            :ARG1 (c3 / change-01 
                  :ARG1 (h / height 
                        :mod (t / tissue)))) 
      :ARG2 (p / presence 
            :domain (c / cell 
                  :mod (i / intermediate))))

# ::snt Further , we observed an apparent loss of tissue masses in areas that are normally occupied primarily by type I and II fibrocytes .
# ::tok Further , we observed an apparent loss of tissue masses in areas that are normally occupied primarily by type I and II fibrocytes .
# ::alignments 22-23|0.0.0.3.1 21-22|0.0.0.2.1+0.0.0.2.0.2+0.0.0.2.0.1+0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 20-21|0.0.0.3 19-20|0.0.0.3.0 18-19|0.0.0.3.1.0 16-17|0.0.0.4 15-16|0.0.0 14-15|0.0.0.1 11-12|0.0.0.0 9-10|0.1.1 8-9|0.1.1.0 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:13.231
(o2 / observe-01 
      :ARG0 (w2 / we 
            :ARG0-of (o / occupy-01 
                  :ARG1 (a2 / area) 
                  :ARG1-of (n2 / normal-02) 
                  :ARG2 (w / war 
                        :name (n / name 
                              :op1 "World" 
                              :op2 "War" 
                              :op3 "II") 
                        :wiki "World_War_II") 
                  :ARG3 (a / and 
                        :op1 (i / i) 
                        :op2 (f / fibrocyt 
                              :mod (t / type))) 
                  :mod (p / primary))) 
      :ARG1 (l / loss 
            :mod (a3 / apparent) 
            :poss (m / mass 
                  :mod (t2 / tissue))) 
      :ARG2 (f2 / further))

# ::snt Spiral prominence in Slc26a4 - / - mice was less prominent , spiral ligament thinner and spiral limbus flatter ( Fig. 5 ) .
# ::tok Spiral prominence in Slc26a4 - / - mice was less prominent , spiral ligament thinner and spiral limbus flatter ( Fig. 5 ) .
# ::alignments 21-22|0.0.0.0.0 18-19|0.0.0.0 17-18|0.0.0.0.3 16-17|0.0.0.0.2 15-16|0 14-15|0.0.0.0.1.1 13-14|0.0.0.0.1.1.0 12-13|0.0.0.0.1.1.1 10-11|0.0 9-10|0.0.0 7-8|0.0.0.0.1.1.1.0 5-6|0.0.0.0.2.0 1-2|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:13.446
(a / and 
      :op1 (p / prominent 
            :degree (l3 / less 
                  :degree-of (f / flatter-01 
                        :ARG0 5 
                        :ARG1 (p2 / prominence 
                              :ARG1-of (s4 / spiral-01) 
                              :ARG1-of (t / thin-01 
                                    :ARG0 (l2 / ligament) 
                                    :ARG1-of (s2 / spiral-01 
                                          :ARG0 (m / mouse)))) 
                        :ARG1-of (s / spiral-01 
                              :ARG0 (s3 / slash)) 
                        :ARG2 (l / limbu)))))

# ::snt The observation that tissue masses were lost in the spiral limbus region is consistent with the finding of a reduced number of 18S rRNA molecules in the spiral ganglia preparation ( see above ) .
# ::tok The observation that tissue masses were lost in the spiral limbus region is consistent with the finding of a reduced number of 18S rRNA molecules in the spiral ganglia preparation ( see above ) .
# ::alignments 32-33|0.0.0.1.0.0 31-32|0 29-30|0.0.0.1.0 28-29|0.0.0.1.0.2 27-28|0.0.0.1.0.1 24-25|0.0.0.1 23-24|0.0.0.1.1 22-23|0.0.0.0.0.1.0.0 20-21|0.0.0 19-20|0.0.0.0 16-17|0.0 13-14|0.0.1 11-12|0.0.0.0.0.1 10-11|0.0.0.0.0.1.1 9-10|0.0.0.0.0.1.0 6-7|0.0.0.0.0 4-5|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:13.915
(s / see-01 
      :ARG1 (f / find-01 
            :ARG1 (n / number 
                  :ARG1-of (r2 / reduce-01 
                        :manner-of (l2 / lose-02 
                              :ARG1 (m2 / mass 
                                    :mod (t / tissue)) 
                              :location (r3 / region 
                                    :ARG1-of (s3 / spiral-01 
                                          :ARG0 18) 
                                    :mod (l / limbu)))) 
                  :quant-of (m / molecule 
                        :ARG0-of (p / prepare-02 
                              :ARG1 (a / above) 
                              :ARG1-of (s2 / spiral-01) 
                              :ARG2 (g / ganglion)) 
                        :mod (r / rRNA))) 
            :ARG2-of (c / consistent-01 
                  :ARG1 (o / observation))))

# ::snt In addition , we observed an apparent degeneration of stria vascularis , including an increase in pigmentation and an irregular pattern of the tight junctions of marginal cells ( Fig. 2c , 6,7 ) .
# ::tok In addition , we observed an apparent degeneration of stria vascularis , including an increase in pigmentation and an irregular pattern of the tight junctions of marginal cells ( Fig. 2c , 6,7 ) .
# ::alignments 29-30|0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 27-28|0.1.0.1 26-27|0.1.0.1.0 24-25|0.1.0 23-24|0.1.0.0 20-21|0.1 19-20|0.1.1 17-18|0 16-17|0.0.0 14-15|0.0 10-11|0.0.0.0.1.1 9-10|0.0.0.0.1.1.0 7-8|0.0.0.0.1 6-7|0.0.0.0.1.2 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:14.229
(a / and 
      :op1 (i2 / increase-01 
            :ARG1 (p2 / pigmentation 
                  :ARG2-of (o / observe-01 
                        :ARG0 (w / we) 
                        :ARG1 (d / degenerate-01 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "Fig.")) 
                              :ARG1 (v / vasculari 
                                    :mod (s / stria)) 
                              :mod (a2 / apparent)) 
                        :prep-in (a3 / addition)))) 
      :op2 (p / pattern 
            :mod (j / junction 
                  :ARG1-of (t / tight-05) 
                  :domain (c2 / cell 
                        :mod (m / marginal))) 
            :mod (i / irregular)))

# ::snt Tight junctions were visualized by F-actin expression .
# ::tok Tight junctions were visualized by F-actin expression .
# ::alignments 6-7|0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:14.243
(v / visualize-01 
      :ARG0 (e / express-01) 
      :ARG1 (j / junction 
            :mod (t / tight)))

# ::snt Marginal cells appeared to form a continuous layer .
# ::tok Marginal cells appeared to form a continuous layer .
# ::alignments 7-8|0.0.1 6-7|0.0.1.0 4-5|0.0 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:14.264
(a / appear-01 
      :ARG1 (f / form-01 
            :ARG0 (c2 / cell 
                  :mod (m / marginal)) 
            :ARG1 (l / layer 
                  :ARG1-of (c / continue-01))))

# ::snt Morphometric analysis of cochlear tissue masses in Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Morphometric analysis of cochlear tissue masses in Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 16-17|0.0.0.1.1 14-15|0.0 11-12|0 9-10|0.0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.0 3-4|0.0.0.1.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:14.441
(a / and 
      :domain-of (s / slash 
            :location-of (a2 / analyze-01 
                  :ARG0 (s2 / slash) 
                  :ARG1 (m2 / mass 
                        :mod (t / tissue 
                              :mod (c / cochlear)) 
                        :poss (m / mouse)))))

# ::snt a : locations of measurements .
# ::tok a : locations of measurements .
# ::alignments 4-5|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:14.451
(m / measure-01 
      :location (l / location))

# ::snt Thickness of stria vascularis ( SV ) was obtained as average of three distance measurements perpendicular to the surface of marginal cells .
# ::tok Thickness of stria vascularis ( SV ) was obtained as average of three distance measurements perpendicular to the surface of marginal cells .
# ::alignments 21-22|0.0 20-21|0 18-19|0.0.0 15-16|0.0.0.0.2 14-15|0.0.0.0.1 13-14|0.0.0.0.1.1 12-13|0.0.0.0.3.0 10-11|0.0.0.0 8-9|0.0.0.0.3 5-6|0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 3-4|0.0.0.0.3.1 2-3|0.0.0.0.3.1.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:14.620
(m / marginal 
      :mod-of (c / cell 
            :domain-of (s / surface 
                  :ARG0-of (a / average-01 
                        :ARG1 (t / thicknes) 
                        :ARG2 (m2 / measure-01 
                              :ARG0 (o2 / organization 
                                    :name (n / name 
                                          :op1 "SV")) 
                              :ARG1 (d / distance-01)) 
                        :ARG3 (p / perpendicular) 
                        :manner-of (o / obtain-01 
                              :ARG0 3 
                              :ARG1 (v / vasculari 
                                    :mod (s2 / stria)))))))

# ::snt Thickness of spiral prominence ( SP ) was measured perpendicular to a tangential line ( dashed ) that connects the surface of the outer sulcus ( OS ) with the basal layer of stria vascularis .
# ::tok Thickness of spiral prominence ( SP ) was measured perpendicular to a tangential line ( dashed ) that connects the surface of the outer sulcus ( OS ) with the basal layer of stria vascularis .
# ::alignments 34-35|0.2 33-34|0.2.0 31-32|0 30-31|0.1 26-27|0.0.1.0.0 24-25|0.0.3.0.0 23-24|0.0.3.0 20-21|0.0.3.0.0.0 18-19|0.0 15-16|0.0.2 13-14|0.0.1 12-13|0.0.1.1 9-10|0.0.1.0.1 8-9|0.0.1.0 5-6|0.0.0 3-4|0.0.3.1 2-3|0.0.3 0-1|0.0.3.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:15.224
(l / layer 
      :ARG2-of (c / connect-01 
            :ARG0 (s4 / SP) 
            :ARG1 (l2 / line 
                  :ARG2-of (m / measure-01 
                        :ARG0 (o / o) 
                        :ARG1 (p / perpendicular)) 
                  :mod (t / tangential)) 
            :ARG1-of (d / dash-01) 
            :ARG2-of (s5 / spiral-01 
                  :ARG0 (o2 / outer 
                        :mod-of (s2 / sulcu 
                              :poss-of (s3 / surface))) 
                  :ARG1 (p2 / prominence 
                        :mod-of (t2 / thicknes)))) 
      :mod (b / basal) 
      :mod (v / vasculari 
            :mod (s / stria)))

# ::snt Thickness of spiral ligament ( SL ) was measured perpendicular to the tangential line as distance between the surface of spiral prominence and the interface between spiral ligament and bone ( B ) .
# ::tok Thickness of spiral ligament ( SL ) was measured perpendicular to the tangential line as distance between the surface of spiral prominence and the interface between spiral ligament and bone ( B ) .
# ::alignments 31-32|0.0.1.3.1+0.0.1.3.0.0+0.0.1.3.0+0.0.1.3 29-30|0 28-29|0.0 27-28|0.0.0 26-27|0.0.0.0 24-25|0.0.1.2 22-23|0.0.1 21-22|0.0.1.1 20-21|0.0.1.1.0 18-19|0.0.1.0.0 15-16|0.0.1.0 13-14|0.0.1.1.0.0 12-13|0.0.1.1.0.0.1 9-10|0.0.1.1.0.0.0.0 8-9|0.0.1.1.0.0.0 5-6|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 3-4|0.0.0.0.1.0 2-3|0.0.0.0.1 0-1|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:16.170
(b / bone 
      :op2-of (a / and 
            :op1 (l2 / ligament 
                  :ARG1-of (s / spiral-01 
                        :ARG0 (c / country 
                              :name (n2 / name 
                                    :op1 "SL") 
                              :wiki "Sri_Lanka") 
                        :ARG2 (s4 / spiral-01 
                              :ARG1 (l4 / ligament 
                                    :mod-of (t2 / thicknes))))) 
            :op4-of (a2 / and 
                  :op1 (d / distance-01 
                        :ARG1 (s3 / surface)) 
                  :op2 (p / prominence 
                        :ARG0-of (s2 / spiral-01 
                              :ARG1 (l3 / line 
                                    :ARG2-of (m / measure-01 
                                          :ARG1 (p2 / perpendicular)) 
                                    :mod (t / tangential)))) 
                  :op3 (i / interface) 
                  :op5 (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -))))

# ::snt Thickness of spiral limbus ( LIM ) was obtained perpendicular to the surface of the bone as a tangential line that touches the inner sulcus ( IS ) and reaches from the surface of the spiral limbus to the interface between spiral limbus connective tissue and bone .
# ::tok Thickness of spiral limbus ( LIM ) was obtained perpendicular to the surface of the bone as a tangential line that touches the inner sulcus ( IS ) and reaches from the surface of the spiral limbus to the interface between spiral limbus connective tissue and bone .
# ::alignments 46-47|0.1.1.0.3 45-46|0.1.1.0 44-45|0.1.1.0.2 43-44|0.1.1.0.1 42-43|0.1.1.0.1.0 41-42|0.1.1.0.1.0.0 39-40|0.1.1.0.1.0.0.0.0.0 36-37|0.1.1.0.1.0.0.0 35-36|0.1.1.0.1.0.0.0.0 32-33|0.1.1 29-30|0.1 28-29|0 26-27|0.1.1.0.0.2 24-25|0.0.1 23-24|0.0.1.0 21-22|0.0 19-20|0.0.0 18-19|0.0.0.0 15-16|0.1.1.0.0.1.0 12-13|0.1.1.0.0.1 9-10|0.1.1.0.0.0 8-9|0.1.1.0.0 5-6|0.1.0.0.0+0.1.0.0+0.1.0 3-4|0.1.1.0.0.2.0.0 2-3|0.1.1.0.0.2.0 0-1|0.1.1.0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.295
(a2 / and 
      :op1 (t2 / touch-01 
            :ARG0 (l3 / line 
                  :mod (t3 / tangential)) 
            :ARG1 (s4 / sulcu 
                  :mod (i2 / inner))) 
      :op2 (r / reach-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "LIM")) 
            :ARG1 (s3 / surface 
                  :op1-of (a / and 
                        :ARG0-of (o / obtain-01 
                              :ARG1 (p / perpendicular) 
                              :ARG2 (s5 / surface 
                                    :poss (b3 / bone)) 
                              :purpose (b2 / be-01 
                                    :ARG2-of (s6 / spiral-01 
                                          :ARG1 (l4 / limbu 
                                                :mod-of (t4 / thicknes))))) 
                        :op2 (c / connective 
                              :consist-of (l / limbu 
                                    :ARG1-of (s / spiral-01 
                                          :ARG0 (l2 / limbu 
                                                :ARG1-of (s2 / spiral-01 
                                                      :ARG2 (i / interface)))))) 
                        :op3 (t / tissue) 
                        :op4 (b / bone)))))

# ::snt b : Summary .
# ::tok b : Summary .
# ::alignments 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.300
(s / summary 
      :mod-of (b / b))

# ::snt Data from 7 -- 8 animals contributed to each column .
# ::tok Data from 7 -- 8 animals contributed to each column .
# ::alignments 9-10|0.2 8-9|0.2.0 6-7|0 5-6|0.1 4-5|0.1.0 2-3|0.2.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.390
(c2 / contribute-01 
      :ARG0 (d / data) 
      :ARG1 (a / animal 
            :quant 8) 
      :ARG2 (c / column 
            :mod (e / each) 
            :mod 7))

# ::snt Analysis of marginal and basal cell barriers by in Slc26a4 - / - mice .
# ::tok Analysis of marginal and basal cell barriers by in Slc26a4 - / - mice .
# ::alignments 13-14|0.3.0 11-12|0.3 9-10|0.2.1 6-7|0.2 5-6|0.2.0 4-5|0.1 3-4|0 2-3|0.0 0-1|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.440
(a / and 
      :op1 (m2 / marginal) 
      :op2 (b2 / basal) 
      :op3 (b / barrier 
            :mod (c / cell) 
            :prep-along-with (s2 / Slc26a4)) 
      :op4 (s / slash 
            :op1 (m / mouse)) 
      :quant (a2 / analysi))

# ::snt Tight junctions were visualized by F actin .
# ::tok Tight junctions were visualized by F actin .
# ::alignments 6-7|0.0 5-6|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.465
(v / visualize-01 
      :ARG0 (a / actin 
            :mod (a2 / aircraft-type 
                  :name (n / name 
                        :op1 "F22") 
                  :wiki "Lockheed_Martin_F-22_Raptor")) 
      :ARG1 (j / junction 
            :mod (t / tight)))

# ::snt Whole-mounts of stria vascularis were viewed either from the basal cell side ( a-f ) or from the marginal cell side ( g-l ) .
# ::tok Whole-mounts of stria vascularis were viewed either from the basal cell side ( a-f ) or from the marginal cell side ( g-l ) .
# ::alignments 20-21|0.0.1.1.0 19-20|0.0.1.1.0.0 18-19|0 15-16|0.0.1.1 11-12|0.0.1 10-11|0.0.1.0 9-10|0.0.1.2 6-7|0.0.2 5-6|0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.621
(m / marginal 
      :ARG0-of (v / view-02 
            :ARG1 (w / whole-mount 
                  :mod (v2 / vasculari 
                        :mod (s3 / stria))) 
            :ARG2 (s2 / side 
                  :mod (c2 / cell) 
                  :op1-of (o / or 
                        :op2 (s / side 
                              :mod (c / cell))) 
                  :poss (b / basal)) 
            :op1-of (e / either)))

# ::snt Bright field images verify that the same area was viewed from either side ( b and h ) .
# ::tok Bright field images verify that the same area was viewed from either side ( b and h ) .
# ::alignments 16-17|0.0.0.1.0 15-16|0 14-15|0.0.0.0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.1.0 9-10|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.0 3-4|0.0.0.0 2-3|0.0.0 1-2|0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:17.818
(a / and 
      :poss-of (f / field 
            :mod-of (i / image 
                  :ARG0-of (v2 / verify-01 
                        :ARG1 (v / view-02 
                              :ARG1 (a2 / area 
                                    :ARG1-of (s2 / same-01 
                                          :ARG0 (b / b))) 
                              :ARG2 (s / side 
                                    :mod (e / either)))) 
                  :ARG1-of (b2 / bright-02 
                        :ARG0 (h / h)))))

# ::snt Colored bright field images were mixed with images of F actin staining to indicate the position of pigment granules ( d , j , f and l ) .
# ::tok Colored bright field images were mixed with images of F actin staining to indicate the position of pigment granules ( d , j , f and l ) .
# ::alignments 26-27|0.0.1.0.0 25-26|0.0.1.0.2 24-25|0.0.1.0.1.0.1 22-23|0.0.1.0.1.0.0 20-21|0.0.1.0.1.1.0 18-19|0.1.0 17-18|0.1.0.0 15-16|0.1 13-14|0 11-12|0.2 10-11|0.0 9-10|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 7-8|0.0.1 5-6|0.0.1.0 3-4|0.0.1.0.1 2-3|0.0.1.0.1.2 1-2|0.0.1.0.1.0 0-1|0.0.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:18.425
(i / indicate-01 
      :ARG0 (a2 / actin 
            :mod (a3 / aircraft-type 
                  :name (n / name 
                        :op1 "F22") 
                  :wiki "Lockheed_Martin_F-22_Raptor") 
            :topic-of (i2 / image 
                  :ARG2-of (m / mix-01 
                        :ARG0 (l / l) 
                        :ARG1 (i3 / image 
                              :ARG1-of (b / bright-02 
                                    :ARG2 (j / j) 
                                    :op1-of (f / f)) 
                              :ARG1-of (c / color-01 
                                    :op1-of (d / d)) 
                              :mod (f2 / field)) 
                        :op1-of (a / and)))) 
      :ARG1 (p2 / position 
            :poss (g / granul 
                  :mod (p / pigment))) 
      :ARG1-of (s / stain-01))

# ::snt Focus was varied to either visualize the marginal cell barrier ( SMC , c-d and i-j ) or the basal cell barrier ( BC , e-f and k-l ) .
# ::tok Focus was varied to either visualize the marginal cell barrier ( SMC , c-d and i-j ) or the basal cell barrier ( BC , e-f and k-l ) .
# ::alignments 26-27|0.0 23-24|0.0.0.0.0.2.0 21-22|0.0.0.0.0.2.2 20-21|0.0.0.0.0.2.2.0 19-20|0.0.0.1 17-18|0.0.0.0.0.2 14-15|0 11-12|0.0.0.0.0.2.1.0.0+0.0.0.0.0.2.1.0+0.0.0.0.0.2.1 9-10|0.0.0.0.0 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0.1 5-6|0.0.0.0 4-5|0.0.0.0.1 2-3|0.0.0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:18.810
(a2 / and 
      :op1 (a / and 
            :ARG2-of (f / focus-01 
                  :ARG0-of (v / visualize-01 
                        :ARG1 (b3 / barrier 
                              :mod (c2 / cell) 
                              :mod (m / marginal) 
                              :op1-of (o / or 
                                    :domain "BC" 
                                    :op2 (o2 / organization 
                                          :name (n / name 
                                                :op1 "SMC")) 
                                    :op3 (b / barrier 
                                          :mod (c / cell)))) 
                        :mod (e / either)) 
                  :ARG1 (b2 / basal) 
                  :ARG1-of (v2 / vary-01))))

# ::snt Both the marginal cell ( e-f ) and the basal cell barrier ( i-f ) appeared to be intact .
# ::tok Both the marginal cell ( e-f ) and the basal cell barrier ( i-f ) appeared to be intact .
# ::alignments 18-19|0.1 15-16|0 11-12|0.0.1 10-11|0.0.1.0 9-10|0.0.1.1 7-8|0.0 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:18.916
(a / appear-01 
      :ARG0 (a2 / and 
            :op1 (c2 / cell 
                  :mod (m / marginal)) 
            :op2 (b / barrier 
                  :mod (c / cell) 
                  :mod (b2 / basal) 
                  :op1-of (b3 / both))) 
      :ARG1 (i / intact))

# ::snt It was critical for this finding that pigmentation did not block the path of the laser .
# ::tok It was critical for this finding that pigmentation did not block the path of the laser .
# ::alignments 15-16|0.0.0.0 12-13|0.0.0 10-11|0.0 9-10|0.0.2 7-8|0 5-6|0.0.1 4-5|0.0.1.1 2-3|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.204
(p2 / pigmentation 
      :ARG0-of (b / block-01 
            :ARG1 (p / path 
                  :mod (l / laser)) 
            :ARG1-of (f / find-01 
                  :ARG1-of (c / critical-02 
                        :ARG0 (i / it)) 
                  :mod (t / this)) 
            :polarity -))

# ::snt Blockage of the laser by pigmentation produces the untrue impression of a discontinuous marginal cell barrier ( c-d ) or basal cell barrier ( k-l ) .
# ::tok Blockage of the laser by pigmentation produces the untrue impression of a discontinuous marginal cell barrier ( c-d ) or basal cell barrier ( k-l ) .
# ::alignments 22-23|0.1.3.0 21-22|0.1.3.0.0 20-21|0.1.3.0.1 19-20|0.1.3 15-16|0.1 14-15|0.1.0 13-14|0.1.2 12-13|0.1.1 9-10|0 8-9|0.3 6-7|0.2 5-6|0.2.0 3-4|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.406
(i / impression-03 
      :ARG0 (b4 / blockage 
            :poss (l / laser)) 
      :ARG1 (b3 / barrier 
            :mod (c2 / cell) 
            :mod (d / discontinuou) 
            :mod (m / marginal) 
            :op1-of (o / or 
                  :op2 (b / barrier 
                        :mod (c / cell) 
                        :mod (b2 / basal)))) 
      :ARG1-of (p / produce-01 
            :ARG0 (p2 / pigmentation)) 
      :mod (u / untrue))

# ::snt Comparison of images is aided by marking a significant area with a star .
# ::tok Comparison of images is aided by marking a significant area with a star .
# ::alignments 12-13|0.0.0 9-10|0.1.0 8-9|0.1.0.0 6-7|0.1 4-5|0 2-3|0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.483
(a2 / aid-01 
      :ARG1 (c / comparison 
            :mod (s / star) 
            :poss (i / image)) 
      :ARG2 (m / mark-01 
            :ARG1 (a / area 
                  :ARG1-of (s2 / significant-02))))

# ::snt Bars = 10 m .
# ::tok Bars = 10 m .
# ::alignments 3-4|0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.490
(m / m 
      :domain (b / bar-01 
            :ARG1 10))

# ::snt Analysis of marginal and basal cell barriers in Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Analysis of marginal and basal cell barriers in Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 17-18|0.0.0.0 15-16|0.0.0 12-13|0 10-11|0.0.4 6-7|0.0.3 5-6|0.0.3.0 4-5|0.0.2 3-4|0.0 2-3|0.0.1 0-1|0.0.5 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.543
(a / and 
      :op1 (a2 / and 
            :mod (s / slash 
                  :mod-of (m / mouse)) 
            :op1 (m2 / marginal) 
            :op2 (b2 / basal) 
            :op3 (b / barrier 
                  :mod (c / cell)) 
            :op4 (s2 / slash) 
            :quant (a3 / analysi)))

# ::snt Tight junctions were visualized by F actin in whole-mounts of stria vascularis .
# ::tok Tight junctions were visualized by F actin in whole-mounts of stria vascularis .
# ::alignments 11-12|0.0.1 10-11|0.0.1.0 8-9|0.0.1.1 6-7|0.0 5-6|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.591
(v2 / visualize-01 
      :ARG0 (a / actin 
            :mod (a2 / aircraft-type 
                  :name (n / name 
                        :op1 "F22") 
                  :wiki "Lockheed_Martin_F-22_Raptor") 
            :source (v / vasculari 
                  :mod (s / stria) 
                  :mod-of (w / whole-mount))) 
      :ARG1 (j / junction 
            :mod (t / tight)))

# ::snt Bright field images were taken to evaluate pigmentation ( a , d and g ) .
# ::tok Bright field images were taken to evaluate pigmentation ( a , d and g ) .
# ::alignments 13-14|0.2 12-13|0 11-12|0.1 7-8|0.0.0.0.0 6-7|0.0.0.0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.2 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:19.747
(a / and 
      :op1 (t / take-01 
            :ARG1 (i / image 
                  :ARG0-of (e / evaluate-01 
                        :ARG1 (p / pigmentation)) 
                  :ARG1-of (b / bright-02) 
                  :mod (f / field))) 
      :op2 (d / d) 
      :op3 (g / g))

# ::snt Note the intact marginal cell ( b ) and basal cell ( c ) barriers in Slc26a4 + / + mice .
# ::tok Note the intact marginal cell ( b ) and basal cell ( c ) barriers in Slc26a4 + / + mice .
# ::alignments 20-21|0.0.3 18-19|0.0.3.0 14-15|0 12-13|0.0.0.0 10-11|0.0.2 9-10|0.0.2.0 8-9|0.0 6-7|0.0.0.1 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0.1.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:20.094
(b / barrier 
      :op3-of (a / and 
            :ARG1-of (n / note-01 
                  :ARG0 (c / c) 
                  :ARG2 (b3 / b)) 
            :op1 (c3 / cell 
                  :mod (m2 / marginal) 
                  :mod (i / intact)) 
            :op2 (c2 / cell 
                  :mod (b2 / basal)) 
            :poss-of (m / mouse 
                  :op1-of (s / slash))))

# ::snt Minimal pigmentation of Slc26a4 + / + mice did not compromise F actin localization .
# ::tok Minimal pigmentation of Slc26a4 + / + mice did not compromise F actin localization .
# ::alignments 13-14|0.1.0.0.0 12-13|0.1.0.0.0.0 11-12|0.1.0.0.1.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 10-11|0.1.0.0 9-10|0.1.0.0.2 7-8|0.1.0 5-6|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:20.372
(p / pigmentation 
      :mod (m2 / minimal) 
      :op1-of (s / slash 
            :op2 (m / mouse 
                  :ARG0-of (c / compromise-01 
                        :ARG1 (l / localization 
                              :mod (a / actin)) 
                        :location (a2 / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :polarity -))))

# ::snt Whole-mounts of stria vascularis from Slc26a4 - / - mice were viewed either from the basal cell side ( e-f ) or from the marginal cell side ( h-i ) .
# ::tok Whole-mounts of stria vascularis from Slc26a4 - / - mice were viewed either from the basal cell side ( e-f ) or from the marginal cell side ( h-i ) .
# ::alignments 26-27|0.0.1.1.1 25-26|0.0.1.1.1.0 24-25|0 21-22|0.0.1.1 17-18|0.0.1 16-17|0.0.1.0 15-16|0.0.1.1.0 12-13|0.0.2 11-12|0.0 9-10|0.0.2.0 7-8|0.0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:20.538
(m / marginal 
      :ARG0-of (v / view-02 
            :ARG1 (w / whole-mount 
                  :mod (v2 / vasculari 
                        :mod (s4 / stria) 
                        :op1-of (s3 / slash))) 
            :ARG2 (s2 / side 
                  :mod (c2 / cell) 
                  :op2-of (o / or 
                        :op1 (b / basal) 
                        :op3 (s / side 
                              :mod (c / cell)))) 
            :op2-of (e / either 
                  :op1 (m2 / mouse))))

# ::snt Bright field images verify that the same area was viewed from either side ( d and g ) .
# ::tok Bright field images verify that the same area was viewed from either side ( d and g ) .
# ::alignments 16-17|0.0.0.1.0 15-16|0 14-15|0.0.0.0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.1.0 9-10|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.0 3-4|0.0.0.0 2-3|0.0.0 1-2|0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:20.771
(a / and 
      :poss-of (f / field 
            :mod-of (i / image 
                  :ARG0-of (v2 / verify-01 
                        :ARG1 (v / view-02 
                              :ARG1 (a2 / area 
                                    :ARG1-of (s2 / same-01 
                                          :ARG0 (d / d))) 
                              :ARG2 (s / side 
                                    :mod (e / either)))) 
                  :ARG1-of (b / bright-02 
                        :ARG0 (g / g)))))

# ::snt Focus was varied to either visualize the marginal cell barrier ( SMC , b , e and h ) or the basal cell barrier ( BC , c , f and i ) .
# ::tok Focus was varied to either visualize the marginal cell barrier ( SMC , b , e and h ) or the basal cell barrier ( BC , c , f and i ) .
# ::alignments 31-32|0.0.2.1.0.2 30-31|0 29-30|0.0.2.1.0.3 27-28|0.0.2.1.0.0.2.0 25-26|0.0.2.0 23-24|0.0.2.2 22-23|0.0.2.2.0 21-22|0.0.2.2.1 19-20|0.0.2 17-18|0.0.1 16-17|0.0 15-16|0.0.0 13-14|0.0.2.1.0.0.1 11-12|0.0.2.1.0.0.0.0.0+0.0.2.1.0.0.0.0+0.0.2.1.0.0.0 9-10|0.0.2.1 8-9|0.0.2.1.1 7-8|0.0.2.1.2 5-6|0.0.2.1.0 4-5|0.0.2.1.0.1 2-3|0.0.2.1.0.0.2 0-1|0.0.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:21.357
(a / and 
      :op1 (a2 / and 
            :op1 (e / e) 
            :op2 (h / h) 
            :op2-of (o / or 
                  :domain "BC" 
                  :op1 (b4 / barrier 
                        :ARG1-of (v / visualize-01 
                              :ARG0 (f2 / focus-01 
                                    :ARG0 (o2 / organization 
                                          :name (n / name 
                                                :op1 "SMC")) 
                                    :ARG1 (b3 / b) 
                                    :ARG1-of (v2 / vary-01 
                                          :ARG2 (c / c))) 
                              :mod (e2 / either) 
                              :op1-of (i / i) 
                              :op1-of (f / f)) 
                        :mod (c3 / cell) 
                        :mod (m / marginal)) 
                  :op3 (b / barrier 
                        :mod (c2 / cell) 
                        :mod (b2 / basal)))))

# ::snt Both the basal cell ( f ) and the marginal cell ( h ) barriers appeared to be intact .
# ::tok Both the basal cell ( f ) and the marginal cell ( h ) barriers appeared to be intact .
# ::alignments 18-19|0.1 15-16|0 14-15|0.0.3 12-13|0.2 10-11|0.0.3.0 9-10|0.0.3.0.0 7-8|0.0 5-6|0.0.2 3-4|0.0.1 2-3|0.0.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:21.786
(a / appear-01 
      :ARG1 (a2 / and 
            :mod (b3 / both) 
            :op1 (c2 / cell 
                  :location (b2 / basal)) 
            :op2 (f / f) 
            :op3 (b / barrier 
                  :mod (c / cell 
                        :mod (m / marginal)))) 
      :ARG2 (i / intact) 
      :ARG3 (h / h))

# ::snt Blockage of the laser by pigmentation produces the untrue impression of ` holes ' in the marginal cell barrier ( e ) or basal cell barrier ( i ) .
# ::tok Blockage of the laser by pigmentation produces the untrue impression of ` holes ' in the marginal cell barrier ( e ) or basal cell barrier ( i ) .
# ::alignments 27-28|0.2.0 25-26|0.2.2.1 24-25|0.2.2.1.0 23-24|0.2.2.1.1 22-23|0.2.2 18-19|0.2.2.0 17-18|0.2.2.0.0 16-17|0.2.2.0.1 12-13|0.1 9-10|0 8-9|0.3 6-7|0.2 5-6|0.2.1 3-4|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:22.157
(i2 / impression-03 
      :ARG0 (b4 / blockage 
            :poss (l / laser)) 
      :ARG1 (h / hole) 
      :ARG1-of (p / produce-01 
            :ARG2 (i / i) 
            :manner (p2 / pigmentation) 
            :op1-of (o / or 
                  :op2 (b3 / barrier 
                        :mod (c2 / cell) 
                        :mod (m / marginal)) 
                  :op3 (b / barrier 
                        :mod (c / cell) 
                        :mod (b2 / basal)))) 
      :mod (u / untrue))

# ::snt Comparison of images is aided by marking three significant areas with colored stars .
# ::tok Comparison of images is aided by marking three significant areas with colored stars .
# ::alignments 12-13|0.1.0.1 11-12|0.1.0.1.0 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1.0.2 6-7|0.1 4-5|0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:22.265
(a2 / aid-01 
      :ARG1 (c2 / comparison 
            :poss (i / image)) 
      :ARG2 (m / mark-01 
            :ARG1 (a / area 
                  :ARG1-of (s2 / significant-02) 
                  :prep-with (s / star 
                        :ARG1-of (c / color-01)) 
                  :quant 3)))

# ::snt Bars = 10 m .
# ::tok Bars = 10 m .
# ::alignments 3-4|0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:22.274
(m / m 
      :domain (b / bar-01 
            :ARG1 10))

# ::snt Pendrin-expressing surface epithelial cells in the spiral prominence region are located in an area where basal cells , which are interconnected by tight junctions , form additional tight junctions with surface epithelial cells [ 29 ] .
# ::tok Pendrin-expressing surface epithelial cells in the spiral prominence region are located in an area where basal cells , which are interconnected by tight junctions , form additional tight junctions with surface epithelial cells [ 29 ] .
# ::alignments 34-35|0.0.1.1.0.0.0.0 32-33|0.1 31-32|0 30-31|0.1.0 28-29|0.0.0 27-28|0.0 26-27|0.0.0.0 25-26|0.0.1.0 23-24|0.0.1.1.0.0.1.0.0 22-23|0.0.1.1.0.0.1.0 20-21|0.0.1.1.0.0.1.0.0.0 16-17|0.0.1.1.0.0.1.0.0.0.0 15-16|0.0.1.1.0.0.1.0.0.0.0.0 13-14|0.0.1.1.0.0.0.1 10-11|0.0.1.1.0.0.0 8-9|0.0.1.1 7-8|0.0.1.1.0 6-7|0.0.1 3-4|0.0.1.1.0.0 2-3|0.0.1.1.0.0.2 1-2|0.0.1.1.0.0.1 0-1|0.0.1.1.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:22.768
(e / epithelial 
      :ARG2-of (t / tight-05 
            :ARG1 (j / junction 
                  :mod (a / additional)) 
            :ARG2-of (s2 / spiral-01 
                  :ARG0 (f / form) 
                  :ARG1 (r / region 
                        :mod (p / prominence 
                              :location-of (c3 / cell 
                                    :ARG1-of (l / locate-01 
                                          :ARG0 29 
                                          :location (a2 / area)) 
                                    :mod (s3 / surface 
                                          :ARG0-of (t2 / tight-05 
                                                :ARG1 (j2 / junction 
                                                      :ARG0-of (i / interconnect-01 
                                                            :ARG1 (c2 / cell 
                                                                  :mod (b / basal)))))) 
                                    :mod (e2 / epithelial) 
                                    :mod (p2 / pendrin-express)))))) 
      :mod-of (c / cell 
            :mod (s / surface)))

# ::snt A discontinuity of this complex junction in Slc26a4 - / - mice would explain the absence of the endocochlear potential .
# ::tok A discontinuity of this complex junction in Slc26a4 - / - mice would explain the absence of the endocochlear potential .
# ::alignments 19-20|0.1.1 18-19|0.1.1.0 15-16|0.1 13-14|0 11-12|0.1.1.0.0 9-10|0.2 5-6|0.0 4-5|0.0.1 3-4|0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:22.912
(e2 / explain-01 
      :ARG0 (j / junction 
            :mod (t / this) 
            :mod (c / complex)) 
      :ARG1 (a / absent-01 
            :ARG0 (d / discontinuity) 
            :ARG1 (p / potential 
                  :mod (e / endocochlear 
                        :mod (m / mouse)))) 
      :ARG2 (s / slash))

# ::snt To evaluate the presence of this connection , we determined by confocal immunocytochemistry the expression of ZO-1 and of F-actin , which associate with tight junction complexes .
# ::tok To evaluate the presence of this connection , we determined by confocal immunocytochemistry the expression of ZO-1 and of F-actin , which associate with tight junction complexes .
# ::alignments 26-27|0.1.0.0 25-26|0.1.0.0.0.0 24-25|0.1.0.0.0 22-23|0.1.0 17-18|0.1 16-17|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 14-15|0.1.1 12-13|0.2 9-10|0 8-9|0.0 6-7|0.3.0.0 5-6|0.3.0.0.0 3-4|0.3.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:23.632
(d / determine-01 
      :ARG0 (w / we) 
      :ARG1 (a2 / and 
            :ARG1-of (a / associate-01 
                  :ARG2 (c / complex 
                        :mod (t / tight-05 
                              :ARG1 (j / junction)))) 
            :op1 (e / express-01 
                  :ARG1 (t2 / thing 
                        :name (n / name 
                              :op1 "ZO-1")))) 
      :ARG2 (i / immunocytochemistry) 
      :time (e2 / evaluate-01 
            :ARG1 (p / presence 
                  :topic (c2 / connect-01 
                        :mod (t3 / this)))))

# ::snt ZO-1 and F-actin expression revealed a continuous layer of basal cells , including a junction of basal cells with surface epithelial cells in Slc26a4 - / - mice , as observed in normal mice ( Fig. 1c ,1 d ,1 e ,1 f ,6,7 ) .
# ::tok ZO-1 and F-actin expression revealed a continuous layer of basal cells , including a junction of basal cells with surface epithelial cells in Slc26a4 - / - mice , as observed in normal mice ( Fig. 1c ,1 d ,1 e ,1 f ,6,7 ) .
# ::alignments 42-43|0.2.0.0.0.1 40-41|0.2.0.0.0.2 38-39|0.2.0.0.0.0 35-36|0.3.0.0+0.3.0+0.3 33-34|0.0.1 32-33|0.0.1.0 30-31|0.0 27-28|0.0.0 25-26|0.2.1 23-24|0.2.0.1.1 21-22|0.2.0.1 20-21|0.2.0.1.3 19-20|0.2.0.1.2 17-18|0.2.0.1.0 16-17|0.2.0.1.0.1 14-15|0.2.0.1.0.0 10-11|0.2.0.0.1 9-10|0.2.0.0.1.0 7-8|0.2.0.0 6-7|0.2.0.0.0 4-5|0.2.0 3-4|0.2 1-2|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:24.907
(a / and 
      :ARG1-of (o / observe-01 
            :ARG2 (m2 / mouse) 
            :beneficiary (m / mouse 
                  :ARG1-of (n2 / normal-02))) 
      :op1 (t / thing 
            :name (n3 / name 
                  :op1 "ZO-1")) 
      :op2 (e3 / express-01 
            :ARG0-of (r / reveal-01 
                  :ARG1 (l / layer 
                        :ARG1-of (c5 / continue-01 
                              :ARG0 (d / d) 
                              :op1-of (f / f) 
                              :op1-of (e / e)) 
                        :domain (c4 / cell 
                              :mod (b2 / basal))) 
                  :ARG2 (c2 / cell 
                        :beneficiary-of (c3 / cell 
                              :domain-of (j / junction) 
                              :mod (b / basal)) 
                        :location (s2 / Slc26a4) 
                        :mod (s3 / surface) 
                        :mod (e2 / epithelial))) 
            :op1-of (s / slash)) 
      :op3 (c / country 
            :name (n / name 
                  :op1 "Fig.")))

# ::snt These observations make it unlikely that the primary cause of the loss of the endocochlear potential is a compromise in the basal cell barrier .
# ::tok These observations make it unlikely that the primary cause of the loss of the endocochlear potential is a compromise in the basal cell barrier .
# ::alignments 23-24|0.0.0.0.0.1 22-23|0.0.0.0.0.1.0 21-22|0.0.0.0.0.1.1 18-19|0.0.0.0.0 15-16|0.0.0.0 14-15|0.0.0 11-12|0.0 8-9|0 7-8|0.2 4-5|0.1.0+0.1 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:25.151
(c3 / cause-01 
      :ARG1 (l / loss 
            :poss (e / endocochlear 
                  :domain-of (p / potential 
                        :domain (c2 / compromise-01 
                              :ARG0 (o / observation 
                                    :mod (t / this)) 
                              :ARG1 (b / barrier 
                                    :mod (c / cell) 
                                    :mod (b2 / basal)))))) 
      :ARG1-of (l2 / likely-01 
            :polarity -) 
      :mod (p2 / primary))

# ::snt The observation that endolymphatic and perilymphatic K + concentrations were normal in Slc26a4 - / - mice suggests that stria vascularis was able to secrete K + in spite of the apparent signs of degeneration .
# ::tok The observation that endolymphatic and perilymphatic K + concentrations were normal in Slc26a4 - / - mice suggests that stria vascularis was able to secrete K + in spite of the apparent signs of degeneration .
# ::alignments 34-35|0.1.0.2 32-33|0.1.0.2.1 31-32|0.1.0.2.1.0 28-29|0.1.0.2.1.1 24-25|0.1.0 22-23|0.1 20-21|0.1.0.0 19-20|0.1.0.0.0 17-18|0 16-17|0.1.1.0.1 14-15|0.1.0.2.0 10-11|0.1.1.0 8-9|0.1.1.0.0 6-7|0.1.0.1 4-5|0.1.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:25.788
(s5 / suggest-01 
      :ARG0 (o / observation) 
      :ARG1 (p / possible-01 
            :ARG1 (s3 / secrete-01 
                  :ARG0 (v / vasculari 
                        :mod (s4 / stria)) 
                  :ARG1 (k / k) 
                  :manner (d / degenerate-01 
                        :ARG1 (s6 / slash) 
                        :topic-of (s / sign 
                              :mod (a / apparent) 
                              :poss-of (s2 / spite)))) 
            :op1-of (a2 / and 
                  :ARG0-of (n / normal-02 
                        :ARG1 (c / concentration) 
                        :manner (m / mouse)))))

# ::snt The rate of K + secretion necessary to maintain endolymphatic K + concentration , however , may be less than necessary in Slc26a4 + / + mice given the reduced numbers of sensory hair cells , which provide a major pathway for K + exit from endolymph [ 30,31 ] .
# ::tok The rate of K + secretion necessary to maintain endolymphatic K + concentration , however , may be less than necessary in Slc26a4 + / + mice given the reduced numbers of sensory hair cells , which provide a major pathway for K + exit from endolymph [ 30,31 ] .
# ::alignments 46-47|0.0.0.1.1 44-45|0.0.0.1 40-41|0.0.0 39-40|0.0.0.0 37-38|0.0 34-35|0.0.1.2 33-34|0.0.1.2.1 32-33|0.0.1.2.0 30-31|0.0.1 29-30|0.0.1.0 27-28|0.0.1.1 26-27|0.0.1.1.1 24-25|0.0.1.1.1.0 18-19|0.0.0.1.0 16-17|0 12-13|0.0.2 8-9|0.0.2.0 3-4|0.0.1.1.0 1-2|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:26.632
(p3 / possible-01 
      :ARG1 (p2 / provide-01 
            :ARG0 (p / pathway 
                  :ARG1-of (m / major-02) 
                  :beneficiary (e2 / exit-01 
                        :ARG1 (l / less) 
                        :location (e / endolymph))) 
            :ARG1 (n / number 
                  :ARG1-of (r / reduce-01) 
                  :ARG2-of (g / give-01 
                        :ARG0 (k / k) 
                        :ARG1 (m2 / mouse 
                              :op1-of (s2 / slash))) 
                  :mod (c / cell 
                        :mod (s / sensory) 
                        :mod (h / hair))) 
            :ARG1-of (c2 / concentrate-02 
                  :ARG1-of (m3 / maintain-01 
                        :ARG0 (r2 / rate)))))

# ::snt In order to substantiate the view that stria vascularis in Slc26a4 - / - secretes K + , we measured the magnitude of the bumetanide-sensitive current exiting stria vascularis across the apical membrane of strial marginal cells and determined the expression of the proteins KCNQ1 , KCNE1 and SLC12A2 , which are essential for K + secretion [ 20,32,33 ] , and of GJB2 ( Cx26 ) , which is thought to contribute to K + cycling [ 23 ] .
# ::tok In order to substantiate the view that stria vascularis in Slc26a4 - / - secretes K + , we measured the magnitude of the bumetanide-sensitive current exiting stria vascularis across the apical membrane of strial marginal cells and determined the expression of the proteins KCNQ1 , KCNE1 and SLC12A2 , which are essential for K + secretion [ 20,32,33 ] , and of GJB2 ( Cx26 ) , which is thought to contribute to K + cycling [ 23 ] .
# ::alignments 78-79|0.0 76-77|0.1.1 72-73|0.1 70-71|0 63-64|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 61-62|0.1.0.0.0.1.1.0 56-57|0.1.1.0 52-53|0.1.0.0.0.1.1.0.0 48-49|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 47-48|0.1.0 44-45|0.1.0.0.2.0+0.1.0.0.2+0.1.0.0 43-44|0.1.0.0.1 40-41|0.1.0.0.0 38-39|0.1.0.0.0.1 37-38|0.1.0.0.0.1.1 36-37|0.1.0.0.0.1.0.0.1.0.1 35-36|0.1.0.0.0.1.0.0.1.0.1.0 32-33|0.1.0.0.0.1.0.0.1.0 31-32|0.1.0.0.0.1.0.0.1.0.0 29-30|0.1.0.0.0.1.0.0.1 28-29|0.1.0.1.1 27-28|0.1.0.1.1.0 26-27|0.1.0.0.0.1.0.1.0.1 25-26|0.1.0.1.1.1 21-22|0.1.0.0.0.1.0.0.0 19-20|0.1.0.0.0.1.0.0 18-19|0.1.0.0.0.1.0 15-16|0.1.0.0.0.1.0.1.0.1.0 14-15|0.1.0.0.0.1.0.1.0.0 12-13|0.1.0.0.0.1.0.1.0.0.1 10-11|0.1.0.0.0.1.0.1.0.2 8-9|0.1.0.0.0.1.0.1.0.0.0 7-8|0.1.0.0.0.1.0.1.0.0.0.0 5-6|0.1.0.0.0.1.0.1.0 3-4|0.1.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:30.328
(t / think-01 
      :ARG0 23 
      :ARG1 (c2 / contribute-01 
            :op3-of (a2 / and 
                  :op1 (t3 / thing 
                        :ARG1-of (e2 / express-01 
                              :ARG0 (p / person 
                                    :name (n / name 
                                          :op1 "GJB2")) 
                              :ARG1-of (d / determine-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (m4 / measure-01 
                                                :ARG1 (m3 / magnitude) 
                                                :destination (a5 / across 
                                                      :op1 (m2 / membrane 
                                                            :mod (a4 / apical) 
                                                            :poss (c3 / cell 
                                                                  :mod (m / marginal))))) 
                                          :ARG0-of (s7 / substantiate-01 
                                                :ARG1 (v3 / view-02 
                                                      :ARG1 (s3 / secrete-01 
                                                            :ARG0 (v2 / vasculari 
                                                                  :mod (s6 / stria)) 
                                                            :ARG1 (s4 / slash)) 
                                                      :ARG1-of (e3 / exit-01 
                                                            :ARG0 (k / k)) 
                                                      :ARG2 (s5 / Slc26a4)))) 
                                    :op1-of (a3 / and 
                                          :op2 (a / and 
                                                :op1 (e / essential))))) 
                        :mod (p2 / protein) 
                        :name (n3 / name 
                              :op1 "KCNQ1")) 
                  :op2 (t2 / thing 
                        :name (n2 / name 
                              :op1 "SLC12A2") 
                        :poss-of (v / vasculari 
                              :mod (s2 / stria) 
                              :time (c4 / current)))) 
            :purpose (c / cycle-01 
                  :ARG1 (s / secretion))))

# ::snt K + secretion is known to be sensitive to 10-5 M bumetanide , a loop-diuretic that inhibits the Na + / 2Cl - / K + cotransporter SLC12A2 [ 26 ] .
# ::tok K + secretion is known to be sensitive to 10-5 M bumetanide , a loop-diuretic that inhibits the Na + / 2Cl - / K + cotransporter SLC12A2 [ 26 ] .
# ::alignments 29-30|0.0.0.0.1.0.0.1 26-28|0+0.0.1+0.0+0.0.0 23-24|0.0.0.0.2 20-21|0.0.0.1 18-19|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 16-17|0.0.0.0 11-12|0.0.0.0.1.0.0.0 10-11|0.0.0.0.1.0.0.0.0.1+0.0.0.0.1.0.0.0.0.0.0+0.0.0.0.1.0.0.0.0.0+0.0.0.0.1.0.0.0.0 7-8|0.0.0.0.1.0.0 4-5|0.0.0.0.1 2-3|0.0.0.0.1.0 0-1|0.0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:31.054
(s / SLC12A2 
      :op2-of (n / name 
            :name-of (t / thing 
                  :ARG0-of (i / inhibit-01 
                        :ARG1 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Na")) 
                        :ARG2-of (k / know-02 
                              :ARG1 (s5 / secretion 
                                    :ARG0-of (s4 / sensitive-03 
                                          :ARG1 (b / bumetanide 
                                                :mod (v / vehicle 
                                                      :name (n3 / name 
                                                            :op1 "M1") 
                                                      :wiki "M1_Abrams")) 
                                          :ARG2 26))) 
                        :manner (s2 / slash) 
                        :op1-of (k2 / k)) 
                  :op1-of (s3 / slash)) 
            :op1 (c / cotransporter)))

# ::snt Bumetanide-sensitive currents were found in both Slc26a4 + / + and Slc26a4 - / - mice although the magnitude of the current was significantly smaller in Slc26a4 - / - mice ( 22  6 A/cm2 , n = 4 versus 14  2 A/cm2 , n = 4 ) .
# ::tok Bumetanide-sensitive currents were found in both Slc26a4 + / + and Slc26a4 - / - mice although the magnitude of the current was significantly smaller in Slc26a4 - / - mice ( 22  6 A/cm2 , n = 4 versus 14  2 A/cm2 , n = 4 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:31.061
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt KCNQ1 and KCNE1 , subunits of the secretory K + channel , were co-localized in the apical membrane of strial marginal cells ; the Na + / 2Cl - / K + cotransporter SLC12A2 , which is located in the basolateral membrane of strial marginal cells , was found in stria vascularis ; and the gap junction protein GJB2 was found in spiral ligament of Slc26a4 + / + and Slc26a4 - / - mice ( Fig. 8 ) .
# ::tok KCNQ1 and KCNE1 , subunits of the secretory K + channel , were co-localized in the apical membrane of strial marginal cells ; the Na + / 2Cl - / K + cotransporter SLC12A2 , which is located in the basolateral membrane of strial marginal cells , was found in stria vascularis ; and the gap junction protein GJB2 was found in spiral ligament of Slc26a4 + / + and Slc26a4 - / - mice ( Fig. 8 ) .
# ::alignments 77-78|0.1.0.1.0.0 76-77|0.1.0.2.3.0.0+0.1.0.2.3.0+0.1.0.2.3 74-75|0.1.0.1.0.1 72-73|0.1.2 69-70|0.1.0.2.2 67-68|0.1.0.2.2.0 63-64|0.1.0.1 62-63|0.1.0.1.0 60-61|0.1.0 58-59|0.1.1.0+0.1.1+0.1 57-58|0 56-57|0.0 55-56|0.1.0.1.0.2 53-54|0.1.0.2 51-52|0.1.0.2.0.1 50-51|0.1.0.2.0.1.0 48-49|0.1.0.2.0 45-46|0.1.0.2.0.0.0.1.0 44-45|0.1.0.2.0.0.0.1.0.0 41-42|0.1.0.2.0.0.0.1 37-38|0.1.0.2.0.0.0 33-34|0.1.0.2.0.0.2.0+0.1.0.2.0.0.2+0.1.0.2.0.0 32-33|0.1.0.2.0.0.1 29-30|0.1.0.2.0.0.3 26-27|0.1.0.2.0.0.3.1 24-25|0.1.0.2.0.0.3.0.0.0+0.1.0.2.0.0.3.0.0+0.1.0.2.0.0.3.0 22-23|0.1.0.2.1 21-22|0.1.0.0.1.0.0.0.0.0 20-21|0.1.0.0.1.0.0.0.0 17-18|0.1.0.0.1.0.0.0.0.0.0 16-17|0.1.0.0.1.0.0.0.0.0.0.0 10-11|0.1.0.0.1.0.0 8-9|0.1.0.0.1.0.0.0 7-8|0.1.0.2.0.0.0.0 4-5|0.1.0.0.1.0 1-2|0.1.0.0.1 0-1|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:39.273
(p2 / protein 
      :mod (j / junction) 
      :mod-of (p / person 
            :ARG1-of (f / find-01 
                  :ARG0 (t3 / thing 
                        :name (n5 / name 
                              :op1 "KCNQ1") 
                        :op1-of (a5 / and 
                              :op2 (s8 / subunit 
                                    :poss (c5 / channel 
                                          :mod (k / k 
                                                :poss (m4 / marginal 
                                                      :mod-of (c4 / cell 
                                                            :poss-of (m5 / membrane 
                                                                  :mod (a4 / apical))))))))) 
                  :location (l / ligament 
                        :mod (s3 / spiral-01 
                              :ARG0 8 
                              :ARG1 (m / mouse) 
                              :mod-of (g / gap))) 
                  :op2-of (a2 / and 
                        :op1 (f2 / find-01 
                              :ARG1 (t / thing 
                                    :ARG1-of (l2 / locate-01 
                                          :ARG0 (s7 / secretory) 
                                          :location (m3 / membrane 
                                                :poss (c2 / cell 
                                                      :mod (m2 / marginal)))) 
                                    :mod (c3 / cotransport) 
                                    :name (n3 / name 
                                          :op1 "SLC12A2") 
                                    :op2-of (s5 / slash 
                                          :op1 (t2 / thing 
                                                :name (n4 / name 
                                                      :op1 "Na")) 
                                          :op1-of (s6 / slash))) 
                              :location (v / vasculari 
                                    :mod (s4 / stria))) 
                        :op1-of (a3 / and) 
                        :op1-of (a / and 
                              :op2 (s2 / slash)) 
                        :op3 (c / country 
                              :name (n / name 
                                    :op1 "Fig.")))) 
            :name (n2 / name 
                  :op1 "GJB2") 
            :op1-of (s / slash)))

# ::snt Co-localization of KCNQ1 and KCNE1 proteins was also observed in vestibular dark cells ( Fig. 1i ) .
# ::tok Co-localization of KCNQ1 and KCNE1 proteins was also observed in vestibular dark cells ( Fig. 1i ) .
# ::alignments 14-16|0.3.0.1+0.3.0.0+0.3.0+0.3 12-13|0.2.0 11-12|0.2.0.0 10-11|0.2.0.1 8-9|0.2 7-8|0.2.1 5-6|0.1 3-4|0 2-3|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:39.417
(a2 / and 
      :op1 (t2 / thing 
            :name (n2 / name 
                  :op1 "KCNQ1")) 
      :op2 (p / protein) 
      :op3 (o / observe-01 
            :ARG1 (c / cell 
                  :ARG1-of (d / dark-02) 
                  :mod (v / vestibular)) 
            :mod (a / also)) 
      :op4 (t / thing 
            :name (n / name 
                  :op1 (f / Fig.) 
                  :op2 1i)))

# ::snt Expression of KCNQ1 protein in stria vascularis of Slc26a4 - / - mice is consistent with the finding of KCNQ1 mRNA expression ( Fig. 3 ) .
# ::tok Expression of KCNQ1 protein in stria vascularis of Slc26a4 - / - mice is consistent with the finding of KCNQ1 mRNA expression ( Fig. 3 ) .
# ::alignments 24-25|0.1.1.1 21-22|0.1.1 20-21|0.1.1.0 17-18|0.1 14-15|0 12-13|0.0.0.0.0.0 10-11|0.1.0 6-7|0.0.0.0.0 5-6|0.0.0.0 3-4|0.0.0 2-3|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:39.624
(c / consistent-01 
      :ARG1 (e2 / expression 
            :mod (p / protein 
                  :location (s2 / stria 
                        :mod-of (v / vasculari 
                              :poss (m2 / mouse))) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "KCNQ1")))) 
      :ARG2 (f / find-01 
            :ARG0 (s / slash) 
            :ARG1 (e / express-01 
                  :ARG0 (m / mrna) 
                  :ARG1 3)))

# ::snt These observations make it unlikely that the primary cause of the loss of the endocochlear potential is a compromise of K + secretion by strial marginal cells or a compromise of gap junction mediated K + cycling .
# ::tok These observations make it unlikely that the primary cause of the loss of the endocochlear potential is a compromise of K + secretion by strial marginal cells or a compromise of gap junction mediated K + cycling .
# ::alignments 36-37|0.0 33-34|0.0.2 32-33|0 31-32|0.1 29-30|0.0.1 27-28|0.0.1.0 26-27|0.0.1.0.2 25-26|0.0.1.0.2.0 22-23|0.0.1.0.0.0 20-21|0.0.1.0.1 18-19|0.0.1.0.0 15-16|0.0.0 14-15|0.0.0.0 11-12|0.0.1.0.0.1.1 8-9|0.0.1.0.0.1 7-8|0.0.1.0.0.1.2 4-5|0.0.1.0.0.1.0.1+0.0.1.0.0.1.0 1-2|0.0.1.0.0.1.0.0 0-1|0.0.1.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:39.983
(j / junction 
      :ARG1-of (c / cycle-01 
            :ARG0 (p / potential 
                  :mod (e / endocochlear)) 
            :ARG1-of (c2 / compromise-01 
                  :op3-of (o / or 
                        :ARG0-of (c4 / compromise-01 
                              :ARG1 (s / secretion) 
                              :ARG2-of (c5 / cause-01 
                                    :ARG0-of (l2 / likely-01 
                                          :ARG1 (o2 / observation 
                                                :mod (t / this)) 
                                          :polarity -) 
                                    :ARG1 (l / loss) 
                                    :mod (p2 / primary))) 
                        :op1 (k / k) 
                        :op2 (c3 / cell 
                              :mod (m2 / marginal)))) 
            :ARG1-of (m / mediate-01)) 
      :mod (g / gap))

# ::snt Protein localization of KCNQ1 , KCNE1 , SLC12A2 and GJB2 in the cochlear lateral wall of Slc26a4 + / + and Slc26a4 - / - mice .
# ::tok Protein localization of KCNQ1 , KCNE1 , SLC12A2 and GJB2 in the cochlear lateral wall of Slc26a4 + / + and Slc26a4 - / - mice .
# ::alignments 25-26|0.0.1.0 23-24|0.0.1 20-21|0 18-19|0.0.2.0.1 14-15|0.0.3 13-14|0.0.3.0 12-13|0.0.3.1 9-10|0.0.0.0+0.0.0+0.0 8-9|0.0.2 7-8|0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 3-4|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 1-2|0.0.2.0.2 0-1|0.0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:40.100
(a / and 
      :op1 (p / person 
            :name (n / name 
                  :op1 "GJB2") 
            :op1-of (s / slash 
                  :mod-of (m / mouse)) 
            :op3-of (a2 / and 
                  :op1 (t2 / thing 
                        :name (n3 / name 
                              :op1 "KCNQ1") 
                        :op1-of (s2 / slash) 
                        :poss-of (l2 / localization 
                              :mod (p2 / protein))) 
                  :op2 (t / thing 
                        :name (n2 / name 
                              :op1 "SLC12A2"))) 
            :poss (w / wall 
                  :mod (l / lateral) 
                  :mod (c / cochlear))))

# ::snt a-f : bars : 10 m .
# ::tok a-f : bars : 10 m .
# ::alignments 5-6|0 4-5|0.1 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:40.111
(m / m 
      :mod-of (b / bar) 
      :quant 10)

# ::snt SMC , strial marginal cells ; SV , stria vascularis ; BC , basal cells ; SL , spiral ligament .
# ::tok SMC , strial marginal cells ; SV , stria vascularis ; BC , basal cells ; SL , spiral ligament .
# ::alignments 19-20|0.2 18-19|0 16-17|0.0.3.1+0.0.3.0.0+0.0.3.0+0.0.3 14-15|0.1.0 13-14|0.1 11-12|0.0.2 9-10|0.3.0 8-9|0.3 6-7|0.0.1.0.0+0.0.1.0+0.0.1 5-6|0.0 4-5|0.4.0 3-4|0.4 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:40.301
(s / spiral-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n3 / name 
                        :op1 "SMC")) 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "SV")) 
            :op3 "BC" 
            :op4 (c / country 
                  :name (n / name 
                        :op1 "SL") 
                  :wiki "Sri_Lanka")) 
      :ARG1 (b / basal 
            :mod-of (c2 / cell)) 
      :mod-of (l / ligament) 
      :op1-of (s2 / stria 
            :mod-of (v / vasculari)) 
      :op1-of (m / marginal 
            :mod-of (c3 / cell)))

# ::snt We described locations of pendrin expression in the cochlea and vestibular labyrinth and detected normal endolymphatic K + concentrations in spite of an enlargement of this fluid compartment .
# ::tok We described locations of pendrin expression in the cochlea and vestibular labyrinth and detected normal endolymphatic K + concentrations in spite of an enlargement of this fluid compartment .
# ::alignments 27-28|0.1.0 26-27|0.1.0.0 25-26|0.1.0.1 23-24|0.0.0.0.0 20-21|0.0.0.0 18-19|0.1.1 16-17|0.0.1.0.1 14-15|0.1.1.0 13-14|0.1 12-13|0 11-12|0.1.2.2 10-11|0.1.2.1 9-10|0.1.2 8-9|0.1.2.0 5-6|0.0.1.0 4-5|0.0.1.0.0 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:40.483
(a / and 
      :op1 (d2 / describe-01 
            :ARG0 (w / we 
                  :poss-of (s / spite 
                        :poss (e / enlargement))) 
            :ARG1 (l2 / location 
                  :location-of (e2 / express-01 
                        :ARG0 (p / pendrin) 
                        :ARG1 (k / k)))) 
      :op2 (d / detect-01 
            :ARG0 (c / compartment 
                  :mod (f / fluid) 
                  :mod (t / this)) 
            :ARG1 (c2 / concentration 
                  :ARG1-of (n / normal-02)) 
            :op4-of (a2 / and 
                  :op1 (c3 / cochlea) 
                  :op2 (v / vestibular) 
                  :op3 (l / labyrinth))))

# ::snt We found that Slc26a4 - / - mice lack the endocochlear potential because they do not express KCNJ10 protein .
# ::tok We found that Slc26a4 - / - mice lack the endocochlear potential because they do not express KCNJ10 protein .
# ::alignments 18-19|0.0.1 17-18|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 16-17|0.0 15-16|0.0.2 13-14|0.0.0 12-13|0 11-12|0.1.1 8-9|0.1 7-8|0.1.0 5-6|0.0.1.0.1 1-2|0.1.1.0 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:40.906
(c / cause-01 
      :ARG0 (e / express-01 
            :ARG0 (t2 / they) 
            :ARG1 (p / protein 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "KCNJ10") 
                        :op1-of (s / slash))) 
            :polarity -) 
      :ARG1 (l / lack-01 
            :ARG0 (m / mouse) 
            :ARG1 (p2 / potential 
                  :ARG1-of (f / find-01 
                        :ARG0 (w / we)))))

# ::snt Intermediate cells protect stria vascularis by converting CO2 to HCO3 - and by detoxifying free radicals ( Fig. 9 ) .
# ::tok Intermediate cells protect stria vascularis by converting CO2 to HCO3 - and by detoxifying free radicals ( Fig. 9 ) .
# ::alignments 18-19|0.0.1.2.0 15-16|0.0.1.2.1 14-15|0.0.1.2 13-14|0.0.1.2.1.0 11-12|0 7-8|0.0.0 6-7|0.0 4-5|0.0.1.1 3-4|0.0.1.1.0 2-3|0.0.1 1-2|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:41.062
(a / and 
      :op1 (c2 / convert-01 
            :ARG1 (c / co2) 
            :manner-of (p / protect-01 
                  :ARG0 (c3 / cell 
                        :mod (i / intermediate)) 
                  :ARG1 (v / vasculari 
                        :mod (s / stria)) 
                  :ARG2-of (f / free-04 
                        :ARG0 9 
                        :ARG1 (r / radical 
                              :mod (d / detoxify))))))

# ::snt CO2 and free radicals are generated by the large numbers of mitochondria in the metabolically highly active strial marginal cells .
# ::tok CO2 and free radicals are generated by the large numbers of mitochondria in the metabolically highly active strial marginal cells .
# ::alignments 19-20|0.2 18-19|0.2.1 16-17|0.2.0 15-16|0.2.0.0 14-15|0.2.2 11-12|0.0.1 9-10|0.0 8-9|0.0.0 5-6|0 3-4|0.1 2-3|0.1.0 1-2|0.1.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:41.347
(g / generate-01 
      :ARG0 (n / number 
            :mod (l / large) 
            :quant-of (m3 / mitochondrion)) 
      :ARG1 (r / radical 
            :ARG1-of (f / free-04 
                  :op2-of (a2 / and 
                        :op1 (c2 / co2)))) 
      :ARG2 (c / cell 
            :ARG1-of (a / activity-06 
                  :degree (h / high)) 
            :mod (m / marginal) 
            :mod (m2 / metabolically)))

# ::snt Intermediate cells employ carbonic anhydrase to convert CO2 to HCO3 - [ 18,19 ] and catalase to detoxify free radicals .
# ::tok Intermediate cells employ carbonic anhydrase to convert CO2 to HCO3 - [ 18,19 ] and catalase to detoxify free radicals .
# ::alignments 19-20|0.1.1.0 18-19|0.1.1.0.0 14-15|0.1.1.2 7-8|0.1.1.1 6-7|0.1.1 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:41.498
(e / employ-02 
      :ARG0 (c4 / cell 
            :mod (i / intermediate)) 
      :ARG1 (a2 / anhydrase 
            :mod (c3 / carbonic) 
            :purpose (c2 / convert-01 
                  :ARG0 (r / radical 
                        :ARG1-of (f / free-04)) 
                  :ARG1 (c / co2) 
                  :op1-of (a / and))))

# ::snt To protect themselves from free radical damage , intermediate cells generate glutathione and melanin pigment [ 34-37 ] .
# ::tok To protect themselves from free radical damage , intermediate cells generate glutathione and melanin pigment [ 34-37 ] .
# ::alignments 14-15|0.2.0.0.0 13-14|0.2.0.0 12-13|0.1 11-12|0.1.0 10-11|0 9-10|0.0 8-9|0.0.0 6-7|0.2.0 5-6|0.2.0.2 4-5|0.2.0.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:41.691
(g2 / generate-01 
      :ARG0 (c / cell 
            :mod (i / intermediate)) 
      :ARG1 (a / and 
            :op1 (g / glutathione)) 
      :purpose (p2 / protect-01 
            :ARG2 (d / damage-01 
                  :ARG1 (m / melanin 
                        :mod-of (p / pigment)) 
                  :ARG1-of (f / free-04) 
                  :mod (r / radical))))

# ::snt It is conceivable that loss of pendrin , which may secrete HCO3 - into endolymph , results in an accumulation of HCO3 - and an alkalinization of the intrastrial spaces .
# ::tok It is conceivable that loss of pendrin , which may secrete HCO3 - into endolymph , results in an accumulation of HCO3 - and an alkalinization of the intrastrial spaces .
# ::alignments 29-30|0.1.0.1.0.0.0 25-26|0.1.0.1.0.0 23-24|0.1.0.1.0 19-20|0.0 16-17|0+0.1 14-15|0.1.0.1.0.0.0.0 10-11|0.1.0 9-10|0.1.0.1 6-7|0.1.0.0.2 4-5|0.1.0.0 3-4|0.1.0.0.1 2-3|0.1.0.0.0 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:42.148
(r / result-01 
      :ARG1 (a3 / accumulation) 
      :ARG2 (t / thing 
            :ARG1-of (s2 / secrete-01 
                  :ARG0 (l / loss 
                        :ARG1-of (c / conceive-01 
                              :ARG0 (i / it)) 
                        :mod (t2 / that) 
                        :mod (p2 / pendrin)) 
                  :ARG1-of (p / possible-01 
                        :op1-of (a2 / and 
                              :op2 (a / alkalinization 
                                    :ARG1-of (s / space-01 
                                          :ARG0 (e / endolymph))))))))

# ::snt This extracellular alkalinization may enhance free radical stress , since it may inhibit the uptake of cysteine and thereby limit production of the protective glutathione [ 38 ] .
# ::tok This extracellular alkalinization may enhance free radical stress , since it may inhibit the uptake of cysteine and thereby limit production of the protective glutathione [ 38 ] .
# ::alignments 26-27|0.0.1.0.0 24-25|0.1.2.0.0 23-24|0.1.2.0.0.0 20-21|0.1.2.0 19-20|0.1.2 18-19|0.1.2.1 17-18|0.1 16-17|0.1.1.0.0 14-15|0.1.1.0 12-13|0.1.1 11-12|0.1.0 9-10|0.1.1.1 7-8|0.0.1 6-7|0.0.1.1 5-6|0.0.1.0 4-5|0.0 3-4|0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:42.848
(p4 / possible-01 
      :ARG1 (e / enhance-01 
            :ARG0 (a2 / alkalinization 
                  :mod (e2 / extracellular) 
                  :mod (t2 / this)) 
            :ARG1 (s2 / stress-02 
                  :ARG1-of (f / free-04 
                        :ARG0 38) 
                  :mod (r / radical))) 
      :op1-of (a / and 
            :ARG1-of (p3 / possible-01) 
            :op2 (i / inhibit-01 
                  :ARG1 (u / uptake 
                        :mod (c / cysteine)) 
                  :op1-of (s / since)) 
            :op3 (l / limit-01 
                  :ARG1 (p2 / produce-01 
                        :ARG1 (g / glutathione 
                              :mod (p / protect-01))) 
                  :manner (t / thereby))))

# ::snt Support for the hypothesis of enhanced free radical stress comes from the observed hyperpigmentation in mice lacking pendrin .
# ::tok Support for the hypothesis of enhanced free radical stress comes from the observed hyperpigmentation in mice lacking pendrin .
# ::alignments 17-18|0.3.1 16-17|0.3 15-16|0.3.0 13-14|0.2 12-13|0.2.0 9-10|0 8-9|0.0 7-8|0.0.1 6-7|0.0.0 5-6|0.0.0.0 3-4|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:43.051
(c / come-01 
      :ARG0 (s / stress-02 
            :ARG1-of (f / free-04 
                  :ARG1-of (e / enhance-01)) 
            :mod (r / radical)) 
      :ARG1 (s2 / support-01 
            :ARG1 (h2 / hypothesi)) 
      :ARG3 (h / hyperpigmentation 
            :ARG1-of (o / observe-01)) 
      :manner (l / lack-01 
            :ARG0 (m / mouse) 
            :ARG1 (p / pendrin)))

# ::snt Strial hyperpigmentation has also been observed in other conditions that are associated with free radical stress , such as acoustic trauma [ 37 ] .
# ::tok Strial hyperpigmentation has also been observed in other conditions that are associated with free radical stress , such as acoustic trauma [ 37 ] .
# ::alignments 22-23|0.2.0.0.0 20-21|0.2.0.0.1 19-20|0.0 17-18|0.2.0.0.2.0 15-16|0.2.0.0 14-15|0.2.0.0.3 13-14|0.2.0.0.2 11-12|0.2.0 8-9|0.2 7-8|0.2.1 5-6|0 3-4|0.3 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:43.231
(o2 / observe-01 
      :ARG0 (a / acoustic) 
      :ARG1 (h / hyperpigmentation) 
      :ARG2 (c / condition 
            :ARG1-of (a2 / associate-01 
                  :ARG2 (s2 / stress-02 
                        :ARG0 37 
                        :ARG1 (t / trauma) 
                        :ARG1-of (f / free-04 
                              :ARG0 (s / such)) 
                        :mod (r / radical))) 
            :mod (o / other)) 
      :mod (a3 / also))

# ::snt Alterations in the cytosolic pH in conjunction with free radical stress may lead to the loss of KCNJ10 protein expression in strial intermediate cells .
# ::tok Alterations in the cytosolic pH in conjunction with free radical stress may lead to the loss of KCNJ10 protein expression in strial intermediate cells .
# ::alignments 23-24|0.0.0 22-23|0.0.0.0 19-20|0.0 18-19|0 17-18|0.0.1.0.1.1.0.0+0.0.1.0.1.1.0+0.0.1.0.1.1 15-16|0.0.1 12-13|0.0.1.0 11-12|0.0.1.0.2 10-11|0.0.1.0.1 9-10|0.0.1.0.1.3 8-9|0.0.1.0.1.2 6-7|0.0.1.0.1.4 4-5|0.0.1.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:43.511
(p / protein 
      :ARG0-of (e / express-01 
            :ARG1 (c / cell 
                  :mod (i / intermediate)) 
            :mod-of (l / loss 
                  :ARG2-of (l2 / lead-03 
                        :ARG0 (a / alteration) 
                        :ARG1 (s / stress-02 
                              :ARG0 (p3 / ph) 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "KCNJ10")) 
                              :ARG1-of (f / free-04) 
                              :mod (r / radical) 
                              :prep-with-of (c2 / conjunction)) 
                        :ARG1-of (p2 / possible-01)))))

# ::snt Function and expression of other K + channels has been shown to be controlled by the cytosolic pH and free radicals , which encode the metabolic state of the cell [ 39 ] .
# ::tok Function and expression of other K + channels has been shown to be controlled by the cytosolic pH and free radicals , which encode the metabolic state of the cell [ 39 ] .
# ::alignments 31-32|0.0 29-30|0.2.0.1.1 26-27|0.2.0.2 25-26|0.2.0.2.1 23-24|0.2.0.2.0 20-21|0.2.0.1 19-20|0.2.0.1.0 18-19|0.2.0 17-18|0.2.0.0 13-14|0.2 10-11|0 7-8|0.2.1.0 5-6|0.1.0.0 4-5|0.2.0.0.0 2-3|0.1.0 1-2|0.1 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:44.007
(s2 / show-01 
      :ARG0 39 
      :ARG1 (a2 / and 
            :op1 (e2 / express-01 
                  :ARG1 (k / k))) 
      :ARG2 (c2 / control-01 
            :ARG0 (a / and 
                  :op1 (p / ph 
                        :poss (o / other)) 
                  :op2 (r / radical 
                        :ARG1-of (f / free-04) 
                        :name-of (c / cell)) 
                  :op3 (s / state 
                        :ARG1-of (e / encode-01) 
                        :mod (m / metabolic))) 
            :ARG1 (f2 / function-01 
                  :ARG1 (c3 / channel))))

# ::snt Suppression of the KCNJ10 K + channel in strial intermediate cells , which is essential for the generation of the endocochlear potential , is probably the direct cause of deafness in Slc26a4 - / - mice and patients suffering from Pendred syndrome .
# ::tok Suppression of the KCNJ10 K + channel in strial intermediate cells , which is essential for the generation of the endocochlear potential , is probably the direct cause of deafness in Slc26a4 - / - mice and patients suffering from Pendred syndrome .
# ::alignments 41-42|0.4.0.1 40-41|0.4.0.1.0 38-39|0.4.0 37-38|0.4.0.0.1.0.0+0.4.0.0.1.0+0.4.0.0.1 36-37|0.4.0.0 35-36|0.4.0.0.0 33-34|0.0.0.0.1.1 31-32|0.4 29-30|0.1 27-28|0 26-27|0.2 24-25|0.3 21-22|0.0.1.0 20-21|0.0.1.0.0 17-18|0.0.1 14-15|0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 6-7|0.0.0.0 3-5|0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.102
(c / cause-01 
      :ARG0 (e2 / essential 
            :location (s5 / suppression 
                  :poss (c3 / channel 
                        :location (c2 / cell 
                              :mod (i / intermediate)) 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 (k / KCNJ10) 
                                    :op2 (k2 / K)) 
                              :op1-of (s3 / slash)))) 
            :purpose (g / generation 
                  :consist-of (p5 / potential 
                        :mod (e / endocochlear)))) 
      :ARG1 (d / deafnes) 
      :ARG1-of (d2 / direct-02) 
      :domain-of (p4 / probable) 
      :location (s4 / Slc26a4 
            :ARG0-of (s2 / suffer-01 
                  :ARG1 (a / and 
                        :op1 (m / mouse) 
                        :op2 (p2 / person 
                              :ARG0-of (h / have-rel-role-91 
                                    :ARG2 (p3 / patient)))) 
                  :source (s / syndrome 
                        :mod (p / pendr)))))

# ::snt Model for the loss of KCNJ10 in the absence of pendrin expression in stria vascularis .
# ::tok Model for the loss of KCNJ10 in the absence of pendrin expression in stria vascularis .
# ::alignments 14-15|0.0.0.0.0 13-14|0.0.0.0.0.0 11-12|0.0.0.0 8-9|0.0.0 5-6|0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.201
(m / model-01 
      :ARG1 (l / loss 
            :ARG0-of (a / absent-01 
                  :ARG1 (e / express-01 
                        :ARG1 (v / vasculari 
                              :mod (s / stria)))) 
            :poss (t / thing 
                  :name (n / name 
                        :op1 "KCNJ10"))))

# ::snt Cys , cysteine , Glu , glutamate , Gly , glycine , CA , carbonic anhydrase , GST , glutathione-S-transferase , GSH , glutathione .
# ::tok Cys , cysteine , Glu , glutamate , Gly , glycine , CA , carbonic anhydrase , GST , glutathione-S-transferase , GSH , glutathione .
# ::alignments 17-18|0.0.5 15-16|0.0.1 14-15|0.0 12-13|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 10-11|0.0.3 6-7|0.0.2 2-3|0.0.4 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.256
(c3 / cy 
      :domain (c / carbonic 
            :mod-of (s / state 
                  :name (n / name 
                        :op1 "CA") 
                  :wiki "California") 
            :mod-of (a / anhydrase) 
            :op1 (g3 / glutamate) 
            :op2 (g2 / glycine) 
            :poss (c2 / cysteine) 
            :poss (g / GST)))

# ::snt None declared .
# ::tok None declared .
# ::alignments 1-2|0 0-1|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.264
(d / declare-01 
      :ARG0 (p / person 
            :quant (n / none)))

# ::snt PW designed and coordinated the immunocytochemical , morphometrical and molecular biological experiments .
# ::tok PW designed and coordinated the immunocytochemical , morphometrical and molecular biological experiments .
# ::alignments 11-12|0.0 10-11|0.0.0 9-10|0.0.1 8-9|0.1.0 7-8|0.1.0.0 5-6|0.2.0 3-4|0.1 2-3|0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.313
(a2 / and 
      :ARG1-of (e / experiment-01 
            :mod (b / biology) 
            :mod (m / molecule)) 
      :ARG2-of (c / coordinate-01 
            :ARG1 (a / and 
                  :op1 (m2 / morphometrical))) 
      :op1 (d / design-01 
            :ARG1 (i / immunocytochemical)))

# ::snt EMI and BA carried out confocal immunocytochemistry on cryosections .
# ::tok EMI and BA carried out confocal immunocytochemistry on cryosections .
# ::alignments 8-9|0.2 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.401
(c3 / carry-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "EMI")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "BA"))) 
      :ARG1 (i / immunocytochemistry 
            :mod (c2 / confocal)) 
      :location (c / cryosection))

# ::snt SJ and SVJ carried out confocal microscopy on whole-mounts of stria vascularis .
# ::tok SJ and SVJ carried out confocal microscopy on whole-mounts of stria vascularis .
# ::alignments 11-12|0.2.0 10-11|0.2 8-9|0.2.0.0 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.520
(c2 / carry-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "SJ")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "SVJ"))) 
      :ARG1 (m / microscopy 
            :mod (c / confocal)) 
      :location (s / stria 
            :mod-of (v / vasculari 
                  :mod-of (w / whole-mount))))

# ::snt SVJ and RJM carried out quantitative RT-PCR .
# ::tok SVJ and RJM carried out quantitative RT-PCR .
# ::alignments 6-7|0.1.1.0+0.1.1+0.1 5-6|0.1.0 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.608
(c / carry-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n3 / name 
                        :op1 "SVJ")) 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "RJM"))) 
      :ARG1 (t / thing 
            :mod (q / quantitative) 
            :name (n / name 
                  :op1 "RT-PCR")))

# ::snt DCM designed and coordinated electrophysiological experiments .
# ::tok DCM designed and coordinated electrophysiological experiments .
# ::alignments 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.0.0 2-3|0 1-2|0.0 0-1|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.638
(a / and 
      :op1 (d / design-01 
            :ARG0 (o / organization 
                  :ARG0-of (c / coordinate-01 
                        :ARG1 e) 
                  :name (n / name 
                        :op1 "DCM")) 
            :ARG1 (e / experiment-01 
                  :ARG1 (e2 / electrophysiological))))

# ::snt TW carried out measurements of the endocochlear potential and the endolymphatic K + concentration .
# ::tok TW carried out measurements of the endocochlear potential and the endolymphatic K + concentration .
# ::alignments 13-14|0.1.0.0 11-12|0.1.0.0.0 8-9|0.0 7-8|0.1.0.1 6-7|0.1.0 3-4|0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.870
(c2 / carry-01 
      :ARG1 (a / and) 
      :ARG3 (m / measure-01 
            :ARG1 (e / endocochlear 
                  :ARG1-of (c / concentrate-02 
                        :ARG0 (k / k)) 
                  :domain-of (p / potential))))

# ::snt JHL carried out current measurements on strial marginal cells .
# ::tok JHL carried out current measurements on strial marginal cells .
# ::alignments 8-9|0.0.0 7-8|0.0.0.0 4-5|0.0 3-4|0.0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.891
(c3 / carry-01 
      :ARG1 (m2 / measure-01 
            :ARG1 (c / cell 
                  :mod (m / marginal)) 
            :time (c2 / current)))

# ::snt SMW , LAE , IER and EDG provided the mice and the pendrin-specific antibody .
# ::tok SMW , LAE , IER and EDG provided the mice and the pendrin-specific antibody .
# ::alignments 13-14|0.0.1 10-11|0.1 9-10|0.2 7-8|0 5-6|0.0 4-5|0.0.0 2-3|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.965
(p / provide-01 
      :ARG0 (a3 / and 
            :op1 (i / i) 
            :op2 (a / antibody)) 
      :ARG1 (a2 / and 
            :op1 (c / country 
                  :name (n / name 
                        :op1 "LAE"))) 
      :ARG2 (m / mouse))

# ::snt PW and DCM conceived the study .
# ::tok PW and DCM conceived the study .
# ::alignments 5-6|0.0.0 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.990
(c / conceive-01 
      :ARG1 (a / and 
            :ARG1-of (s / study-01) 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "DCM"))))

# ::snt PW wrote the manuscript .
# ::tok PW wrote the manuscript .
# ::alignments 3-4|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:45.997
(w / write-01 
      :ARG1 (m / manuscript))

# ::snt All authors read and approved the final manuscript .
# ::tok All authors read and approved the final manuscript .
# ::alignments 7-8|0.1.0.0 6-7|0.1.0.0.0 4-5|0.1.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:46.072
(r / read-01 
      :ARG1 (a3 / author-01 
            :mod (a4 / all)) 
      :op1-of (a2 / and 
            :ARG0-of (a / approve-01 
                  :ARG1 (m / manuscript 
                        :mod (f / final)))))

# ::snt The pre-publication history for this paper can be accessed here : .
# ::tok The pre-publication history for this paper can be accessed here : .
# ::alignments 9-10|0.0.1 8-9|0.0 6-7|0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:46.113
(p / possible-01 
      :ARG1 (a / access-01 
            :ARG1 (h2 / history 
                  :topic (p2 / paper 
                        :mod (t / this))) 
            :location (h / here)))

# ::snt This work was supported by NIH-R01-DC01098 ( PW ) , NIH-R01-DC00212 ( DCM ) , NIH-R01-DK52935 ( SMW ) and Core facilities funded by NIH-P20-RR017686 ( Confocal Microfluorometry and Microscopy Core , Molecular Biology Core ) are gratefully acknowledged .
# ::tok This work was supported by NIH-R01-DC01098 ( PW ) , NIH-R01-DC00212 ( DCM ) , NIH-R01-DK52935 ( SMW ) and Core facilities funded by NIH-P20-RR017686 ( Confocal Microfluorometry and Microscopy Core , Molecular Biology Core ) are gratefully acknowledged .
# ::alignments 38-39|0.0.0.0.0.0.0.1.0 37-38|0.0.0.0.0.0.0.1.0.0 32-35|0.3.0.2+0.3.0.1+0.3.0.0+0.3.0+0.3 30-31|0.2 29-30|0.2.0 28-29|0 26-28|0.1.0.1+0.1.0.0+0.1.0+0.1 24-25|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 22-23|0.0.0.0.0.0 21-22|0.0.0.0.0.0.0 20-21|0.0.0.0.0.0.0.0 19-20|0.0.0.0.0.0.0.1 15-16|0.0.0.0.0.0.0.1.3.0.0+0.0.0.0.0.0.0.1.3.0+0.0.0.0.0.0.0.1.3 12-13|0.0.0.0.0.0.0.1.2.0.0+0.0.0.0.0.0.0.1.2.0+0.0.0.0.0.0.0.1.2 10-11|0.0.0.0.0.0.0.1.1.0.0+0.0.0.0.0.0.0.1.1.0+0.0.0.0.0.0.0.1.1 5-6|0.0.1.0+0.0.1+0.0 3-4|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:48:48.751
(a2 / and 
      :op1 (p5 / person 
            :ARG0-of (s / support-01 
                  :ARG1 (w / work-01 
                        :ARG0 (p2 / person 
                              :ARG0-of (f / fund-01 
                                    :ARG1 (f2 / facility 
                                          :ARG0-of (c2 / core-01) 
                                          :op4-of (a3 / and 
                                                :ARG1-of (a / acknowledge-01 
                                                      :manner (g / grateful)) 
                                                :op1 (p4 / person 
                                                      :name (n6 / name 
                                                            :op1 "NIH-R01-DC00212")) 
                                                :op2 (o2 / organization 
                                                      :name (n5 / name 
                                                            :op1 "DCM")) 
                                                :op3 (p3 / person 
                                                      :name (n4 / name 
                                                            :op1 "NIH-R01-DK52935"))))) 
                              :name (n3 / name 
                                    :op1 "NIH-P20-RR017686")) 
                        :mod (t / this))) 
            :name (n7 / name 
                  :op1 "NIH-R01-DC01098")) 
      :op2 (p / person 
            :name (n2 / name 
                  :op1 "Confocal" 
                  :op2 "Microfluorometry")) 
      :op3 (c / core-01 
            :ARG1 (m / microscopy)) 
      :op4 (o / organization 
            :name (n / name 
                  :op1 "Molecular" 
                  :op2 "Biology" 
                  :op3 "Core")))

